Cinemark Usa 10-K 21 Feb 20 2019 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Feb. 20, 2020	Jun. 30, 2019
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	0000885975
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Public Float			$ 0
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity File Number	33-47040
Entity Tax Identification Number	75-2206284
Entity Address, Address Line One	3900 Dallas Parkway
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75093
City Area Code	972
Local Phone Number	665-1000
Entity Incorporation, State or Country Code	TX
Document Annual Report	true
Document Transition Report	false
Documents Incorporated by Reference	Certain portions of the definitive proxy statement of Cinemark Holdings, Inc. the registrant’s parent company, to be filed within 120 days of December 31, 2019, are incorporated by reference into Part III, Items 10-14, of this annual report on Form 10-K.
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents		$ 488,215	$ 426,216
Inventories		21,686	19,319
Accounts receivable		83,722	95,076
Current income tax receivable		4,082	3,288
Prepaid expenses and other		37,187	15,114
Accounts receivable from parent		24,319	19,530
Total current assets		659,211	578,543
Theatre properties and equipment
Land		105,035	103,739
Buildings		536,037	522,355
Property under capital and finance leases		152,519	387,480
Theatre furniture and equipment		1,337,715	1,239,122
Leasehold interests and improvements		1,216,931	1,151,454
Total		3,348,237	3,404,150
Less: accumulated depreciation and amortization		1,612,990	1,571,017
Theatre properties and equipment, net		1,735,247	1,833,133
Operating Lease right-of-use assets	[1]	1,383,080
Other assets
Goodwill	[2]	1,283,371	1,276,324
Intangible assets - net		321,769	330,910
Investments in and advances to affiliates		155,285	156,766
Long-term deferred tax asset		9,369	9,028
Deferred charges and other assets - net		39,114	41,055
Total other assets		2,074,700	2,089,675
Total assets		5,852,238	4,501,351
Current liabilities
Current portion of long-term debt		6,595	7,984
Current portion of operating lease obligations	[1]	217,406
Current portion of capital and finance lease obligations		15,432	27,065
Current income tax payable		5,195	12,179
Current liability for uncertain tax positions		13,446	573
Accounts payable		91,587	104,615
Accrued film rentals		93,849	95,754
Accrued payroll		55,227	46,500
Accrued property taxes		34,337	31,154
Accrued other current liabilities		175,097	148,229
Total current liabilities		708,171	474,053
Long-term liabilities
Long-term debt, less current portion		1,771,342	1,772,627
Operating lease obligations, less current portion	[1]	1,223,462
Capital and finance lease obligations, less current portion		141,017	232,467
Long-term deferred tax liability		141,836	140,280
Long-term liability for uncertain tax positions		848	13,380
Deferred lease expenses			39,235
Other long-term liabilities		43,001	49,431
Total long-term liabilities		3,669,860	2,597,662
Commitments and contingencies (see Note 17)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)	(24,233)
Additional paid-in-capital		1,291,618	1,277,921
Retained earnings		484,883	433,033
Accumulated other comprehensive loss		(340,112)	(319,007)
Total Cinemark USA, Inc.'s stockholder's equity		1,461,699	1,417,257
Noncontrolling interests		12,508	12,379
Total equity		1,474,207	1,429,636
Total liabilities and equity		5,852,238	4,501,351
NCM
Other assets
Investment in NCM		265,792	275,592
Long-term liabilities
Deferred revenue - NCM		348,354	350,242
Class A common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		0	0
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Total equity		$ 49,543	$ 49,543
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.
[2]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Treasury stock, shares	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648
Common stock, par value

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenues
Total revenues		$ 3,283,099	$ 3,221,735	$ 2,991,547
Cost of operations
Film rentals and advertising		1,003,832	999,755	966,510
Concession supplies		206,441	180,974	166,320
Salaries and wages		410,086	383,860	354,510
Facility lease expense		346,094	323,316	328,197
Utilities and other		474,711	448,070	355,041
General and administrative expenses		170,828	162,640	150,911
Depreciation and amortization	[1]	261,155	261,162	237,513
Impairment of long-lived assets		57,001	32,372	15,084
Loss on disposal of assets and other		12,008	38,702	22,812
Total cost of operations		2,942,156	2,830,851	2,596,898
Operating income		340,943	390,884	394,649
Other income (expense)
Interest expense	[1],[2]	(99,941)	(109,994)	(105,918)
Loss on debt amendments and refinancing			(1,484)	(521)
Interest income		12,570	10,592	6,243
Foreign currency exchange gain (loss)		(3,394)	(11,660)	893
Equity in income of affiliates		41,870	39,242	35,985
Total other expense		(64,646)	(77,639)	(46,911)
Income before income taxes		276,297	313,245	347,738
Income taxes		80,520	96,032	80,256
Net income		195,777	217,213	267,482
Less: Net income attributable to noncontrolling interests		2,462	1,478	1,839
Net income attributable to Cinemark USA, Inc.		193,315	215,735	265,643
Admissions
Revenues
Total revenues		1,805,321	1,834,173	1,794,982
Concession
Revenues
Total revenues		1,161,083	1,108,793	1,038,788
Other
Revenues
Total revenues		316,695	278,769	157,777
NCM
Other income (expense)
Distributions from NCM		12,873	15,389	$ 16,407
Interest expense - NCM		$ (28,624)	$ (19,724)
[1]	Amounts for the year ended December 31, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases.  See Note 3 for further discussion.
[2]	Includes amortization of debt issue costs.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 195,777	$ 217,213	$ 267,482
Other comprehensive income (loss), net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	(8,210)	(3,851)	0
Other comprehensive income (loss) in equity method investments	(142)	(139)	248
Foreign currency translation adjustments	(12,753)	(62,253)	(4,966)
Total other comprehensive loss, net of tax	(21,105)	(66,243)	(4,718)
Total comprehensive income, net of tax	174,672	150,970	262,764
Comprehensive income attributable to noncontrolling interests	(2,462)	(1,478)	(1,839)
Comprehensive income attributable to Cinemark USA, Inc.	$ 172,210	$ 149,492	$ 260,925

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statement Of Income And Comprehensive Income [Abstract]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 2,692	$ 1,243	$ 0

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A common stock	Class B common stock	Treasury Stock	Additional Paid-in- Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Total Cinemark USA, Inc.'s Stockholder's Equity	Noncontrolling Interests
Balance at Dec. 31, 2016	$ 1,284,080		$ 49,543	$ (24,233)	$ 1,252,715	$ 241,926	$ (247,013)	$ 1,272,938	$ 11,142
Balance (in shares) at Dec. 31, 2016		2	240	(57)
Share based awards compensation expense	11,825				11,825			11,825
Tax expense related to share based award vestings	(35)				(35)			(35)
Dividends paid to parent	(134,500)					(134,500)		(134,500)
Dividends paid to noncontrolling interests	(1,088)								(1,088)
Net income	267,482					265,643		265,643	1,839
Reclassification of cumulative translation adjustments	(1,551)						(1,551)	(1,551)
Other comprehensive loss	(4,718)						(4,718)	(4,718)
Balance at Dec. 31, 2017	1,421,495		$ 49,543	$ (24,233)	1,264,505	373,069	(253,282)	1,409,602	11,893
Balance (in shares) at Dec. 31, 2017		2	240	(57)
Cumulative effect of change in accounting principle, net of taxes	(7,021)					(7,021)		(7,021)
Share based awards compensation expense	13,416				13,416			13,416
Dividends paid to parent	(148,750)					(148,750)		(148,750)
Dividends paid to noncontrolling interests	(992)								(992)
Net income	217,213					215,735		215,735	1,478
Reclassification of cumulative translation adjustments	518						518	518
Other comprehensive loss	(66,243)						(66,243)	(66,243)
Balance at Dec. 31, 2018	1,429,636		$ 49,543	$ (24,233)	1,277,921	433,033	(319,007)	1,417,257	12,379
Balance (in shares) at Dec. 31, 2018		2	240	(57)
Cumulative effect of change in accounting principle, net of taxes	16,985					16,985		16,985
Share based awards compensation expense	13,697				13,697			13,697
Dividends paid to parent	(158,450)					(158,450)		(158,450)
Dividends paid to noncontrolling interests	(2,333)								(2,333)
Net income	195,777					193,315		193,315	2,462
Other comprehensive loss	(21,105)						(21,105)	(21,105)
Balance at Dec. 31, 2019	$ 1,474,207		$ 49,543	$ (24,233)	$ 1,291,618	$ 484,883	$ (340,112)	$ 1,461,699	$ 12,508
Balance (in shares) at Dec. 31, 2019		2	240	(57)

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Statement Of Stockholders Equity [Abstract]
Cumulative effect of change in accounting principle, taxes	$ 6,054	$ 2,267

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Operating activities
Net income		$ 195,777	$ 217,213	$ 267,482
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		256,118	257,826	235,093
Amortization of intangible and other assets and favorable/unfavorable leases		5,037	3,336	2,420
Amortization of long-term prepaid rents	[1]		2,382	2,274
Amortization of debt issue costs		5,311	5,561	6,197
Amortization of deferred revenues, deferred lease incentives and other		(13,665)	(21,706)	(16,211)
Impairment of long-lived assets		57,001	32,372	15,084
Share based awards compensation expense		13,697	13,416	11,825
Loss on disposal of assets and other		12,008	38,702	22,812
Loss on debt amendments and refinancing			1,484	521
Non-cash rent expense	[2]	(4,360)
Deferred lease expenses	[1]		(1,320)	(1,268)
Reclassification of cumulative translation adjustments			518	(1,551)
Equity in income of affiliates		(41,870)	(39,242)	(35,985)
Deferred income tax expenses		(1,843)	23,187	(15,015)
Distributions from equity investees		53,366	30,143	25,973
Changes in other assets and liabilities
Inventories		(2,367)	(1,813)	(541)
Accounts receivable		8,873	(6,620)	(14,753)
Income tax receivable		(794)	8,442	(4,363)
Prepaid expenses and other		(24,016)	1,422	(782)
Deferred charges and other assets - net		(8,495)	(6,303)	(4,956)
Accounts payable and accrued expenses		36,639	(11,272)	23,355
Income tax payable		(6,998)	6,670	438
Liabilities for uncertain tax positions		341	(10,066)	2,041
Other long-term liabilities		21,312	11,967	8,294
Net cash provided by operating activities		561,072	556,299	528,384
Investing activities
Additions to theatre properties and equipment and other		(303,627)	(346,073)	(380,862)
Proceeds from sale of theatre properties and equipment and other		3,155	3,920	15,098
Acquisitions of theatres in the U.S. and international markets, net of cash acquired		(10,170)	(11,289)	(40,997)
Investment in joint ventures and other, net			(19,535)	(3,715)
Net cash used for investing activities		(310,642)	(451,370)	(410,476)
Financing activities
Dividends paid to parent		(158,450)	(148,750)	(134,500)
Payroll taxes paid as a result of restricted stock withholdings		(2,308)	(2,905)	(2,943)
Repayments of long-term debt		(7,984)	(7,984)	(5,671)
Payment of debt issue costs			(5,218)	(1,146)
Fees paid related to debt amendments			(704)	(521)
Payments on capital and finance leases		(14,600)	(25,353)	(21,725)
Proceeds from financing lease				10,200
Other		(2,333)	(992)	(1,123)
Net cash used for financing activities		(185,675)	(191,906)	(157,429)
Effect of exchange rate changes on cash and cash equivalents		(2,756)	(9,222)	798
Increase (decrease) in cash and cash equivalents		61,999	(96,199)	(38,723)
Cash and cash equivalents:
Beginning of period		426,216	522,415	561,138
End of period		$ 488,215	426,216	$ 522,415
NCM
Investing activities
Acquisition of NCM common units			$ (78,393)
[1]	Amounts for the year ended December 31, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases.  See Note 3 for further discussion.
[2]	The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives.  Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases.  See Note 3 for discussion of the impact of ASC Topic 842.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business — Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay. Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation. Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres and highly liquid investments with original maturities of three months or less when purchased. Cash investments are primarily in money market funds, certificates of deposit, commercial paper or other similar funds. Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to discounted tickets and gift cards sold to third party retail locations, receivables from landlords related to theatre construction and remodels, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables. Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market. Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital and finance leases (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, operating lease right-of-use asset carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its impairment assessment. Long-lived assets are evaluated for impairment on a theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2017, 2018 and 2019 . The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 8 for further discussion. Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and we have allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill. A quantitative analysis requires the Company to estimate the fair value of each reporting unit and compare it with its carrying value. If the carrying value of the reporting unit exceeds its estimated fair value, goodwill would be written down such that the carrying value would equal estimated fair value. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2017, 2018 and 2019. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2018 and 2019. A qualitative assessment includes consideration of historical and expected future industry performance, estimated future performance of the Company, current industry trading multiples and other economic factors, and a review of current carrying values to estimated fair values as determined during our most recent quantitative assessment. The Company performed a quantitative goodwill impairment analysis for all reporting units during the year ended December 31, 2017. For the year ended December 31, 2018, the Company performed a quantitative goodwill assessment for three new domestic reporting units and a qualitative assessment for all other reporting units. For the year ended December 31, 2019 the Company performed a qualitative analysis for all reporting units. The Company did not record any goodwill impairment charges as a result of the assessments performed during the years ended December 31, 2017, 2018 and 2019. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to an estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. A qualitative assessment considers our historical and forecasted revenues and changes in estimated royalty rates, and a comparison of current carrying values to estimated fair values from our most recent quantitative assessment. During the year ended December 31, 2017, the Company performed a quantitative tradename impairment assessment for its tradename in Ecuador and performed a qualitative tradename impairment analysis for all other tradename intangible assets. During the year ended December 31, 2018, the Company performed a quantitative tradename impairment evaluation for all of its tradename assets. During the year ended December 31, 2019, the Company performed a qualitative tradename impairment analysis for all of its tradename assets. As a result of the analysis performed during each year, no impairment charges were recorded related to tradename intangible assets for the years ended December 31, 2017, 2018 and 2019. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately one to six years. Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is one year. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. See Note 3 for discussion of the impact of ASC Topic 842 on the recording of favorable and unfavorable leases. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to five years. Lease Accounting — See Note 3 for discussion of the Company’s lease accounting policies as well as the impact of new lease accounting pronouncements. Deferred Charges — Deferred charges and other assets consist of construction and other deposits, equipment to be placed in service, and other assets of a long-term nature. Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims subject to an annual cap. For the years ended December 31, 2017, 2018 and 2019, general liability claims were capped at $250, $250 and $500, respectively, per occurrence with aggregate annual caps of approximately $3,900, $4,750 and $6,000, respectively. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. During 2017, the Company implemented a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $250 per occurrence, with an annual cap of $5,000 for the years ended December 31, 2017, 2018 and 2019. The Company was also self-insured for domestic medical claims up to $250 per occurrence for the years ended December 31, 2017, 2018 and 2019. As of December 31, 2018 and 2019, the Company’s insurance reserves were $10,827 and $11,577, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets Revenue and Expense Recognition — See Note 4 for discussion of revenue recognition and deferred revenues. Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established prior to the opening of the film, 2) firm terms or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale formula, we pay a percentage of box office revenues using a pre-determined matrix that is based upon box office performance of the film for its full run. Under a firm terms formula, we pay the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time. Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is estimated using a market observed price. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 14 for discussion of the Company’s share based awards and related compensation expense. Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense. Segments — For the years ended December 31, 2017, 2018 and 2019, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 18. Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 12 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2017, 2018 and 2019. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency. Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 11 for a discussion of our fair value measurements for the years ended December 31, 2018 and 2019. Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.

New Accounting Pronouncements

New Accounting Pronouncements	12 Months Ended
	Dec. 31, 2019
Accounting Changes And Error Corrections [Abstract]
New Accounting Pronouncements	2. NEW ACCOUNTING PRONOUNCEMENTS Impact of New Lease Accounting Standard The Company adopted ASC Topic 842 effective January 1, 2019. See Note 3 for further discussion. Other Accounting Pronouncements ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes

Adoption of ASC Topic 842 - Lea

Adoption of ASC Topic 842 - Lease Accounting	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Adoption of ASC Topic 842 – Lease Accounting	3. ADOPTION OF ASC TOPIC 842 – LEASE ACCOUNTING The Company adopted ASC Topic 842 as of January 1, 2019 under the modified retrospective approach that resulted in the recognition of a cumulative-effect adjustment to the opening balance of retained earnings and elected certain practical expedients. The Company elected the following practical expedients, as allowed by ASC Topic 842: • The Company chose not to separate nonlease components from lease components, accounting for lease components and nonlease components associated with a lease as a single lease component. More specifically, for theatre leases, the Company elected not to separate fixed common area maintenance costs from lease costs when calculating lease liabilities and assets. • The Company did not reassess whether existing contracts in effect as of the transition date of January 1, 2019 were, or contained, a lease. • The Company did not reassess the classification of existing leases as operating or finance as of the transition date. • The Company did not reassess whether any initial direct costs were incurred for any of its existing leases. • The Company did not elect to apply the recognition requirements of ASC 842 to short-term leases. The adoption of ASC Topic 842 included the following primary impacts: 1. The Company recorded a right-of-use asset and lease liability for all of its operating leases as required by the standard. The lease liability for each lease was determined based on the present value of lease payments. The right-of-use asset was based on the lease liability value, adjusted for offsets that existed as of adoption, including deferred rent liabilities of ($39,235), net favorable and unfavorable lease intangibles of ($5,780), deferred lease incentive liabilities of ($12,960) and long-term prepaid rents of $7,707. The Company recorded operating lease right-of-use assets of $1,491,245 and operating lease liabilities of $1,545,210 upon adoption. 2. Certain of the Company’s existing lease assets and liabilities, which were accounted for under prior sale-leaseback accounting guidance, were derecognized in accordance with ASC Topic 842 and reevaluated for classification per the new accounting guidance. Several of these leases have been reestablished as operating leases based on ASC Topic 842. a. For those leases that are now classified as operating leases in accordance with ASC Topic 842, approximately $110,442 and $126,376 of lease assets and liabilities, respectively, were recorded as an adjustment to beginning retained earnings. The related net deferred income tax asset for these accounts was also recorded as an adjustment to beginning retained earnings. See additional impact discussed in item 3 below. b. The Company recognized finance lease assets and liabilities in the amount of $57,440 as of January 1, 2019 for the remaining leases that were determined to be finance leases under ASC Topic 842. 3. For the leases noted in item 2a above, the Company will now record the related operating lease payments as facility lease expense, compared to prior periods in which the capitalized asset was depreciated and lease payments were recorded as a reduction of a lease liability and interest expense. Real Estate Leases - The Company conducts a significant part of its theatre operations in leased properties under noncancelable operating and finance leases with terms generally ranging from 10 to 25 years. In addition to fixed lease payments, some of the leases provide for variable lease payments and some require the payment of taxes, insurance and other costs applicable to the property. Variable lease payments include payments based on a percentage of retail sales over contractual levels or payments adjusted periodically for inflation or changes in attendance. The Company can renew, at its option, a substantial portion of the leases at defined or then market rental rates for various periods. Some leases also provide for escalating rent payments throughout the lease term. The Company also leases certain office and warehouse facilities in the U.S. and in international locations. The lease terms for these facilities generally only include fixed payments. The Company recognizes fixed lease expense for the operating leases on a straight-line basis over the lease term. The Company’s real estate lease agreements do not contain any residual value guarantees or restrictive covenants. Equipment Leases - The Company has certain equipment operating leases primarily including projectors, trash compactors and various other equipment used in the day-to-day operation of the business. Certain of the leases require fixed lease payments to be made over the duration of the lease term, while others are variable in nature based on usage or sales. Certain of these leases are month-to-month, while others are noncancelable with terms generally ranging from 5 to 11 years. The Company’s equipment lease agreements do not contain any residual value guarantees or restrictive covenants. The following table represents the operating and finance right-of-use assets and lease liabilities as of December 31, 2019. As of Leases Classification December 31, 2019 Assets (1) Operating lease assets Operating lease assets $ 1,383,080 Finance lease assets Theatre properties and equipment, net of accumulated depreciation (2) 116,135 Total lease assets $ 1,499,215 Liabilities (1) Current Operating Current portion of operating lease obligations $ 217,406 Finance Current portion of finance lease obligations 15,432 Noncurrent Operating Operating lease obligations, less current portion 1,223,462 Finance Finance lease obligations, less current portion 141,017 Total lease liabilities $ 1,597,317 (1) The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) Finance lease assets are net of accumulated amortization of $36,384 as of December 31, 2019. As of December 31, 2019, the Company had signed lease agreements with total noncancelable lease payments of approximately $242,898 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of December 31, 2019. There were no significant noncancelable lease agreements signed, but not yet commenced, related to equipment leases. The following table represents the Company’s aggregate lease costs, by lease classification, for the year ended December 31, 2019. Year Ended Lease Cost Classification December 31, 2019 Operating lease costs Equipment (1) Utilities and other $ 9,172 Real Estate (2)(3) Facility lease expense 346,222 Total operating lease costs $ 355,394 Finance lease costs Depreciation of leased assets Depreciation and amortization $ 14,734 Interest on lease liabilities Interest expense 7,786 Total finance lease costs $ 22,520 (1) Includes approximately $4,700 of short-term lease payments for the year ended December 31, 2019. (2) Includes approximately $68,799 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the year ended December 31, 2019 (3) Approximately $1,614 of lease payments are included in general and administrative expenses primarily related to office leases for the year ended December 31, 2019. The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2019. Operating Finance Years Ending Leases Leases Total 2020 $ 280,268 $ 22,416 $ 302,684 2021 263,978 22,671 286,649 2022 235,266 21,935 257,201 2023 205,210 21,246 226,456 2024 166,233 20,165 186,398 After 2024 580,852 88,913 669,765 Total lease payments $ 1,731,807 $ 197,346 $ 1,929,153 Less: Interest 290,939 40,897 331,836 Present value of lease liabilities $ 1,440,868 $ 156,449 $ 1,597,317 The following table represents future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 as presented in the Company’s Annual Report on Form 10-K filed March 4, 2019: Operating Capital Years Ending Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467 The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2019. As of Lease Term and Discount Rate December 31, 2019 Weighted-average remaining lease term (years) (1) Operating leases - equipment 3.9 Operating leases - real estate 7.9 Finance leases - equipment 5.3 Finance leases - real estate 10.0 Weighted-average discount rate (2) Operating leases - equipment 4.3 % Operating leases - real estate 4.8 % Finance leases - equipment 4.6 % Finance leases - real estate 4.8 % (1) The lease assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment. The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the twelve months ended December 31, 2019. Year Ended Other Information December 31, 2019 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 281,895 Cash outflows for finance leases - operating activities $ 7,575 Cash outflows for finance leases - financing activities $ 14,600 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities - real estate $ 113,318 Operating lease liabilities - equipment $ 795 Finance lease liabilities $ 21,535 Lessor Arrangements As noted above, the Company did not reassess whether existing contracts in effect as of the transition date of January 1, 2019 were, or contained, a lease. However, effective September 17, 2019, the Company amended its Exhibitor Services Agreement (“ESA”) with National CineMedia, LLC (“NCM”) and, as a result of this amendment, the Company reassessed the ESA under ASC Topic 842. The Company’s assessment resulted in the determination that the nonconsecutive periods of use of the theatre screens by NCM under the ESA qualify as a lease in accordance with ASC Topic 842. See further discussion in Note 5. The Company rents its theatre auditoriums for corporate meetings, screenings, education and training sessions and other private events. These rentals, which are not significant to the Company, are generally one-time events and the related revenue is reflected as other revenue on the consolidated statement of income.

Revenue Recognition

Revenue Recognition	12 Months Ended
	Dec. 31, 2019
Revenue From Contract With Customer [Abstract]
Revenue Recognition	4. REVENUE RECOGNITION Revenue Recognition Policy The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenues when the showtime for a purchased movie ticket has passed. Concession revenues are recognized when products are sold to the consumer. Other revenues primarily consist of screen advertising and screen rental revenues, promotional income, studio trailer placements and transactional fees. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenues. Deferred revenues for gift cards and discount ticket vouchers are recognized when they are redeemed for movie tickets or concession items. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the monthly subscription program fees as deferred revenues and record admissions revenues when the showtime for a movie ticket purchased with a credit has passed. The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual membership fee or award points to customers as purchases are made. For those loyalty programs that have an annual membership fee, the Company recognizes the fee collected as other revenues on a straight-line basis over the term of the membership. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenues based on the number of reward points issued to customers and recognizes the deferred revenues when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue on gift cards and discount ticket vouchers generally based on redemption activity and historical experience with unused balances. The Company records breakage revenue upon the expiration of loyalty points and subscription credits. Breakage revenue is recorded as other revenues on the consolidated income statements. Advances collected on concession and other contracts are deferred and recognized during the period in which we satisfy the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company meets its performance obligations in accordance with the terms of the contracts. Screen advertising and screen rental revenues for the U.S. operating segment primarily relate to the ESA with NCM and the Company’s beverage concessionaire agreement. Prior to September 17, 2019, such screen advertising was accounted for under ASC Topic 606, Revenue from Contracts with Customers, and effective upon the amendment of the ESA, NCM screen advertising was accounted for under ASC Topic 842. See table at Note 7 for screen advertising revenues recorded in other revenue under ASC Topic 606 prior to the amendment of the ESA and screen rental revenues recorded in other revenue under ASC Topic 842 subsequent to the amendment of the ESA. Accounts receivable as of December 31, 2019 included approximately $31,620 of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the year ended December 31, 2019. Disaggregation of Revenue The following table presents revenues for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment. Twelve Months Ended Twelve Months Ended December 31, 2018 December 31, 2019 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 1,461,151 $ 373,022 $ 1,834,173 $ 1,431,790 $ 373,531 $ 1,805,321 Concession revenues 892,391 216,402 1,108,793 936,241 224,842 1,161,083 Screen advertising, screen rental and promotional revenues 78,591 61,269 139,860 128,839 35,888 164,727 Other revenues 106,824 32,085 138,909 84,033 67,935 151,968 Total revenues $ 2,538,957 $ 682,778 $ 3,221,735 $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 18 for additional information on intercompany eliminations. The following table presents revenues for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above). Twelve Months Ended Twelve Months Ended December 31, 2018 December 31, 2019 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 2,453,313 $ 608,347 $ 3,061,660 $ 2,488,716 $ 621,785 $ 3,110,501 Goods and services transferred over time 85,644 74,431 160,075 92,187 80,411 172,598 Total $ 2,538,957 $ 682,778 $ 3,221,735 $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 18 for additional information on intercompany eliminations. Screen Advertising Advances and Other Deferred Revenues The following table presents changes in the Company’s deferred revenues for the year ended December 31, 2019 . Deferred Revenues NCM Screen Advertising Advances (1) Other Deferred Revenues (2) Total Balance at January 1, 2019 $ 350,242 $ 106,075 $ 456,317 Amounts recognized as accounts receivable — 12,767 12,767 Cash received from customers in advance — 227,125 227,125 Common units received from NCM (see Note 7) 1,552 — 1,552 Interest accrued related to significant financing component 28,624 — 28,624 Revenue recognized during period (32,064 ) (206,367 ) (238,431 ) Foreign currency translation adjustments — (1,174 ) (1,174 ) Balance at December 31, 2019 $ 348,354 $ 138,426 $ 486,780 (1) See Significant Financing Component (2) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheet. The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of December 31, 2019 and when the Company expects to recognize this revenue. Twelve Months Ended December 31, Remaining Performance Obligations 2020 2021 2022 2023 2024 Thereafter Total Deferred revenue - other $ 125,334 12,897 195 — — — $ 138,426 Significant Financing Component As discussed further in Note 5, in connection with the completion of the NCM, Inc. (“NCMI”) initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2041. In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. See Note 5 for additional information regarding the common unit adjustment and related accounting. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 4.4% to 8.0%. See Note 5 for table detailing activity with NCM, which includes interest revenue and expense recorded in 2018 and 2019 related to the significant financing component.

Investment in National CineMedi

Investment in National CineMedia LLC	12 Months Ended
	Dec. 31, 2019
NCM
Investment in National CineMedia LLC	5. INVESTMENT IN NATIONAL CINEMEDIA LLC Summary of Activity with NCM Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 4 for discussion of the impact of the new revenue recognition accounting pronouncement. Investment in NCM NCM Screen Advertising Advances Distributions from NCM Equity in Earnings Other Revenue Interest Expense - NCM (3) Cash Received Balance as of January 1, 2017 $ 189,995 $ (343,928 ) Receipt of common units due to annual common unit adjustment 18,363 (18,363 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,274 ) — 11,274 Receipt of excess cash distributions (15,093 ) — (14,158 ) — — — 29,251 Receipt under tax receivable agreement (2,265 ) — (2,249 ) — — — 4,514 Equity in earnings 9,550 — — (9,550 ) — — — Amortization of screen advertising advances — 10,585 — — (10,585 ) — — Balance as of and for the twelve months ended December 31, 2017 $ 200,550 $ (351,706 ) $ (16,407 ) $ (9,550 ) $ (21,859 ) $ — $ 45,039 Impact of adoption of ASC Topic 606 (2) — (9,288 ) — — — — — Receipt of common units due to annual common unit adjustment 5,012 (5,012 ) — — — — — Purchase of additional common units 78,393 — — — — — — Revenues earned under ESA (1) (2) — — — — (31,867 ) 19,724 12,143 Receipt of excess cash distributions (19,786 ) — (13,231 ) — — — 33,017 Receipt under tax receivable agreement (2,419 ) — (2,158 ) — — — 4,577 Equity in earnings 13,842 — — (13,842 ) — — — Amortization of screen advertising advances — 15,764 — — (15,764 ) — — Balance as of and for the twelve months ended December 31, 2018 $ 275,592 $ (350,242 ) $ (15,389 ) $ (13,842 ) $ (47,631 ) $ 19,724 $ 49,737 Receipt of common units due to annual common unit adjustment 1,552 (1,552 ) — — — — — Revenues earned under ESA (1) (3) — — — — (13,782 ) — 13,782 Interest accrued related to significant financing component (2) — (28,624 ) — — — 28,624 — Receipt of excess cash distributions (23,452 ) — (11,631 ) — — — 35,083 Receipt under tax receivable agreement (2,492 ) — (1,242 ) — — — 3,734 Equity in earnings 14,592 — — (14,592 ) — — — Amortization of screen advertising advances (2) — 32,064 — — (32,064 ) — — Balance as of and for the twelve months ended December 31, 2019 $ 265,792 $ (348,354 ) $ (12,873 ) $ (14,592 ) $ (45,846 ) $ 28,624 $ 52,599 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $11,110, $11,965 and $11,478 for the years ended December 31, 2017, 2018 and 2019, respectively. (2) As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. In addition, the Company determined that a significant financing component existed for the ESA. See Note 4 for further discussion of the impact of the adoption of ASC Topic 606. (3) Approximately $4,828 represents screen rental revenues earned under the amendment to the ESA. See Note 4. In addition to the activity in the table above, the Company made payments to NCM of approximately $102, $74 and $61 during the years ended December 31, 2017, 2018 and 2019, respectively, related to certain equipment used for digital advertising, which is included in theatre furniture and equipment on the consolidated balance sheets. Investment in National CineMedia NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM primarily provides advertising to our theatres. As described in Note 6 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K, on February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. At the time of the NCMI IPO and as a result of amending the ESA, the Company received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue or NCM screen advertising advances and was being amortized over the term of the Amended and Restated ESA, or through February 2041. Following the NCMI IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution. Common Unit Adjustments In addition to the consideration received upon the NCMI IPO and ESA modification in 2007, the Company also periodically receives consideration in the form of common units from NCM. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As discussed in Note 6 to the Company’s financial statements as included in its 2018 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue or NCM screen advertising advances. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis During March 2019, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 29, 2019, the Company received an additional 219,056 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to deferred revenue of approximately $1,552. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. The deferred revenue is recognized on a straight-line basis over the remaining term of the first amendment to the Amended and Restated ESA. Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2017, 2018 and 2019: Event Date Common Units Received Number of Common Units Received Fair Value of Common Units Received 2017 annual common unit adjustment 3/31/2017 1,487,218 $ 18,363 2018 annual common unit adjustment 3/29/2018 908,042 $ 5,012 2019 annual common unit adjustment 3/31/2019 219,056 $ 1,552 Each common unit received by the Company is convertible into one share of NCMI common stock. The fair value of the common units received was estimated based on the market price of NCMI stock at the time that the common units were received, adjusted for volatility associated with the estimated period of time it would take to convert the common units and register the respective NCMI shares. The fair value measurement used for the common units falls under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC Topic 820-10-35. The Company records the additional common units it receives as part of its Tranche 2 Investment at estimated fair value with a corresponding adjustment to deferred revenue. The deferred revenue is amortized over the remaining term of the ESA. Acquisition of Common Units On July 5, 2018, the Company acquired 10,738,740 common units of NCM from AMC for $78,393 in cash, or approximately $7.30 per common unit. As a result of the acquisition of these shares, the Company’s ownership of NCM increased from approximately 18% to 25%. The amount paid for the additional common units was recorded as an increase in the Company’s Tranche 2 investment in NCM. As of December 31, 2019, the Company owned a total of 39,737,700 common units of NCM, which represented an interest of approximately 25%. The estimated fair value of the Company’s investment in NCM was approximately $289,688 based on NCMI’s stock price as of December 31, 2019 of $7.29 per share (Level 1 input as defined in FASB ASC Topic 820), which was more than the Company’s carrying value of $265,792. Exhibitor Services Agreement As previously discussed, our domestic theatres are part of the in-theatre digital network operated by NCM under the ESA. NCM provides advertising to our theatres through its branded “ Noovie Revenue from Contracts with Customers. Leases The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA or February 2041. Twelve Months Ended December 31, Remaining Maturity 2020 2021 2022 2023 2024 Thereafter Total NCM screen advertising advances (1) $ 7,669 8,197 8,762 9,368 10,016 304,342 $ 348,354 (1) Amounts are net of the estimated interest to be accrued for the periods presented Significant Financing Component Prior to the September 17, 2019 amendment of the ESA, the Company applied a significant financing component, as required by ASC Topic 606, due to the significant length of time between receiving the NCM screen advertising advances (the $174,000 received at the NCMI IPO and the periodic common unit adjustments) and completion of the performance obligation. Effective September 17, 2019, upon the Company’s evaluation and determination that ASC Topic 842 applies to the amended ESA, the Company determined it acceptable to apply the significant financing component guidance from ASC Topic 606 by analogy as the economic substance of the agreement represents a financing arrangement. Subsequent to the issuance of the Company’s audited consolidated financial statements for the year ended December 31, 2018, the Company identified an error in the January 1, 2018 adoption of ASC Topic 606 specifically related to the significant financing component associated with the NCM ESA. The error impacted the cumulative effect of change in accounting principle for the adoption of ASC Topic 606 at January 1, 2018 and the recorded amounts of revenue and interest expense related to the amortization of NCM screen advertising advances associated with the significant financing component during 2018 and 2019. The Company evaluated the error and, based on an analysis of the relevant quantitative and qualitative factors, determined the impact was not material to the Company’s consolidated financial statements for any prior annual or interim period. The consolidated balance sheet, consolidated statement of equity, and corresponding notes to consolidated financial statements as of and for the year ended December 31, 2018 have been restated from the amounts previously reported to correct the cumulative effect of change in accounting principle for the adoption of ASC Topic 606. This resulted in a $62,893 increase in NCM screen advertising advances, a $ 15,346 increase in deferred tax assets, and a corresponding $47,547 reduction of retained earnings as of the January 1, 2018 adoption date. The impact for the year ended December 31, 2018 was corrected in the fourth quarter of 2019, resulting in a $1,403 reduction in other revenues, $4,721 increase in interest expense – NCM and a $4,630 reduction of net income. Summary Financial Information for NCM The tables below present summary financial information for NCM for the periods indicated: Year Ended Year Ended Year Ended December 28, 2017 December 27, 2018 December 26, 2019 Revenues $ 426,100 $ 441,400 $ 444,800 Operating income $ 153,900 $ 154,300 $ 155,700 Net income $ 101,900 $ 98,400 $ 98,800 As of As of December 27, 2018 December 26, 2019 Current assets $ 172,700 $ 185,400 Noncurrent assets $ 726,800 $ 706,600 Current liabilities $ 115,200 $ 125,500 Noncurrent liabilities $ 924,900 $ 947,800 Members' deficit $ (140,600 ) $ (181,300 )

Other Investments

Other Investments	12 Months Ended
	Dec. 31, 2019
Financial Support For Nonconsolidated Legal Entity [Abstract]
Other Investments	6. OTHER INVESTMENTS Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP AC LLC DCDC FE Concepts Other Total Balance at January 1, 2017 $ 87,819 $ 5,980 $ 2,750 $ — $ 1,768 $ 98,317 Cash contributions 1,112 — — 104 2,499 3,715 Equity in income 22,900 2,336 1,199 — — 26,435 Equity in comprehensive income 248 — — — — 248 Cash distributions received (5,864 ) (2,400 ) (351 ) — — (8,615 ) Other — — — — (55 ) (55 ) Balance at December 31, 2017 $ 106,215 $ 5,916 $ 3,598 $ 104.00 $ 4,212 $ 120,045 Cash contributions 2,076 — — 20,000 — 22,076 Equity in income (loss) 22,899 1,270 1,313 (82 ) — 25,400 Equity in comprehensive loss (139 ) — — — — (139 ) Cash distributions received (5,799 ) (1,920 ) (219 ) — — (7,938 ) Other (1) — — (2,437 ) (104 ) (137 ) (2,678 ) Balance at December 31, 2018 $ 125,252 $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 Equity in income (loss) 23,281 3,276 1,120 (399 ) — 27,278 Equity in comprehensive loss (141 ) — — — — (141 ) Cash distributions received (23,696 ) (3,520 ) (206 ) — — (27,422 ) Other (2) — — — — (1,196 ) (1,196 ) Balance at December 31, 2019 $ 124,696 $ 5,022 $ 3,169 $ 19,519 $ 2,879 $ 155,285 (1) (2) Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, DCIP and its subsidiaries completed an initial financing transaction to enable the purchase, deployment and leasing of digital projection systems to the Exhibitors under equipment lease and installation agreements. On March 31, 2011, DCIP obtained incremental financing necessary to complete the deployment of digital projection systems. DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with six major motion picture studios pursuant to which Kasima LLC, one of DCIP’s subsidiaries, receives a virtual print fee ("VPF") each time the studio books a film or certain other content on the leased digital projection systems. Other content distributors entered into similar DCDAs that provide for the payment of VPFs for bookings of the distributor's content on a leased digital projection system. The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs. Cost recoupment occurs when revenues attributable to the digital projection systems exceed the financing, deployment, administration and other costs associated with the purchase of the digital projection systems. DCIP expects cost recoupment to occur during late 2020. Pursuant to the operating agreement between the Exhibitors and DCIP, DCIP began to distribute excess cash to the Exhibitors upon the payoff of its outstanding debt, which occurred during the year ended December 31, 2019. As of December 31, 2019, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP as of and for the years ended December 31, 2017, 2018 and 2019: Year ended December 31, 2017 2018 2019 Revenues $ 177,382 $ 172,534 $ 171,531 Operating income $ 106,687 $ 102,236 $ 99,812 Net income $ 93,103 $ 94,757 $ 95,820 As of December 31, 2018 December 31, 2019 Current assets $ 57,907 $ 51,382 Noncurrent assets $ 684,545 $ 581,547 Current liabilities $ 67,408 $ 70,515 Noncurrent liabilities $ 125,596 $ 190 Members' equity $ 549,448 $ 562,224 As of December 31, 2019, the Company had 3,866 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. See Note 3 for discussion of the weighted-average remaining lease term and discount rate of equipment operating leases, which includes digital projection systems leased from Kasima, LLC. The Company had the following transactions with DCIP during the years ended December 31, 2017, 2018 and 2019: Year Ended December 31, 2017 2018 2019 Equipment lease payments $ 5,743 $ 4,862 $ 4,399 Warranty reimbursements from DCIP $ (8,511 ) $ (10,800 ) $ (11,800 ) Management services fees $ 823 $ 730 $ 596 AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Company paid event fees to AC of $13,950, $12,481 and $15,376 for the years ended December 31, 2017, 2018 and 2019, respectively, which are included in film rentals and advertising costs on the consolidated statements of income. The Company accounts for its investment in AC under the equity method of accounting. Digital Cinema Distribution Coalition The Company is a party to a joint venture with certain exhibitors and distributors called Digital Cinema Distribution Coalition (“DCDC”). DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $848, $927 and $896 to DCDC during the years ended December 31, 2017, 2018 and 2019, respectively, related to content delivery services, which is included in film rentals and advertising costs on the consolidated statements of income. The Company accounts for its investment in DCDC under the equity method of accounting. FE Concepts, LLC During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. In December of 2019, FE Concepts opened a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting. The Company has a theatre services agreement with FE Concepts under which it receives management fees for providing film booking and equipment monitoring services for the facility. The Company recorded $64 of related management fees during the year ended December 31, 2019.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets - Net	12 Months Ended
	Dec. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS - NET	7. GOODWILL AND OTHER INTANGIBLE ASSETS — NET The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2017 (1) $ 1,174,041 $ 110,038 $ 1,284,079 Acquisition of theatres (2) — 7,204 7,204 Foreign currency translation adjustments — (14,959 ) (14,959 ) Balance at December 31, 2018 (1) $ 1,174,041 $ 102,283 $ 1,276,324 Acquisition of theatres (3) 8,812 868 9,680 Foreign currency translation adjustments — (2,633 ) (2,633 ) Balance at December 31, 2019 (1) $ 1,182,853 $ 100,518 $ 1,283,371 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) Amount represents preliminary purchase price allocation for theatres acquired in Brazil. (3) Amounts represent acquisition of two theatres in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018. As of December 31, intangible assets-net, consisted of the following: Balance at January 1, 2018 Additions (1) Amortization Other (2) Balance at December 31, 2018 Intangible assets with finite lives: Gross carrying amount $ 105,895 $ 1,203 $ — $ (1,842 ) $ 105,256 Accumulated amortization (68,869 ) — (5,734 ) - (74,603 ) Total net intangible assets with finite lives $ 37,026 $ 1,203 $ (5,734 ) $ (1,842 ) $ 30,653 Intangible assets with indefinite lives: Tradename and other 299,735 853 — (331 ) 300,257 Total intangible assets — net $ 336,761 $ 2,056 $ (5,734 ) $ (2,173 ) $ 330,910 Balance at January 1, 2019 Additions (3) Impact of ASC Topic 842 (4) Amortization Other (2) Balance at December 31, 2019 Intangible assets with finite lives: Gross carrying amount $ 105,256 $ (143 ) $ (4,427 ) $ — $ (6 ) $ 100,680 Accumulated amortization (74,603 ) — — (4,994 ) — (79,597 ) Total net intangible assets with finite lives $ 30,653 $ (143 ) $ — $ (4,994 ) $ (6 ) $ 21,083 Intangible assets with indefinite lives: Tradename and other 300,257 492 — — (63 ) 300,686 Total intangible assets — net $ 330,910 $ 349 $ — $ (4,994 ) $ (69 ) $ 321,769 (1) Activity represents preliminary fair values recorded as a result of the acquisition of theatres in Brazil. (2) Amount represents the write-off of fully amortized intangible assets related to non-compete agreements, the acquisition of tradeable liquor licenses, and foreign currency translation adjustments. (3) Amount represents intangible assets recorded as a result of two theatres acquired in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018. (4) See Note 3 for further discussion of the impact of the adoption of ASC Topic 842. Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2020 $ 5,036 For the year ended December 31, 2021 3,127 For the year ended December 31, 2022 2,974 For the year ended December 31, 2023 2,876 For the year ended December 31, 2024 2,876 Thereafter 4,194 Total $ 21,083

IMPAIRMENT OF LONG-LIVED ASSETS

IMPAIRMENT OF LONG-LIVED ASSETS	12 Months Ended
	Dec. 31, 2019
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
IMPAIRMENT OF LONG-LIVED ASSETS	8 . IMPAIRMENT OF LONG-LIVED ASSETS The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See Note 1 for discussion of the Company’s impairment policy. The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2017 2018 2019 U.S. theatre properties $ 5,227 $ 18,597 $ 36,005 U.S. theatre operating lease right-of-use assets — — 10,457 International theatre properties 9,857 13,775 8,821 International theatre operating lease right-of-use assets — — 1,718 Impairment of long-lived assets $ 15,084 $ 32,372 $ 57,001 The long-lived asset impairment charges recorded during each of the periods presented were for certain new concept theatres being developed and tested by the Company and other theatres that were individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. As of December 31, 2019, the estimated aggregate remaining fair value of the long-lived assets impaired during the year ended December 31, 2019 was approximately $62,649.

Deferred Charges and Other Ass

Deferred Charges and Other Assets - Net	12 Months Ended
	Dec. 31, 2019
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Deferred Charges and Other Assets - Net	9. DEFERRED CHARGES AND OTHER ASSETS — NET As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2018 2019 Long-term prepaid rents (1) $ 15,943 $ — Construction and other deposits 8,183 6,981 Equipment to be placed in service 10,466 12,929 Other 6,463 19,204 Total $ 41,055 $ 39,114 (1)

LONG-TERM DEBT

LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
LONG-TERM DEBT	10. LONG-TERM DEBT As of December 31, long-term debt consisted of the following: December 31, 2018 2019 Cinemark USA, Inc. term loan $ 652,922 $ 646,327 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 755,000 Other 1,389 — Total long-term debt 1,809,311 1,801,327 Less current portion 7,984 6,595 Less debt issuance costs, net of accumulated amortization of $30,289 and $35,599, respectively 28,700 23,390 Long-term debt, less current portion $ 1,772,627 $ 1,771,342 Senior Secured Credit Facility Cinemark USA, Inc. has a senior secured credit facility that includes a $700,000 term loan and a $100,000 revolving credit line (the “Credit Agreement”). Cinemark USA, Inc. made the following amendments to its Credit Agreement as follows during 2017 and 2018: Debt Issue Loss on Debt Effective Date Nature of Amendment Costs Paid (1) Amendment (2) June 16, 2017 Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement $ 521 $ 190 November 28, 2017 Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line $ 330 $ 331 March 29, 2018 Extended maturity of term loan to March 2025; reduced term loan interest rate by 0.25%; reduced real property mortgage requirements $ 4,962 $ 1,484 (1) (2) Under the amended Credit Agreement, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. Subsequent to the March 29, 2018 amendment noted in the table above, interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement. At December 31, 2019, there was $ 646,327 Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries. The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to keep a consolidated net senior secured leverage ratio, as defined in the Credit Agreement, not to exceed 5.0 to 1. As of December 31, 2019, the Company’s actual ratio was 2.98 to 1. The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $3,196,752 to its parent company and sole stockholder, Cinemark Holdings, Inc. 4.875% Senior Notes On May 24, 2013, Cinemark USA, Inc. issued $530,000 aggregate principal amount of 4.875% senior notes due 2023, at par value, (the “4.875% Senior Notes”). Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023. On March 21, 2016, Cinemark USA, Inc. issued an additional $225,000 aggregate principal amount of the 4.875% Senior Notes, at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755,000 of 4.875% Senior Notes mature on June 1, 2023. The 4.875% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 4.875% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior subordinated debt. The 4.875% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 4.875% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 4.875% Senior Notes. The indenture to the 4.875% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $3,353,829 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2019 was approximately 6.6 to 1. Cinemark USA, Inc. may redeem the 4.875% Senior Notes in whole or in part at redemption prices specified in the indenture. 5.125% Senior Notes On December 18, 2012, Cinemark USA, Inc. issued $400,000 aggregate principal amount of 5.125% senior notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022. The 5.125% Senior Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by certain of Cinemark USA, Inc.’s subsidiaries that guarantee, assume or become liable with respect to any of Cinemark USA, Inc.’s or a guarantor’s debt. The 5.125% Senior Notes and the guarantees are senior unsecured obligations and rank equally in right of payment with all of Cinemark USA, Inc.’s and its guarantor’s existing and future senior unsecured debt and senior in right of payment to all of Cinemark USA, Inc.’s and its guarantor’s existing and future subordinated debt. The 5.125% Senior Notes and the guarantees are effectively subordinated to all of Cinemark USA, Inc.’s and its guarantor’s existing and future secured debt to the extent of the value of the assets securing such debt, including all borrowings under Cinemark USA, Inc.’s Credit Agreement. The 5.125% Senior Notes and the guarantees are structurally subordinated to all existing and future debt and other liabilities of Cinemark USA, Inc.’s subsidiaries that do not guarantee the 5.125% Senior Notes. The indenture to the 5.125% Senior Notes contains covenants that limit, among other things, the ability of Cinemark USA, Inc. and certain of its subsidiaries to (1) make investments or other restricted payments, including paying dividends, making other distributions or repurchasing subordinated debt or equity, (2) incur additional indebtedness and issue preferred stock, (3) enter into transactions with affiliates, (4) enter new lines of business, (5) merge or consolidate with, or sell all or substantially all of its assets to, another person and (6) create liens. As of December 31, 2019, Cinemark USA, Inc. could have distributed up to approximately $3,347,932 to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The required minimum coverage ratio is 2 to 1 and our actual ratio as of December 31, 2019 was approximately 6.6 to 1. Cinemark USA, Inc. may redeem the 5.125% Senior Notes in whole or in part at redemption prices specified in the indenture. Fair Value of Long Term Debt The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35. The carrying value of the Company’s long term debt was $1,809,311 and $1,801,327 as of December 31, 2018 and 2019. The fair value of the Company’s long term debt was $1,774,066 and $1,826,503 as of December 31, 2018 and 2019, respectively. Covenant Compliance and Debt Maturity As of December 31, 2019, the Company believes it was in full financial compliance with all agreements, including related covenants, governing its outstanding debt. The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2019 matures as follows: 2020 $ 6,595 2021 6,595 2022 406,595 2023 761,595 2024 6,595 Thereafter 613,352 Total $ 1,801,327 Interest Rate Swap Agreements The Company is currently a party to three interest rate swap agreements that are used to hedge a portion of the interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting. The fair values of the interest rate swaps are recorded on the Company’s consolidated balance sheet as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by counterparty to the interest rate swap agreement and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 3 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. See Note 11 for a summary of unrealized gains or losses recorded in accumulated other comprehensive loss. Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2019: Estimated Fair Value at Notional December 31, Amount Effective Date Pay Rate Receive Rate Expiration Date 2019 (1) $ 175,000 December 31, 2018 2.751% 1-Month LIBOR December 31, 2022 $ 6,213 $ 137,500 December 31, 2018 2.765% 1-Month LIBOR December 31, 2022 $ 4,956 $ 137,500 December 31, 2018 2.746% 1-Month LIBOR December 31, 2022 $ 4,826 Total $ 15,995 (1) The total estimated fair value of the interest rate swaps of $15,995, net of deferred taxes of $3,935, is reflected in accumulated other comprehensive loss for the year ended December 31, 2019.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurements	11. FAIR VALUE MEASUREMENTS The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2019: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities $ (15,995 ) $ — $ — $ (15,995 ) Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities (1) 2019 Beginning balance - January 1 $ 5,093 Total loss included in accumulated other comprehensive loss 13,039 Settlements included in interest expense (2,137 ) Ending balance - December 31 $ 15,995 (1) Represents interest rate swap liabilities. See Note 10 for further discussion. The Company also uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 1 and Note 8). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 10). There were no changes in valuation techniques during the period. There were no transfers in or out of Level 1, Level 2 or Level 3 during the years ended December 31, 2017, 2018 and 2019.

FOREIGN CURRENCY TRANSLATION

FOREIGN CURRENCY TRANSLATION	12 Months Ended
	Dec. 31, 2019
Foreign Currency [Abstract]
FOREIGN CURRENCY TRANSLATION	12. FOREIGN CURRENCY TRANSLATION The accumulated other comprehensive loss account in stockholders’ equity of $319,007 and $340,112 at December 31, 2018 and 2019, respectively, includes the cumulative foreign currency losses of $315,300 and $328,053, respectively, from translating the financial statements of the Company’s international subsidiaries and the change in fair values of the Company’s interest rate swap agreements designated as hedges. As of December 31, 2019, all foreign countries where the Company has operations, other than Argentina, are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year Foreign Currency Matters Below is a summary of the impact of translating the financial statements of all of the Company’s international subsidiaries as of and for the years ended December 31, 2017, 2018 and 2019. Other Comprehensive Income (Loss) Exchange Rate as of December 31, For the Year Ended December 31, Country 2017 2018 2019 2017 2018 (1) 2019 (1) Brazil 3.31 3.88 4.02 $ (4,567 ) $ (34,086 ) $ (8,140 ) Argentina (1) 18.65 37.68 59.89 (8,200 ) (14,357 ) — Colombia 2,936.67 3,249.75 3,277.14 246 (1,795 ) (362 ) Chile 615.97 694.74 736.86 5,672 (8,924 ) (5,158 ) Peru 3.24 3.39 3.37 2,752 (2,136 ) 257 All other (869 ) (955 ) 650 $ (4,966 ) $ (62,253 ) $ (12,753 ) (1) For Argentina, represents the cumulative comprehensive loss recorded through June 30, 2018. The impact of translating Argentina financial results to U.S. dollars, subsequent to June 30, 2018, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statements of income. Losses of $1,463 and $3,707 were recorded for the years ended December 31, 2018 and 2019, respectively. During the year ended December 31, 2017, the Company reclassified $1,551 of cumulative foreign currency translation adjustments, related to a Canadian subsidiary that was liquidated, from accumulated other comprehensive loss to foreign currency exchange gain (loss) on the consolidated statement of income. During the year ended December 31, 2018, the Company reclassified $518 of cumulative foreign currency translation adjustments, related to the settlement of an intercompany note between a domestic and an international subsidiary, from accumulated other comprehensive loss to foreign currency exchange gain (loss) on the consolidated statement of income.

NONCONTROLLING INTERESTS IN SUB

NONCONTROLLING INTERESTS IN SUBSIDIARIES	12 Months Ended
	Dec. 31, 2019
Noncontrolling Interest [Abstract]
NONCONTROLLING INTERESTS IN SUBSIDIARIES	13. NONCONTROLLING INTERESTS IN SUBSIDIARIES Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2018 2019 Cinemark Partners II — 24.6% interest (in one theatre) $ 8,152 $ 7,953 Laredo Theatres – 25% interest (in two theatres) 2,308 2,139 Greeley Ltd. — 49% interest (in one theatre) 1,411 1,908 Other 508 508 Total $ 12,379 $ 12,508 There were no changes in the Company’s ownership interest in its subsidiaries during the years ended December 31, 2017, 2018 and 2019.

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
CAPITAL STOCK	14. CAPITAL STOCK Common and Preferred Stock — Cinemark USA, Inc. has 1,500 shares of Class A common stock and 182,648 shares of Class B common stock outstanding, all of which are held by Cinemark Holdings, Inc. Holders of Class A common stock have exclusive voting rights. Holders of Class B common stock have no voting rights except upon any proposed amendments to the articles of incorporation. However, they may convert their Class B common stock, at their option, to Class A common stock. In the event of any liquidation, holders of the Class A and Class B common stock will be entitled to their pro-rata share of assets remaining after any holders of preferred stock have received their preferential amounts based on their respective shares held. The Company has 1,000,000 shares of preferred stock, $1.00 par value, authorized with none issued or outstanding. The rights and preferences of preferred stock will be determined by the Board of Directors at the time of issuance. The Company’s ability to pay dividends is effectively limited by the terms of its indentures and its senior secured credit facility, which also significantly restricts the ability of certain of the Company’s subsidiaries to pay dividends directly or indirectly to it. See Note 10 for a discussion of restrictions contained within the debt agreements. Restricted Stock — Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2017, 2018 and 2019. Year Ended Year Ended Year Ended December 31, 2017 December 31, 2018 December 31, 2019 Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Outstanding at January 1 606,618 $ 33.51 650,581 $ 35.81 704,353 $ 38.68 Granted 246,534 $ 41.70 328,734 $ 38.72 315,899 $ 37.34 Vested (192,230 ) $ 36.26 (250,442 ) $ 31.27 (209,821 ) $ 41.10 Forfeited (10,341 ) $ 33.48 (24,520 ) $ 38.62 (26,608 ) $ 37.69 Outstanding at December 31 650,581 $ 35.81 704,353 $ 38.68 783,823 $ 37.53 During the year ended December 31, 2019, Cinemark Holdings, Inc. granted 315,899 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $34.01 to $41.61 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. Restricted stock granted to directors vests over a one-year Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2017 2018 2019 Compensation expense recognized by the Company during the period $ 7,528 $ 8,735 $ 9,266 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 856 $ 920 $ 919 Fair value of restricted shares held by Company employees that vested during the period $ 7,255 $ 8,699 $ 7,044 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 917 $ 802 $ 980 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 2,281 $ 1,543 $ 1,271 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 386 $ 201 $ 245 As of December 31, 2019, the remaining unrecognized compensation expense related to these restricted stock awards was approximately $15,524, of which $15,107 will be recognized by the Company and $417 of which will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. Restricted Stock Units — During the years ended December 31, 2017, 2018 and 2019, Cinemark Holdings, Inc. granted restricted stock units representing 175,634, 228,194 and 306,651 hypothetical shares of Cinemark Holdings, Inc.’s common stock, respectively, to employees of the Company. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement). The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. As an example, if the Company achieves an IRR equal to 9.0% for the 2017 grant, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date. At the time of each of the restricted stock unit grants, the Company assumes the IRR level to be reached for the defined measurement period will be the target IRR level in determining the amount of compensation expense to record for such grants. If and when additional information becomes available to indicate that something other than the target IRR level will be achieved, the Company adjusts compensation expense on a prospective basis over the remaining service period. The Company assumed forfeiture rates ranging from 0% to 5% for the restricted stock unit awards granted during 2017, 2018 and 2019. Restricted stock unit award participants are eligible to receive dividend equivalent payments if and at the time the restricted stock unit awards vest. Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2017, 2018 and 2019 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2017 2018 2019 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 58,545 $ 2,481 76,065 $ 2,967 136,285 $ 5,011 at target IRR 117,089 $ 4,961 152,129 $ 5,938 204,427 $ 7,517 at maximum IRR 175,634 $ 7,442 228,194 $ 8,906 306,651 $ 11,276 (1) The grant date fair value for units issued during the year ended December 31, 2017 was $42.37. The grant date fair values for the units issued during the year ended December 31, 2018 ranged from $37.55 to $39.03. The grant date fair value for units issued during the year ended December 31, 2019 was $36.77 per share. Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2017 2018 2019 Number of restricted stock unit awards that vested during the period 97,115 127,084 90,895 Fair value of restricted stock unit awards that vested during the period $ 4,155 $ 4,846 $ 3,658 Accumulated dividends paid upon vesting of restricted stock unit awards $ 558 $ 526 $ 386 Compensation expense recognized during the period $ 4,297 $ 4,681 $ 4,430 Income tax benefit recognized upon vesting of restricted stock unit awards $ 1,745 $ 708 $ 397 During the year ended December 31, 2019, the Company modified the performance target levels for the restricted stock unit awards granted during February 2017 and February 2018 for all participants other than certain executive officers. The modification adjusted the threshold, target and maximum IRR levels from 7.0%, 9.5% and 13.0%, respectively, to 6.0%, 8.0% and 14.0%, respectively. The Company accounted for the change in performance measures as modifications of each award, and recorded a reduction to compensation expense of $132 at the time of the modification. Simultaneous with the modification of the restricted stock unit awards granted during February 2017, the Company determined that the final IRR reached for the respective measurement period was 9.3%, which resulted in a reduction in compensation expense of approximately $563. The current financial performance factors and respective vesting rates for each of the 2017, 2018 and 2019 grants are as follows: Year Ended December 31, Percentage of Shares Vesting 2017 2018 2019 Threshold IRR 6.0% 6.0% 6.0% 33.3% Target IRR 8.0% 8.0% 8.0% 66.6% Maximum IRR 14.0% 14.0% 14.0% 100.0% As of December 31, 2019, the Company had restricted stock units outstanding that represented a total 749,895 hypothetical shares of common stock, net of actual cumulative forfeitures of 6,195 units, assuming the maximum IRR is achieved for all of the outstanding restricted stock unit awards. As of December 31, 2019, the remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $9,872, which reflects an IRR level of 7.2% that was achieved for the 2016 grant, an IRR level of 9.3% that was achieved for the 2017 grant and an IRR level of 8.0% that is estimated for the 2018 and 2019 grants. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

SUPPLEMENTAL CASH FLOW INFORMAT

SUPPLEMENTAL CASH FLOW INFORMATION	12 Months Ended
	Dec. 31, 2019
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL CASH FLOW INFORMATION	15. SUPPLEMENTAL CASH FLOW INFORMATION The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2017 2018 2019 Cash paid for interest $ 99,232 $ 98,411 $ 93,907 Cash paid for income taxes, net of refunds received $ 95,043 $ 64,199 $ 88,670 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ 9,349 $ (5,728 ) $ 22,013 Theatre properties acquired under finance leases $ 46,727 $ 18,851 $ 21,535 Investment in NCM – receipt of common units (see Note 5) $ 18,363 $ 5,012 $ 1,552 Interest expense - NCM (see Notes 4 and 5) $ — $ (19,724 ) $ (28,624 ) (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2018 and 2019 were $37,004 and $14,991, respectively.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	16. INCOME TAXES On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries, and (4) created new taxes on certain foreign-sourced earnings. As of December 31, 2018, the amounts recorded for the Tax Act were final for the 2017 transition tax, the remeasurement of deferred taxes and the Company’s reassessment of valuation allowances. The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2017 2018 2019 Income before income taxes: U.S. $ 282,896 $ 292,238 $ 238,108 Foreign 64,842 21,007 38,189 Total $ 347,738 $ 313,245 $ 276,297 Current and deferred income taxes were as follows: Year Ended December 31, 2017 2018 2019 Current: Federal $ 55,224 $ 47,333 $ 45,758 Foreign 29,306 11,822 24,022 State 10,741 13,690 12,583 Total current expense $ 95,271 $ 72,845 $ 82,363 Deferred: Federal $ (14,046 ) $ 27,055 $ (298 ) Foreign (4,270 ) (6,166 ) 5 State 3,301 2,298 (1,550 ) Total deferred taxes $ (15,015 ) $ 23,187 $ (1,843 ) Income taxes $ 80,256 $ 96,032 $ 80,520 A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2017 2018 2019 Computed statutory tax expense $ 121,708 $ 65,781 $ 58,022 State and local income taxes, net of federal income tax impact 12,858 12,687 8,555 Changes in valuation allowance 44 131 2,532 Foreign tax rate differential (245 ) 2,235 4,646 Foreign dividends 13,662 — — Foreign tax credits (21,647 ) 3,927 4,143 Impacts related to 2017 Tax Act (1)(2) (44,889 ) 19,180 — Changes in uncertain tax positions 983 (6,139 ) 197 Other — net (2,218 ) (1,770 ) 2,425 Income taxes $ 80,256 $ 96,032 $ 80,520 (1) The amount for the year ended December 31, 2018 includes a one-time charge to true-up deferred taxes of $1,913 and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $17,267. (2) The amount for the year ended December 31, 2017 includes a one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433. As of December 31, 2019, the Company had approximately $432,994 of accumulated undistributed earnings and profits, approximately $370,389 of which was subject to the one-time transition tax pursuant to the Tax Act. Any additional tax due on the repatriation of previously taxed earnings would generally be foreign withholding and U.S. state income taxes. The Company does not intend to repatriate these offshore earnings and profits, and therefore has not recorded any deferred taxes on such earnings. The Company considers any excess of the amount for financial reporting over the tax basis of its investment in its foreign subsidiaries to be indefinitely reinvested. At this time, the determination of deferred tax liabilities on this amount is not practicable. Deferred Income Taxes The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2018 and 2019 consisted of the following: December 31, 2018 2019 Deferred liabilities: Theatre properties and equipment $ 158,797 $ 138,382 Operating lease right-of-use assets — 322,750 Intangible asset — other 33,561 39,282 Intangible asset — tradenames 73,261 72,821 Investment in partnerships 63,217 62,914 Total deferred liabilities 328,836 636,149 Deferred assets: Deferred lease expenses 13,464 — Deferred revenue - NCM 86,035 85,362 Deferred revenue - Other 4,153 9,953 Gift Cards 6,173 7,402 Operating lease obligations — 336,034 Finance lease obligations 63,895 34,956 Tax impact of items in accumulated other comprehensive income 2,237 5,131 Other tax loss carryforwards 15,608 17,053 Other tax credit carryforwards 42,989 46,577 Other expenses, not currently deductible for tax purposes 17,755 21,573 Total deferred assets 252,309 564,041 Net deferred income tax liability before valuation allowance 76,527 72,108 Valuation allowance against deferred assets – non-current 54,725 60,359 Net deferred income tax liability $ 131,252 $ 132,467 Net deferred tax (asset) liability — Foreign $ (5,449 ) $ (4,539 ) Net deferred tax liability — U.S. 136,701 137,006 Total $ 131,252 $ 132,467 A significant portion of our foreign tax credit carryforwards expire in 2024. Some foreign net operating losses expired in 2019; however, some losses may be carried forward indefinitely. State net operating losses may be carried forward for periods of between five and twenty years with the last expiring year being 2037. The Company’s valuation allowance changed from $54,725 at December 31, 2018 to $60,359 at December 31, 2019 (see Note 20). The change was a result of an increase for foreign tax credit carryovers and certain foreign net operating losses, partially offset by a decrease for state net operating losses. Uncertain Tax Positions The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2017, 2018 and 2019: Year Ended December 31, 2017 2018 2019 Balance at January 1, $ 17,403 $ 18,266 $ 10,561 Gross increases - tax positions in prior periods 92 — 1 Gross decreases - tax positions in prior periods (12 ) (143 ) — Gross increases - current period tax positions 265 424 202 Settlements (177 ) (7,191 ) (522 ) Foreign currency translation adjustments 695 (795 ) (7 ) Balance at December 31, $ 18,266 $ 10,561 $ 10,235 The Company had $13,953 and $14,294 of unrecognized tax benefits, including interest and penalties, as of December 31, 2018 and 2019, respectively. Of these amounts, $13,953 and $14,294 represent the amount of unrecognized tax benefits that, if recognized, would impact the effective income tax rate for the years ended December 31, 2018 and 2019, respectively. The Company had $3,390 and $4,058 accrued for interest and penalties as of December 31, 2018 and 2019, respectively. The Company believes that it is reasonably possible that certain tax positions related to its unrecognized tax benefits will be effectively settled within the next twelve months. The Company estimates a potential decrease of $9,494 to its unrecognized tax benefits and a corresponding decrease in accrued interest of $3,952. The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and in certain state and foreign jurisdictions and are routinely under audit by many different tax authorities. The Company believes that its accrual for tax liabilities is adequate for all open audit years based on its assessment of many factors including past experience and interpretations of tax law. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events. The Company is no longer subject to income tax audits from the Internal Revenue Service for years before 2017. The Company is no longer subject to state income tax examinations by tax authorities in its major state jurisdictions for years before 2015. The Company is no longer subject to non-U.S. income tax examinations by tax authorities in its major non-U.S. tax jurisdictions for years before 2006. The Company is currently under audit in the non-U.S. tax jurisdiction of Brazil.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2019
Commitments And Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	17. COMMITMENTS AND CONTINGENCIES Employment Agreements — As of December 31, 2019, the Company had employment agreements with Lee Roy Mitchell, Mark Zoradi, Sean Gamble, Valmir Fernandes and Michael Cavalier. The employment agreements for Messrs. Mitchell, Gamble, Fernandes and Cavalier are subject to automatic extensions for a one year period, unless the employment agreements are terminated. The employment agreement for Mr. Zoradi will expire on December 31, 2020 unless extended by the Company and Mr. Zoradi. The base salaries stipulated in the employment agreements are subject to review at least annually during the term of the agreements for increase (but not decrease) by Cinemark Holdings, Inc.’s Compensation Committee. Management personnel subject to these employment agreements are eligible to receive annual cash incentive bonuses upon the Company meeting certain performance targets established by the Compensation Committee within the first 90 days of the fiscal year. Retirement Savings Plan — The Company has a 401(k) retirement savings plan (“401(k) Plan”) for the benefit of all eligible employees and makes matching contributions as determined annually in accordance with the 401(k) Plan. Employer matching contribution payments of $5,076 and $6,052 were made during 2018 and 2019, respectively. A liability of approximately $1,539 was recorded at December 31, 2019 for employer contribution payments to be made in 2020 for the remaining amounts owed for plan year 2019. Legal Proceedings Intertrust Technologies Corporation (“Intertrust”) v. Cinemark Holdings, Inc., Regal, AMC, et al . This case was filed against the Company on August 7, 2019 in the Eastern District of Texas – Marshall Division alleging patent infringement. The Company firmly maintains that the contentions of the Plaintiff are without merit and will vigorously defend itself against the lawsuit. Although the Company does not believe that it has infringed on any of Intertrust’s patents, it cannot predict the outcome of this litigation. Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles . Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortiously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During 2018, the Company recorded a litigation reserve based on the jury award, court costs and attorney’s fees. The trial court denied a motion for a judgment notwithstanding the verdict and a motion for a new trial. The Company has appealed the judgment. Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals. Civil Investigative Demand. The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations. From time to time, the Company is involved in other various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance or by indemnification from vendors. The Company believes its potential liability with respect to these types of proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

SEGMENTS

SEGMENTS	12 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
SEGMENTS	18. SEGMENTS The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report asset information by segment because that information is not used to evaluate Company performance or allocate resources between segments. Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2017 2018 2019 Revenues U.S. $ 2,236,237 $ 2,551,719 $ 2,594,246 International 769,436 682,778 702,196 Eliminations (14,126 ) (12,762 ) (13,343 ) Total revenues $ 2,991,547 $ 3,221,735 $ 3,283,099 Adjusted EBITDA U.S. $ 559,693 $ 650,189 $ 616,799 International 165,576 132,941 129,884 Total Adjusted EBITDA $ 725,269 $ 783,130 $ 746,683 Capital expenditures U.S. $ 321,040 $ 270,870 $ 230,561 International 59,822 75,203 73,066 Total capital expenditures $ 380,862 $ 346,073 $ 303,627 (1) The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2017 2018 2019 Net income $ 267,482 $ 217,213 $ 195,777 Add (deduct): Income taxes 80,256 96,032 80,520 Interest expense (1)(2) 105,918 109,994 99,941 Loss on debt amendments and refinancing 521 1,484 — Other income (3) (43,121 ) (18,450 ) (22,422 ) Distributions from DCIP (4) 5,864 5,799 23,696 Other cash distributions from equity investees (5) 20,109 24,344 29,670 Depreciation and amortization (2) 237,513 261,162 261,155 Impairment of long-lived assets 15,084 32,372 57,001 Loss on disposal of assets and other 22,812 38,702 12,008 Non-cash rent expense (6) — — (4,360 ) Deferred lease expenses (2) (1,268 ) (1,320 ) — Amortization of long-term prepaid rents (2) 2,274 2,382 — Share based awards compensation expense 11,825 13,416 13,697 Adjusted EBITDA (2) $ 725,269 $ 783,130 $ 746,683 (1) (2) (3) (4) (5) (6) The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives. Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases. See Note 3 for discussion of the impact of ASC Topic 842. Financial Information About Geographic Area Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2017 2018 2019 Revenues U.S. $ 2,236,237 $ 2,551,719 $ 2,594,246 Brazil 341,485 283,009 302,074 Other international countries 427,951 399,769 400,122 Eliminations (14,126 ) (12,762 ) (13,343 ) Total $ 2,991,547 $ 3,221,735 $ 3,283,099 December 31, 2018 December 31, 2019 Theatre Properties and Equipment-net U.S. $ 1,479,603 $ 1,436,275 Brazil 140,570 118,367 Other international countries 212,960 180,605 Total $ 1,833,133 $ 1,735,247

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	19. RELATED PARTY TRANSACTIONS The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board and directly and indirectly owns approximately 8% of Cinemark Holding’s Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $586, $654 and $694 of management fee revenues during the years ended December 31, 2017, 2018 and 2019, respectively. All such amounts are included in the Company’s consolidated financial statements with the intercompany amounts eliminated in consolidation. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the years ended December 31, 2017, 2018 and 2019, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was approximately $131, $68 and $114, respectively. The Company holds events for its employees and their families at Pinstack, an entertainment facility, at various times throughout the year. Pinstack is majority-owned by Mr. Mitchell and his wife, Tandy Mitchell. In connection with these events, the Company paid Pinstack approximately $36 and $5 during the years ended December 31, 2017 and 2018 , respectively. The Company currently leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the years ended December 31, 2017, 2018 and 2019, the Company paid total rent of approximately $22,483, $23,447 and $25,678, respectively, to Syufy. During 2019, the Company began providing digital equipment support to drive-in theatres owned by Syufy. The Company recorded approximately $30 of management fees related to these services during the year ended December 31, 2019. The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 6 for further discussion. The Company has a theatre services agreement with FE Concepts under which the Company receives management fees for providing film booking and equipment monitoring services for the facility. The Company recorded $64 of management fees during the year ended December 31, 2019. The Company held its 2019 holiday party at the facility owned by FE Concepts for which the Company paid FE Concepts $78 in event fees.

VALUATION AND QUALIFYING ACCOUN

VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2019
Valuation And Qualifying Accounts [Abstract]
VALUATION AND QUALIFYING ACCOUNTS	20. VALUATION AND QUALIFYING ACCOUNTS The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2017, 2018 and 2019 were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2017 $ 14,524 Additions 21,347 Deductions (625 ) Balance at December 31, 2017 $ 35,246 Additions 22,005 Deductions (2,526 ) Balance at December 31, 2018 $ 54,725 Additions 7,611 Deductions (1,977 ) Balance at December 31, 2019 $ 60,359

Condensed Consolidating Financi

Condensed Consolidating Financial Information of Subsidiary Guarantors	12 Months Ended
	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Condensed Consolidating Financial Information of Subsidiary Guarantors	21. Condensed Consolidating Financial Information of Subsidiary Guarantors As of December 31, 2019, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.: Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC. The following supplemental condensed consolidating financial information presents: a. Condensed consolidating balance sheet information as of December 31, 2018 and December 31, 2019 and condensed consolidating statements of income information, condensed consolidating statements of comprehensive income information and condensed consolidating statements of cash flows information for the years ended December 31, 2017, 2018 and 2019. b. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column. c. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 Other current assets 60,829 19,997 67,149 (15,178 ) 132,797 Accounts receivable from parent or subsidiaries — 284,893 — (265,363 ) 19,530 Total current assets 258,794 315,776 284,514 (280,541 ) 578,543 Theatre properties and equipment - net 664,759 789,536 378,838 - 1,833,133 Investment in subsidiaries 1,806,255 57,845 - (1,864,100 ) - Other assets 1,500,366 155,011 546,834 (112,536 ) 2,089,675 Total assets $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of capital lease obligations 11,918 9,406 5,741 — 27,065 Accounts payable and accrued expenses 297,302 58,544 96,780 (13,622 ) 439,004 Accounts payable to parent or subsidiaries 40,421 — 224,942 (265,363 ) - Total current liabilities 356,236 67,950 328,852 (278,985 ) 474,053 Long-term liabilities Long-term debt, less current portion 1,872,627 — 7,955 (107,955 ) 1,772,627 Capital lease obligations, less current portion 123,329 59,539 49,599 — 232,467 Other long-term liabilities and deferrals 460,725 60,137 77,843 (6,137 ) 592,568 Total long-term liabilities 2,456,681 119,676 135,397 (114,092 ) 2,597,662 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,367,714 673,174 723,320 (1,396,494 ) 1,367,714 Total Cinemark USA, Inc. stockholder's equity 1,417,257 1,130,542 733,558 (1,864,100 ) 1,417,257 Noncontrolling interests — — 12,379 — 12,379 Total equity 1,417,257 1,130,542 745,937 (1,864,100 ) 1,429,636 Total liabilities and equity $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 179,162 $ 5,704 $ 303,349 $ — $ 488,215 Other current assets 64,901 30,532 68,274 (17,030 ) 146,677 Accounts receivable from parent or subsidiaries — 408,245 — (383,926 ) 24,319 Total current assets 244,063 444,481 371,623 (400,956 ) 659,211 Theatre properties and equipment - net 659,538 752,599 323,110 — 1,735,247 Operating lease right-of-use assets 710,192 467,344 205,544 — 1,383,080 Investment in subsidiaries 1,961,159 26,719 — (1,987,878 ) — Other assets 1,489,285 157,025 538,083 (109,693 ) 2,074,700 Total assets $ 5,064,237 $ 1,848,168 $ 1,438,360 $ (2,498,527 ) $ 5,852,238 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ — $ — $ 6,595 Current portion of operating lease obligations 99,924 86,828 30,654 — 217,406 Current portion of finance lease obligations 11,073 4,289 70 — 15,432 Accounts payable and accrued expenses 322,849 56,249 104,575 (14,935 ) 468,738 Accounts payable to parent or subsidiaries 132,832 — 251,094 (383,926 ) — Total current liabilities 573,273 147,366 386,393 (398,861 ) 708,171 Long-term liabilities Long-term debt, less current portion 1,871,342 — 4,455 (104,455 ) 1,771,342 Operating lease obligations, less current portion 639,847 414,099 169,516 — 1,223,462 Finance lease obligations, less current portion 91,524 49,121 372 — 141,017 Other long-term liabilities and deferrals 426,552 37,346 77,474 (7,333 ) 534,039 Total long-term liabilities 3,029,265 500,566 251,817 (111,788 ) 3,669,860 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,412,156 742,868 777,404 (1,520,272 ) 1,412,156 Total Cinemark USA, Inc. stockholder's equity 1,461,699 1,200,236 787,642 (1,987,878 ) 1,461,699 Noncontrolling interests — — 12,508 — 12,508 Total equity 1,461,699 1,200,236 800,150 (1,987,878 ) 1,474,207 Total liabilities and equity $ 5,064,237 $ 1,848,168 $ 1,438,360 $ (2,498,527 ) $ 5,852,238 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,013,960 $ 1,220,993 $ 807,350 $ (50,756 ) $ 2,991,547 Cost of operations Theatre operating expenses 795,976 834,135 591,223 (50,756 ) 2,170,578 General and administrative expenses 13,176 82,955 54,780 — 150,911 Depreciation and amortization 79,676 87,463 70,374 — 237,513 Impairment of long-lived assets 3,725 1,502 9,857 — 15,084 Loss on disposal of assets and other 16,895 3,372 2,545 — 22,812 Total cost of operations 909,448 1,009,427 728,779 (50,756 ) 2,596,898 Operating income 104,512 211,566 78,571 — 394,649 Other income (expense) Interest expense (94,229 ) (7,675 ) (5,447 ) 1,433 (105,918 ) Loss on debt amendments and refinancing (521 ) — — — (521 ) Distributions from NCM — — 16,407 — 16,407 Equity in income of affiliates 255,594 16,838 33,742 (270,189 ) 35,985 Other income 2,475 1,040 5,054 (1,433 ) 7,136 Total other income 163,319 10,203 49,756 (270,189 ) (46,911 ) Income before income taxes 267,831 221,769 128,327 (270,189 ) 347,738 Income taxes 2,188 69,770 8,298 — 80,256 Net income 265,643 151,999 120,029 (270,189 ) 267,482 Less: Net income attributable to noncontrolling interests — — 1,839 — 1,839 Net income attributable to Cinemark USA, Inc. $ 265,643 $ 151,999 $ 118,190 $ (270,189 ) $ 265,643 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,192,478 $ 1,362,043 $ 723,804 $ (56,590 ) $ 3,221,735 Cost of operations Theatre operating expenses 916,726 933,858 541,981 (56,590 ) 2,335,975 General and administrative expenses 11,497 100,407 50,736 — 162,640 Depreciation and amortization 89,429 99,627 72,106 — 261,162 Impairment of long-lived assets 4,118 13,612 14,642 — 32,372 Loss on disposal of assets and other 13,321 23,337 2,044 — 38,702 Total cost of operations 1,035,091 1,170,841 681,509 (56,590 ) 2,830,851 Operating income 157,387 191,202 42,295 — 390,884 Other income (expense) Interest expense (97,585 ) (6,520 ) (7,266 ) 1,377 (109,994 ) Loss on debt amendments and refinancing (1,484 ) — — — (1,484 ) Distributions from NCM — — 15,389 — 15,389 Interest expense - NCM (19,724 ) — — — (19,724 ) Equity in income of affiliates 183,463 (12,561 ) 33,167 (164,827 ) 39,242 Other income (loss) 4,287 (14 ) (3,964 ) (1,377 ) (1,068 ) Total other income 68,957 (19,095 ) 37,326 (164,827 ) (77,639 ) Income before income taxes 226,344 172,107 79,621 (164,827 ) 313,245 Income taxes 10,609 68,624 16,799 — 96,032 Net income 215,735 103,483 62,822 (164,827 ) 217,213 Less: Net income attributable to noncontrolling interests — — 1,478 — 1,478 Net income attributable to Cinemark USA, Inc. $ 215,735 $ 103,483 $ 61,344 $ (164,827 ) $ 215,735 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,216,308 $ 1,376,109 $ 746,858 $ (56,176 ) $ 3,283,099 Cost of operations Theatre operating expenses 947,745 981,665 567,930 (56,176 ) 2,441,164 General and administrative expenses 11,975 109,422 49,431 — 170,828 Depreciation and amortization 91,681 103,168 66,306 — 261,155 Impairment of long-lived assets 9,951 36,511 10,539 — 57,001 Loss on disposal of assets and other 5,068 4,925 2,015 — 12,008 Total cost of operations 1,066,420 1,235,691 696,221 (56,176 ) 2,942,156 Operating income 149,888 140,418 50,637 — 340,943 Other income (expense) Interest expense (97,894 ) (2,432 ) (923 ) 1,308 (99,941 ) Distributions from NCM — — 12,873 — 12,873 Interest expense - NCM (28,624 ) — — — (28,624 ) Equity in income of affiliates 171,193 (9,270 ) 33,647 (153,700 ) 41,870 Other income (loss) 4,050 (24 ) 6,458 (1,308 ) 9,176 Total other income 48,725 (11,726 ) 52,055 (153,700 ) (64,646 ) Income before income taxes 198,613 128,692 102,692 (153,700 ) 276,297 Income taxes 5,298 41,646 33,576 — 80,520 Net income 193,315 87,046 69,116 (153,700 ) 195,777 Less: Net income attributable to noncontrolling interests — — 2,462 — 2,462 Net income attributable to Cinemark USA, Inc. $ 193,315 $ 87,046 $ 66,654 $ (153,700 ) $ 193,315 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED December Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Other comprehensive loss, net of tax Other comprehensive income of equity method investments 248 — 248 (248 ) 248 Foreign currency translation adjustments (4,966 ) — (4,966 ) 4,966 (4,966 ) Total other comprehensive loss, net of tax (4,718 ) — (4,718 ) 4,718 (4,718 ) Total comprehensive income, net of tax $ 260,925 $ 151,999 $ 115,311 $ (265,471 ) $ 262,764 Comprehensive income attributable to noncontrolling interests — — (1,839 ) — (1,839 ) Comprehensive income attributable to Cinemark USA, Inc. $ 260,925 $ 151,999 $ 113,472 $ (265,471 ) $ 260,925 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 215,735 $ 103,483 $ 62,822 $ (164,827 ) $ 217,213 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1,243, net of settlements (3,851 ) — — — (3,851 ) Other comprehensive loss of equity method investments (139 ) — (139 ) 139 (139 ) Foreign currency translation adjustments (62,253 ) — (62,253 ) 62,253 (62,253 ) Total other comprehensive loss, net of tax (66,243 ) — (62,392 ) 62,392 (66,243 ) Total comprehensive income, net of tax $ 149,492 $ 103,483 $ 430 $ (102,435 ) $ 150,970 Comprehensive income attributable to noncontrolling interests — — (1,478 ) — (1,478 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 149,492 $ 103,483 $ (1,048 ) $ (102,435 ) $ 149,492 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 193,315 $ 87,046 $ 69,116 $ (153,700 ) $ 195,777 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $2,692, net of settlements (8,210 ) — — — (8,210 ) Other comprehensive income of equity method investments (142 ) — (142 ) 142 (142 ) Foreign currency translation adjustments (12,753 ) — (12,753 ) 12,753 (12,753 ) Total other comprehensive loss, net of tax (21,105 ) — (12,895 ) 12,895 (21,105 ) Total comprehensive income, net of tax $ 172,210 $ 87,046 $ 56,221 $ (140,805 ) $ 174,672 Comprehensive income attributable to noncontrolling interests — — (2,462 ) — (2,462 ) Comprehensive income attributable to Cinemark USA, Inc. $ 172,210 $ 87,046 $ 53,759 $ (140,805 ) $ 172,210 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED December Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Adjustments to reconcile net income to cash provided by operating activities (122,559 ) 71,023 33,515 270,189 252,168 Changes in assets and liabilities 18,223 (35,138 ) 25,649 — 8,734 Net cash provided by operating activities 161,307 187,884 179,193 — 528,384 Investing activities Additions to theatre properties and equipment (146,385 ) (172,874 ) (61,603 ) — (380,862 ) Acquisition of theatres in the U.S. and international markets, net of cash acquired (12,500 ) — (28,497 ) — (40,997 ) Proceeds from sale of theatre properties and equipment and other 2,149 12,271 678 — 15,098 Dividends received from subsidiaries 127,600 1,873 — (129,473 ) — Investment in joint ventures and other — (104 ) (3,611 ) — (3,715 ) Net cash used for investing activities (29,136 ) (158,834 ) (93,033 ) (129,473 ) (410,476 ) Financing Activities Dividends paid to parent (134,500 ) (127,000 ) (2,473 ) 129,473 (134,500 ) Repayments of long-term debt (4,282 ) — (1,389 ) — (5,671 ) Payments on capital leases (7,952 ) (9,707 ) (4,066 ) — (21,725 ) Fees paid related to debt amendments (521 ) — — — (521 ) Proceeds from financing lease — 10,200 — — 10,200 Other (1,181 ) (2,943 ) (1,088 ) — (5,212 ) Net cash used for financing activities (148,436 ) (129,450 ) (9,016 ) 129,473 (157,429 ) Effect of exchange rate changes on cash and cash equivalents — — 798 — 798 Increase (decrease) in cash and cash equivalents (16,265 ) (100,400 ) 77,942 — (38,723 ) Cash and cash equivalents: Beginning of year 146,855 281,023 133,260 — 561,138 End of year $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 215,735 $ 103,483 $ 62,822 $ (164,827 ) $ 217,213 Adjustments to reconcile net income to cash provided by operating activities (36,894 ) 162,811 55,915 164,827 346,659 Changes in assets and liabilities 229,326 (233,263 ) (3,636 ) — (7,573 ) Net cash provided by operating activities 408,167 33,031 115,101 — 556,299 Investing activities Additions to theatre properties and equipment (91,244 ) (173,042 ) (81,787 ) — (346,073 ) Acquisition of theatres in international markets, net of cash acquired — — (11,289 ) — (11,289 ) Proceeds from sale of theatre properties and equipment and other 1,244 2,025 651 — 3,920 Proceeds from intercompany note repayments 1,867 — — (1,867 ) — Acquisition of NCM common units (78,393 ) — — — (78,393 ) Investment in joint ventures and other — (19,896 ) 361 — (19,535 ) Net cash used for investing activities (166,526 ) (190,913 ) (92,064 ) (1,867 ) (451,370 ) Financing activities Dividends paid to parent (148,750 ) — — — (148,750 ) Repayments of long-term debt (7,984 ) — — — (7,984 ) Payment of debt issue costs (5,218 ) — — — (5,218 ) Payments on capital leases (11,610 ) (8,950 ) (4,793 ) — (25,353 ) Payments on intercompany loans — — (1,867 ) 1,867 — Other (704 ) (2,905 ) (992 ) — (4,601 ) Net cash used for financing activities (174,266 ) (11,855 ) (7,652 ) 1,867 (191,906 ) Effect of exchange rate changes on cash and cash equivalents — — (9,222 ) — (9,222 ) Increase (decrease) in cash and cash equivalents 67,375 (169,737 ) 6,163 — (96,199 ) Cash and cash equivalents: Beginning of year 130,590 180,623 211,202 — 522,415 End of year $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 193,315 $ 87,046 $ 69,116 $ (153,700 ) $ 195,777 Adjustments to reconcile net income to cash provided by operating activities (57,371 ) 159,150 85,242 153,700 340,721 Changes in assets and liabilities 135,883 (128,525 ) 17,216 — 24,574 Net cash provided by operating activities 271,827 117,671 171,574 — 561,072 Investing activities Additions to theatre properties and equipment (107,955 ) (121,434 ) (74,238 ) — (303,627 ) Acquisition of theatres in U.S. markets, net of cash acquired (10,170 ) — — — (10,170 ) Proceeds from sale of theatre properties and equipment and other 1,687 1,154 314 — 3,155 Dividends received from subsidiary 1,345 4,523 — (5,868 ) — Net cash used for investing activities (115,093 ) (115,757 ) (73,924 ) (5,868 ) (310,642 ) Financing activities Dividends paid to parent (158,450 ) (745 ) (5,123 ) 5,868 (158,450 ) Repayments of long-term debt (6,595 ) — (1,389 ) — (7,984 ) Payments on finance leases (10,492 ) (4,043 ) (65 ) — (14,600 ) Other — (2,308 ) (2,333 ) — (4,641 ) Net cash used for financing activities (175,537 ) (7,096 ) (8,910 ) 5,868 (185,675 ) Effect of exchange rate changes on cash and cash equivalents — — (2,756 ) — (2,756 ) Increase (decrease) in cash and cash equivalents (18,803 ) (5,182 ) 85,984 — 61,999 Cash and cash equivalents: Beginning of year 197,965 10,886 217,365 — 426,216 End of year $ 179,162 $ 5,704 $ 303,349 $ — $ 488,215 * * * * *

Unaudited Supplemental Schedule

Unaudited Supplemental Schedules	12 Months Ended
	Dec. 31, 2019
Supplemental Financial Information For Indentures [Abstract]
Unaudited Supplemental Schedules	UNAUDITED SUPPLEMENTAL SCHEDULES As required by the indentures governing the Company’s 5.125% Senior Notes and 4.875% Senior Notes (collectively the “Notes”), the Company has included in this filing, financial information for its subsidiaries that have been designated as unrestricted subsidiaries as defined by the indentures. As required by the indentures governing the Notes, the Company has included a condensed consolidating balance sheet and condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. These supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2019 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 364,218 $ 123,997 $ — $ 488,215 Other current assets 296,608 (121,210 ) (4,402 ) 170,996 Total current assets 660,826 2,787 (4,402 ) 659,211 Theatre properties and equipment, net 1,735,247 — — 1,735,247 Operating lease right-of-use assets 1,383,080 — — 1,383,080 Other assets 1,905,837 523,082 (354,219 ) 2,074,700 Total assets $ 5,684,990 $ 525,869 $ (358,621 ) $ 5,852,238 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ — $ 6,595 Current portion of operating lease obligations 217,406 — — 217,406 Current portion of finance lease obligations 15,432 — — 15,432 Accounts payable and accrued expenses 473,140 — (4,402 ) 468,738 Total current liabilities 712,573 — (4,402 ) 708,171 Long-term liabilities Long-term debt, less current portion 2,018,542 — (247,200 ) 1,771,342 Operating lease obligations, less current portion 1,223,462 — — 1,223,462 Finance lease obligations, less current portion 141,017 — — 141,017 Other long-term liabilities and deferrals 475,112 58,927 — 534,039 Total long-term liabilities 3,858,133 58,927 (247,200 ) 3,669,860 Commitments and contingencies Equity 1,114,284 466,942 (107,019 ) 1,474,207 Total liabilities and equity $ 5,684,990 $ 525,869 $ (358,621 ) $ 5,852,238 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2019 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Revenues $ 3,283,099 $ — $ — $ 3,283,099 Cost of operations — Theatre operating costs 2,441,164 — — 2,441,164 General and administrative expenses 170,819 9 — 170,828 Depreciation and amortization 261,155 — — 261,155 Impairment of long-lived assets 57,001 — — 57,001 Loss on sale of assets and other 12,008 — — 12,008 Total cost of operations 2,942,147 9 — 2,942,156 Operating income (loss) 340,952 (9 ) — 340,943 Other income (expense) (140,932 ) 76,286 — (64,646 ) Income before income taxes 200,020 76,277 — 276,297 Income taxes 61,372 19,148 — 80,520 Net income 138,648 57,129 — 195,777 Less: Net income attributable to noncontrolling interests 2,462 — — 2,462 Net income attributable to Cinemark USA, Inc. $ 136,186 $ 57,129 $ — $ 193,315 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2019 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Net income $ 138,648 $ 57,129 $ — $ 195,777 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $2,692, net of settlements (8,210 ) — — (8,210 ) Other comprehensive loss in equity method investments — (142 ) — (142 ) Foreign currency translation adjustments (12,753 ) — — (12,753 ) Total other comprehensive loss, net of tax (20,963 ) (142 ) — (21,105 ) Total comprehensive income, net of tax 117,685 56,987 — 174,672 Comprehensive income attributable to noncontrolling interests (2,462 ) — — (2,462 ) Comprehensive income attributable to Cinemark USA, Inc. $ 115,223 $ 56,987 $ — $ 172,210 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes. CINEMARK USA, INC. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2019 (In thousands) Restricted Unrestricted Group Group Eliminations Consolidated Operating activities Net income $ 138,648 $ 57,129 $ - $ 195,777 Adjustments to reconcile net income to cash provided by operating activities 336,220 4,501 — 340,721 Changes in assets and liabilities 11,074 13,500 — 24,574 Net cash provided by operating activities 485,942 75,130 — 561,072 Investing activities Additions to theatre properties and equipment and other (303,627 ) — — (303,627 ) Acquisition of theatres in international markets, net of cash acquired (10,170 ) — — (10,170 ) Proceeds from sale of theatre properties and equipment and other 3,155 — — 3,155 Loans to parent/subsidiaries — (5,500 ) 5,500 — Net cash used for investing activities (310,642 ) (5,500 ) 5,500 (310,642 ) Financing activities Dividends paid to parent (158,450 ) — — (158,450 ) Borrowings from parent/subsidiary 5,500 — (5,500 ) — Repayments on long-term debt (6,595 ) (1,389 ) — (7,984 ) Payments on finance leases (14,600 ) — — (14,600 ) Other (4,641 ) — — (4,641 ) Net cash used for financing activities (178,786 ) (1,389 ) (5,500 ) (185,675 ) Effect of exchange rate changes on cash and cash equivalents (2,756 ) — — (2,756 ) Increase (decrease) in cash and cash equivalents (6,242 ) 68,241 — 61,999 Cash and cash equivalents: Beginning of year 370,460 55,756 — 426,216 End of year $ 364,218 $ 123,997 $ — $ 488,215 Note: "Restricted Group" and "Unrestricted Group" are defined in the indentures for the senior notes.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Business	Business — Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curaçao and Paraguay.
Principles of Consolidation	Principles of Consolidation — The consolidated financial statements include the accounts of Cinemark USA, Inc. and its subsidiaries. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these equity method investees are included in the consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.
Cash and Cash Equivalents	Cash and Cash Equivalents — Cash and cash equivalents consist of operating funds held in financial institutions, petty cash held by the theatres and highly liquid investments with original maturities of three months or less when purchased. Cash investments are primarily in money market funds, certificates of deposit, commercial paper or other similar funds.
Accounts Receivable	Accounts Receivable – Accounts receivable, which are recorded at net realizable value, consist primarily of receivables related to screen advertising, screen rental, receivables related to discounted tickets and gift cards sold to third party retail locations, receivables from landlords related to theatre construction and remodels, rebates earned from the Company’s concession vendors and value-added and other non-income tax receivables.
Inventories	Inventories — Concession and theatre supplies inventories are stated at the lower of cost (first-in, first-out method) or market.
Theatre Properties and Equipment	Theatre Properties and Equipment — Theatre properties and equipment are stated at cost less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital and finance leases (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1) The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company also performs a full quantitative impairment evaluation on an annual basis. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, operating lease right-of-use asset carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, the impact of recent theatre remodels or other substantial improvements, available lease renewal options and other factors considered relevant in its impairment assessment. Long-lived assets are evaluated for impairment on a theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods or extensions, for leased properties and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When the estimated fair value is determined to be lower than the carrying value of the asset group, the asset group is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during 2017, 2018 and 2019 . The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics, or adverse changes in the development or the conditions of the areas surrounding the theatre. See Note 8 for further discussion.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets — The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and we have allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its twenty regions in the U.S. and seven of its international countries with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). Under ASC Topic 350, Goodwill, Intangibles and Other (“ASC Topic 350”), the Company may perform a qualitative impairment assessment or a quantitative impairment assessment of our goodwill. A quantitative analysis requires the Company to estimate the fair value of each reporting unit and compare it with its carrying value. If the carrying value of the reporting unit exceeds its estimated fair value, goodwill would be written down such that the carrying value would equal estimated fair value. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2017, 2018 and 2019. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was eight times for the evaluations performed during 2018 and 2019. A qualitative assessment includes consideration of historical and expected future industry performance, estimated future performance of the Company, current industry trading multiples and other economic factors, and a review of current carrying values to estimated fair values as determined during our most recent quantitative assessment. The Company performed a quantitative goodwill impairment analysis for all reporting units during the year ended December 31, 2017. For the year ended December 31, 2018, the Company performed a quantitative goodwill assessment for three new domestic reporting units and a qualitative assessment for all other reporting units. For the year ended December 31, 2019 the Company performed a qualitative analysis for all reporting units. The Company did not record any goodwill impairment charges as a result of the assessments performed during the years ended December 31, 2017, 2018 and 2019. Tradename intangible assets are tested for impairment at least annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value may not be fully recoverable. Under ASC Topic 350, the Company can elect to perform a qualitative or quantitative impairment assessment for our tradename intangible assets. A quantitative tradename impairment assessment includes comparing the carrying values of tradename assets to an estimated fair value. Fair values are estimated by applying an estimated market royalty rate that could be charged for the use of our tradename to forecasted future revenues, with an adjustment for the present value of such royalties. If the estimated fair value is less than the carrying value, the tradename intangible asset is written down to its estimated fair value. Significant judgment is involved in estimating market royalty rates and long-term revenue forecasts. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected revenue performance and industry trends. A qualitative assessment considers our historical and forecasted revenues and changes in estimated royalty rates, and a comparison of current carrying values to estimated fair values from our most recent quantitative assessment. During the year ended December 31, 2017, the Company performed a quantitative tradename impairment assessment for its tradename in Ecuador and performed a qualitative tradename impairment analysis for all other tradename intangible assets. During the year ended December 31, 2018, the Company performed a quantitative tradename impairment evaluation for all of its tradename assets. During the year ended December 31, 2019, the Company performed a qualitative tradename impairment analysis for all of its tradename assets. As a result of the analysis performed during each year, no impairment charges were recorded related to tradename intangible assets for the years ended December 31, 2017, 2018 and 2019. The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately one to six years. Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is one year. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. See Note 3 for discussion of the impact of ASC Topic 842 on the recording of favorable and unfavorable leases. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to five years.
Lease Accounting	Lease Accounting — See Note 3 for discussion of the Company’s lease accounting policies as well as the impact of new lease accounting pronouncements.
Deferred Charges	Deferred Charges — Deferred charges and other assets consist of construction and other deposits, equipment to be placed in service, and other assets of a long-term nature.
Self-Insurance Reserves	Self-Insurance Reserves — In the U.S., the Company is self-insured for general liability claims subject to an annual cap. For the years ended December 31, 2017, 2018 and 2019, general liability claims were capped at $250, $250 and $500, respectively, per occurrence with aggregate annual caps of approximately $3,900, $4,750 and $6,000, respectively. For its international locations, the Company is fully insured for general liability claims with little or no deductibles per occurrence. During 2017, the Company implemented a fully-funded deductible workers compensation insurance plan under which the Company is responsible for pre-funding claims and is responsible for claims up to $250 per occurrence, with an annual cap of $5,000 for the years ended December 31, 2017, 2018 and 2019. The Company was also self-insured for domestic medical claims up to $250 per occurrence for the years ended December 31, 2017, 2018 and 2019. As of December 31, 2018 and 2019, the Company’s insurance reserves were $10,827 and $11,577, respectively, and are reflected in accrued other current liabilities on the consolidated balance sheets
Revenue and Expense Recognition	Revenue and Expense Recognition — See Note 4 for discussion of revenue recognition and deferred revenues. Film rental costs are subject to the film licensing arrangement and accrued based on the applicable box office receipts and either; 1) a sliding scale formula, which is generally established prior to the opening of the film, 2) firm terms or 3) estimates of the final settlement rate, which occurs at the conclusion of the film run. Under a sliding scale formula, we pay a percentage of box office revenues using a pre-determined matrix that is based upon box office performance of the film for its full run. Under a firm terms formula, we pay the distributor a percentage of box office receipts, which reflects either an aggregate rate for the life of the film or rates that decline over the term of the run. The settlement process allows for negotiation of film rental fees upon the conclusion of the film run based upon how the film performs. Estimates are based on the expected success of a film. The success of a film can typically be determined a few weeks after a film is released when the initial box office performance of the film is known. If actual settlements are different than those estimates, film rental costs are adjusted at that time.
Accounting for Share Based Awards	Accounting for Share Based Awards — The Company measures the cost of employee services received in exchange for an equity award based on the fair value of the award on the date of the grant. The grant date fair value is estimated using a market observed price. Such costs are recognized over the period during which an employee is required to provide service in exchange for the award (which is usually the vesting period). At the time of the grant, the Company also estimates the number of awards that will ultimately be forfeited. See Note 14 for discussion of the Company’s share based awards and related compensation expense.
Income Taxes	Income Taxes — The Company uses an asset and liability approach to financial accounting and reporting for income taxes. Deferred income taxes are provided when tax laws and financial accounting standards differ with respect to the amount of income for a year and the basis of assets and liabilities. A valuation allowance is recorded to reduce the carrying amount of deferred tax assets unless it is more likely than not that such assets will be realized. Income taxes are provided on unremitted earnings from foreign subsidiaries unless such earnings are expected to be indefinitely reinvested. Income taxes have also been provided for potential tax assessments. The evaluation of an uncertain tax position is a two-step process. The first step is recognition: The Company determines whether it is more likely than not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. In evaluating whether a tax position has met the more-likely-than-not recognition threshold, the Company should presume that the position would be examined by the appropriate taxing authority that would have full knowledge of all relevant information. The second step is measurement: A tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Differences between tax positions taken in a tax return and amounts recognized in the financial statements result in (1) a change in a liability for income taxes payable or (2) a change in an income tax refund receivable, a deferred tax asset or a deferred tax liability or both (1) and (2). The Company accrues interest and penalties on its uncertain tax positions as a component of income tax expense.
Segments	Segments — For the years ended December 31, 2017, 2018 and 2019, the Company managed its business under two reportable operating segments, U.S. markets and international markets. See Note 18.
Use of Estimates	Use of Estimates — The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Foreign Currency Translations	Foreign Currency Translations — The assets and liabilities of the Company’s foreign subsidiaries are translated into U.S. dollars at current exchange rates as of the balance sheet date, and revenues and expenses are translated at average monthly exchange rates. The resulting translation adjustments are recorded in the consolidated balance sheets in accumulated other comprehensive loss. See Note 12 for a summary of the translation adjustments recorded in accumulated other comprehensive loss for the years ended December 31, 2017, 2018 and 2019. The Company recognizes foreign currency transaction gains and losses when changes in exchange rates impact transactions, other than intercompany transactions of a long-term investment nature, that have been denominated in a currency other than the functional currency.
Fair Value Measurements	Fair Value Measurements — According to authoritative guidance, inputs used in fair value measurements fall into three different categories; Level 1, Level 2 and Level 3. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. See Note 11 for a discussion of our fair value measurements for the years ended December 31, 2018 and 2019.
Acquisitions	Acquisitions — The Company accounts for acquisitions under the acquisition method of accounting. The acquisition method requires that the acquired assets and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and changes thereafter reflected in income. For certain acquisitions, the Company obtains independent third party valuation studies for certain of the assets acquired and liabilities assumed to assist the Company in determining fair value. The estimation of the fair values of the assets acquired and liabilities assumed involves a number of estimates and assumptions that could differ materially from the actual amounts realized. The Company provides assumptions, including both quantitative and qualitative information, about the specified asset or liability to the third party valuation firms. The Company primarily utilizes the third parties to accumulate comparative data from multiple sources and assemble a report that summarizes the information obtained. The Company then uses the information to record estimated fair value. The third party valuation firms are supervised by Company personnel who are knowledgeable about valuations and fair value. The Company evaluates the appropriateness of the assumptions and valuation methodologies utilized by the third party valuation firm.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Estimated Useful Life of Assets	Depreciation is provided using the straight-line method over the estimated useful lives of the assets as follows: Category Useful Life Buildings on owned land 40 years Buildings on leased land Lesser of lease term or useful life Land and buildings under capital and finance leases (1) Lesser of lease term or useful life Theatre furniture and equipment 3 to 15 years Leasehold improvements Lesser of lease term or useful life (1)
Intangible Assets and Amortization Method	The table below summarizes the Company’s intangible assets and the amortization method used for each type of intangible asset: Intangible Asset Amortization Method Goodwill Indefinite-lived Tradename Indefinite-lived and definite-lived. Definite-lived tradename assets have a remaining useful life of approximately one to six years. Vendor contracts Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is one year. Favorable/unfavorable leases Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. See Note 3 for discussion of the impact of ASC Topic 842 on the recording of favorable and unfavorable leases. Other intangible assets Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to five years.

Adoption of ASC Topic 842 - L_2

Adoption of ASC Topic 842 - Lease Accounting (Tables)	12 Months Ended
	Dec. 31, 2019
Leases [Abstract]
Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities	The following table represents the operating and finance right-of-use assets and lease liabilities as of December 31, 2019. As of Leases Classification December 31, 2019 Assets (1) Operating lease assets Operating lease assets $ 1,383,080 Finance lease assets Theatre properties and equipment, net of accumulated depreciation (2) 116,135 Total lease assets $ 1,499,215 Liabilities (1) Current Operating Current portion of operating lease obligations $ 217,406 Finance Current portion of finance lease obligations 15,432 Noncurrent Operating Operating lease obligations, less current portion 1,223,462 Finance Finance lease obligations, less current portion 141,017 Total lease liabilities $ 1,597,317 (1) The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised. The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) Finance lease assets are net of accumulated amortization of $36,384 as of December 31, 2019.
Schedule of Aggregate Lease Costs by Lease Classification	The following table represents the Company’s aggregate lease costs, by lease classification, for the year ended December 31, 2019. Year Ended Lease Cost Classification December 31, 2019 Operating lease costs Equipment (1) Utilities and other $ 9,172 Real Estate (2)(3) Facility lease expense 346,222 Total operating lease costs $ 355,394 Finance lease costs Depreciation of leased assets Depreciation and amortization $ 14,734 Interest on lease liabilities Interest expense 7,786 Total finance lease costs $ 22,520 (1) Includes approximately $4,700 of short-term lease payments for the year ended December 31, 2019. (2) Includes approximately $68,799 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the year ended December 31, 2019 (3) Approximately $1,614 of lease payments are included in general and administrative expenses primarily related to office leases for the year ended December 31, 2019.
Schedule of Maturity of Lease Liabilities by Lease Classification	The following table represents the maturity of lease liabilities, by lease classification, as of December 31, 2019. Operating Finance Years Ending Leases Leases Total 2020 $ 280,268 $ 22,416 $ 302,684 2021 263,978 22,671 286,649 2022 235,266 21,935 257,201 2023 205,210 21,246 226,456 2024 166,233 20,165 186,398 After 2024 580,852 88,913 669,765 Total lease payments $ 1,731,807 $ 197,346 $ 1,929,153 Less: Interest 290,939 40,897 331,836 Present value of lease liabilities $ 1,440,868 $ 156,449 $ 1,597,317
Estimated Future Minimum Lease Payments Under Operating Leases	The following table represents future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 as presented in the Company’s Annual Report on Form 10-K filed March 4, 2019: Operating Capital Years Ending Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467
Estimated Future Minimum Lease Payments Under Capital Leases	The following table represents future minimum lease payments under noncancelable operating and capital leases at December 31, 2018 as presented in the Company’s Annual Report on Form 10-K filed March 4, 2019: Operating Capital Years Ending Leases Leases 2019 $ 253,323 $ 42,434 2020 242,336 41,502 2021 230,396 34,589 2022 204,628 32,462 2023 176,802 28,534 Thereafter 677,091 166,375 Total $ 1,784,576 345,896 Amounts representing interest payments (86,364 ) Present value of future minimum payments 259,532 Current portion of capital lease obligations (27,065 ) Capital lease obligations, less current portion $ 232,467
Schedule of Weighted-Average Remaining Lease Term and Discount Rate	The following table represents the weighted-average remaining lease term and discount rate, disaggregated by lease classification, as of December 31, 2019. As of Lease Term and Discount Rate December 31, 2019 Weighted-average remaining lease term (years) (1) Operating leases - equipment 3.9 Operating leases - real estate 7.9 Finance leases - equipment 5.3 Finance leases - real estate 10.0 Weighted-average discount rate (2) Operating leases - equipment 4.3 % Operating leases - real estate 4.8 % Finance leases - equipment 4.6 % Finance leases - real estate 4.8 % (1) The lease assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been executed. The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord. (2) The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.
Schedule of Minimum Cash Lease Payments	The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of right-of-use assets for the twelve months ended December 31, 2019. Year Ended Other Information December 31, 2019 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 281,895 Cash outflows for finance leases - operating activities $ 7,575 Cash outflows for finance leases - financing activities $ 14,600 Non-cash amount of leased assets obtained in exchange for: Operating lease liabilities - real estate $ 113,318 Operating lease liabilities - equipment $ 795 Finance lease liabilities $ 21,535

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
	Dec. 31, 2019
Revenue From Contract With Customer [Abstract]
Summary of Revenues Disaggregated Based on Type of Good Or Service By Reportable Operating Segment and On Timing of Revenue Recognition	The following table presents revenues for the periods indicated, disaggregated based on major type of good or service and by reportable operating segment. Twelve Months Ended Twelve Months Ended December 31, 2018 December 31, 2019 U.S. International U.S. International Operating Operating Operating Operating Major Goods/Services Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenues $ 1,461,151 $ 373,022 $ 1,834,173 $ 1,431,790 $ 373,531 $ 1,805,321 Concession revenues 892,391 216,402 1,108,793 936,241 224,842 1,161,083 Screen advertising, screen rental and promotional revenues 78,591 61,269 139,860 128,839 35,888 164,727 Other revenues 106,824 32,085 138,909 84,033 67,935 151,968 Total revenues $ 2,538,957 $ 682,778 $ 3,221,735 $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 18 for additional information on intercompany eliminations. The following table presents revenues for the periods indicated, disaggregated based on timing of revenue recognition (as discussed above). Twelve Months Ended Twelve Months Ended December 31, 2018 December 31, 2019 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 2,453,313 $ 608,347 $ 3,061,660 $ 2,488,716 $ 621,785 $ 3,110,501 Goods and services transferred over time 85,644 74,431 160,075 92,187 80,411 172,598 Total $ 2,538,957 $ 682,778 $ 3,221,735 $ 2,580,903 $ 702,196 $ 3,283,099 (1) U.S. segment revenues include eliminations of intercompany transactions with the international operating segment. See Note 18 for additional information on intercompany eliminations.
Changes in Deferred Revenues	The following table presents changes in the Company’s deferred revenues for the year ended December 31, 2019 . Deferred Revenues NCM Screen Advertising Advances (1) Other Deferred Revenues (2) Total Balance at January 1, 2019 $ 350,242 $ 106,075 $ 456,317 Amounts recognized as accounts receivable — 12,767 12,767 Cash received from customers in advance — 227,125 227,125 Common units received from NCM (see Note 7) 1,552 — 1,552 Interest accrued related to significant financing component 28,624 — 28,624 Revenue recognized during period (32,064 ) (206,367 ) (238,431 ) Foreign currency translation adjustments — (1,174 ) (1,174 ) Balance at December 31, 2019 $ 348,354 $ 138,426 $ 486,780 (1) See Significant Financing Component (2) Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheet.
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of December 31, 2019 and when the Company expects to recognize this revenue. Twelve Months Ended December 31, Remaining Performance Obligations 2020 2021 2022 2023 2024 Thereafter Total Deferred revenue - other $ 125,334 12,897 195 — — — $ 138,426

Investment in National CineMe_2

Investment in National CineMedia LLC (Tables)	12 Months Ended
	Dec. 31, 2019
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of December 31, 2019 and when the Company expects to recognize this revenue. Twelve Months Ended December 31, Remaining Performance Obligations 2020 2021 2022 2023 2024 Thereafter Total Deferred revenue - other $ 125,334 12,897 195 — — — $ 138,426
NCM
Summary of Activity With Equity Investee Included in the Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s consolidated financial statements for the periods indicated. See Note 4 for discussion of the impact of the new revenue recognition accounting pronouncement. Investment in NCM NCM Screen Advertising Advances Distributions from NCM Equity in Earnings Other Revenue Interest Expense - NCM (3) Cash Received Balance as of January 1, 2017 $ 189,995 $ (343,928 ) Receipt of common units due to annual common unit adjustment 18,363 (18,363 ) $ — $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (11,274 ) — 11,274 Receipt of excess cash distributions (15,093 ) — (14,158 ) — — — 29,251 Receipt under tax receivable agreement (2,265 ) — (2,249 ) — — — 4,514 Equity in earnings 9,550 — — (9,550 ) — — — Amortization of screen advertising advances — 10,585 — — (10,585 ) — — Balance as of and for the twelve months ended December 31, 2017 $ 200,550 $ (351,706 ) $ (16,407 ) $ (9,550 ) $ (21,859 ) $ — $ 45,039 Impact of adoption of ASC Topic 606 (2) — (9,288 ) — — — — — Receipt of common units due to annual common unit adjustment 5,012 (5,012 ) — — — — — Purchase of additional common units 78,393 — — — — — — Revenues earned under ESA (1) (2) — — — — (31,867 ) 19,724 12,143 Receipt of excess cash distributions (19,786 ) — (13,231 ) — — — 33,017 Receipt under tax receivable agreement (2,419 ) — (2,158 ) — — — 4,577 Equity in earnings 13,842 — — (13,842 ) — — — Amortization of screen advertising advances — 15,764 — — (15,764 ) — — Balance as of and for the twelve months ended December 31, 2018 $ 275,592 $ (350,242 ) $ (15,389 ) $ (13,842 ) $ (47,631 ) $ 19,724 $ 49,737 Receipt of common units due to annual common unit adjustment 1,552 (1,552 ) — — — — — Revenues earned under ESA (1) (3) — — — — (13,782 ) — 13,782 Interest accrued related to significant financing component (2) — (28,624 ) — — — 28,624 — Receipt of excess cash distributions (23,452 ) — (11,631 ) — — — 35,083 Receipt under tax receivable agreement (2,492 ) — (1,242 ) — — — 3,734 Equity in earnings 14,592 — — (14,592 ) — — — Amortization of screen advertising advances (2) — 32,064 — — (32,064 ) — — Balance as of and for the twelve months ended December 31, 2019 $ 265,792 $ (348,354 ) $ (12,873 ) $ (14,592 ) $ (45,846 ) $ 28,624 $ 52,599 (1) Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $11,110, $11,965 and $11,478 for the years ended December 31, 2017, 2018 and 2019, respectively. (2) As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption. In addition, the Company determined that a significant financing component existed for the ESA. See Note 4 for further discussion of the impact of the adoption of ASC Topic 606. (3) Approximately $4,828 represents screen rental revenues earned under the amendment to the ESA. See Note 4.
Summary of Common Units Received Under Common Unit Adjustment Agreement	Below is a summary of common units received by the Company under the Common Unit Adjustment (“CUA”) Agreement during the years ended December 31, 2017, 2018 and 2019: Event Date Common Units Received Number of Common Units Received Fair Value of Common Units Received 2017 annual common unit adjustment 3/31/2017 1,487,218 $ 18,363 2018 annual common unit adjustment 3/29/2018 908,042 $ 5,012 2019 annual common unit adjustment 3/31/2019 219,056 $ 1,552
Summary Financial Information	The tables below present summary financial information for NCM for the periods indicated: Year Ended Year Ended Year Ended December 28, 2017 December 27, 2018 December 26, 2019 Revenues $ 426,100 $ 441,400 $ 444,800 Operating income $ 153,900 $ 154,300 $ 155,700 Net income $ 101,900 $ 98,400 $ 98,800 As of As of December 27, 2018 December 26, 2019 Current assets $ 172,700 $ 185,400 Noncurrent assets $ 726,800 $ 706,600 Current liabilities $ 115,200 $ 125,500 Noncurrent liabilities $ 924,900 $ 947,800 Members' deficit $ (140,600 ) $ (181,300 )
NCM Screen Advertising Advances
Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized	The recognition of revenue related to the deferred revenue or NCM screen advertising advances will continue to be recorded on a straight-line basis over the new term of the amended ESA or February 2041. Twelve Months Ended December 31, Remaining Maturity 2020 2021 2022 2023 2024 Thereafter Total NCM screen advertising advances (1) $ 7,669 8,197 8,762 9,368 10,016 304,342 $ 348,354 (1) Amounts are net of the estimated interest to be accrued for the periods presented

Other Investments (Tables)

Other Investments (Tables)	12 Months Ended
	Dec. 31, 2019
Summary of Activity for Each of Company's Other Investments	Below is a summary of activity for each of the Company’s other investments for the periods indicated: DCIP AC LLC DCDC FE Concepts Other Total Balance at January 1, 2017 $ 87,819 $ 5,980 $ 2,750 $ — $ 1,768 $ 98,317 Cash contributions 1,112 — — 104 2,499 3,715 Equity in income 22,900 2,336 1,199 — — 26,435 Equity in comprehensive income 248 — — — — 248 Cash distributions received (5,864 ) (2,400 ) (351 ) — — (8,615 ) Other — — — — (55 ) (55 ) Balance at December 31, 2017 $ 106,215 $ 5,916 $ 3,598 $ 104.00 $ 4,212 $ 120,045 Cash contributions 2,076 — — 20,000 — 22,076 Equity in income (loss) 22,899 1,270 1,313 (82 ) — 25,400 Equity in comprehensive loss (139 ) — — — — (139 ) Cash distributions received (5,799 ) (1,920 ) (219 ) — — (7,938 ) Other (1) — — (2,437 ) (104 ) (137 ) (2,678 ) Balance at December 31, 2018 $ 125,252 $ 5,266 $ 2,255 $ 19,918 $ 4,075 $ 156,766 Equity in income (loss) 23,281 3,276 1,120 (399 ) — 27,278 Equity in comprehensive loss (141 ) — — — — (141 ) Cash distributions received (23,696 ) (3,520 ) (206 ) — — (27,422 ) Other (2) — — — — (1,196 ) (1,196 ) Balance at December 31, 2019 $ 124,696 $ 5,022 $ 3,169 $ 19,519 $ 2,879 $ 155,285 (1) (2)
Digital Cinema Implementation Partners
Summary Financial Information	Below is summary financial information for DCIP as of and for the years ended December 31, 2017, 2018 and 2019: Year ended December 31, 2017 2018 2019 Revenues $ 177,382 $ 172,534 $ 171,531 Operating income $ 106,687 $ 102,236 $ 99,812 Net income $ 93,103 $ 94,757 $ 95,820 As of December 31, 2018 December 31, 2019 Current assets $ 57,907 $ 51,382 Noncurrent assets $ 684,545 $ 581,547 Current liabilities $ 67,408 $ 70,515 Noncurrent liabilities $ 125,596 $ 190 Members' equity $ 549,448 $ 562,224
Transactions with DCIP	The Company had the following transactions with DCIP during the years ended December 31, 2017, 2018 and 2019: Year Ended December 31, 2017 2018 2019 Equipment lease payments $ 5,743 $ 4,862 $ 4,399 Warranty reimbursements from DCIP $ (8,511 ) $ (10,800 ) $ (11,800 ) Management services fees $ 823 $ 730 $ 596

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets - Net (Tables)	12 Months Ended
	Dec. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Goodwill	The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at December 31, 2017 (1) $ 1,174,041 $ 110,038 $ 1,284,079 Acquisition of theatres (2) — 7,204 7,204 Foreign currency translation adjustments — (14,959 ) (14,959 ) Balance at December 31, 2018 (1) $ 1,174,041 $ 102,283 $ 1,276,324 Acquisition of theatres (3) 8,812 868 9,680 Foreign currency translation adjustments — (2,633 ) (2,633 ) Balance at December 31, 2019 (1) $ 1,182,853 $ 100,518 $ 1,283,371 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. (2) Amount represents preliminary purchase price allocation for theatres acquired in Brazil. (3) Amounts represent acquisition of two theatres in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018.
Intangible Assets	As of December 31, intangible assets-net, consisted of the following: Balance at January 1, 2018 Additions (1) Amortization Other (2) Balance at December 31, 2018 Intangible assets with finite lives: Gross carrying amount $ 105,895 $ 1,203 $ — $ (1,842 ) $ 105,256 Accumulated amortization (68,869 ) — (5,734 ) - (74,603 ) Total net intangible assets with finite lives $ 37,026 $ 1,203 $ (5,734 ) $ (1,842 ) $ 30,653 Intangible assets with indefinite lives: Tradename and other 299,735 853 — (331 ) 300,257 Total intangible assets — net $ 336,761 $ 2,056 $ (5,734 ) $ (2,173 ) $ 330,910 Balance at January 1, 2019 Additions (3) Impact of ASC Topic 842 (4) Amortization Other (2) Balance at December 31, 2019 Intangible assets with finite lives: Gross carrying amount $ 105,256 $ (143 ) $ (4,427 ) $ — $ (6 ) $ 100,680 Accumulated amortization (74,603 ) — — (4,994 ) — (79,597 ) Total net intangible assets with finite lives $ 30,653 $ (143 ) $ — $ (4,994 ) $ (6 ) $ 21,083 Intangible assets with indefinite lives: Tradename and other 300,257 492 — — (63 ) 300,686 Total intangible assets — net $ 330,910 $ 349 $ — $ (4,994 ) $ (69 ) $ 321,769 (1) Activity represents preliminary fair values recorded as a result of the acquisition of theatres in Brazil. (2) Amount represents the write-off of fully amortized intangible assets related to non-compete agreements, the acquisition of tradeable liquor licenses, and foreign currency translation adjustments. (3) Amount represents intangible assets recorded as a result of two theatres acquired in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018. (4) See Note 3 for further discussion of the impact of the adoption of ASC Topic 842.
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows: For the year ended December 31, 2020 $ 5,036 For the year ended December 31, 2021 3,127 For the year ended December 31, 2022 2,974 For the year ended December 31, 2023 2,876 For the year ended December 31, 2024 2,876 Thereafter 4,194 Total $ 21,083

IMPAIRMENT OF LONG-LIVED ASSE_2

IMPAIRMENT OF LONG-LIVED ASSETS (Tables)	12 Months Ended
	Dec. 31, 2019
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Long-Lived Asset Impairment Losses	The Company’s long-lived asset impairment losses are summarized in the following table: Year Ended December 31, 2017 2018 2019 U.S. theatre properties $ 5,227 $ 18,597 $ 36,005 U.S. theatre operating lease right-of-use assets — — 10,457 International theatre properties 9,857 13,775 8,821 International theatre operating lease right-of-use assets — — 1,718 Impairment of long-lived assets $ 15,084 $ 32,372 $ 57,001

Deferred Charges and Other A_2

Deferred Charges and Other Assets - Net (Tables)	12 Months Ended
	Dec. 31, 2019
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Deferred Charges and Other Assets Net	As of December 31, deferred charges and other assets — net consisted of the following: December 31, 2018 2019 Long-term prepaid rents (1) $ 15,943 $ — Construction and other deposits 8,183 6,981 Equipment to be placed in service 10,466 12,929 Other 6,463 19,204 Total $ 41,055 $ 39,114 (1)

LONG-TERM DEBT (Tables)

LONG-TERM DEBT (Tables)	12 Months Ended
	Dec. 31, 2019
Debt Disclosure [Abstract]
Components of Long-Term Debt	As of December 31, long-term debt consisted of the following: December 31, 2018 2019 Cinemark USA, Inc. term loan $ 652,922 $ 646,327 Cinemark USA, Inc. 5.125% senior notes due 2022 400,000 400,000 Cinemark USA, Inc. 4.875% senior notes due 2023 755,000 755,000 Other 1,389 — Total long-term debt 1,809,311 1,801,327 Less current portion 7,984 6,595 Less debt issuance costs, net of accumulated amortization of $30,289 and $35,599, respectively 28,700 23,390 Long-term debt, less current portion $ 1,772,627 $ 1,771,342
Amendment of Credit Agreement	Cinemark USA, Inc. made the following amendments to its Credit Agreement as follows during 2017 and 2018: Debt Issue Loss on Debt Effective Date Nature of Amendment Costs Paid (1) Amendment (2) June 16, 2017 Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement $ 521 $ 190 November 28, 2017 Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line $ 330 $ 331 March 29, 2018 Extended maturity of term loan to March 2025; reduced term loan interest rate by 0.25%; reduced real property mortgage requirements $ 4,962 $ 1,484 (1) (2)
Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs	The Company’s long-term debt, excluding unamortized debt issuance costs, at December 31, 2019 matures as follows: 2020 $ 6,595 2021 6,595 2022 406,595 2023 761,595 2024 6,595 Thereafter 613,352 Total $ 1,801,327
Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges	Below is a summary of the Company’s interest rate swap agreements designated as cash flow hedges as of December 31, 2019: Estimated Fair Value at Notional December 31, Amount Effective Date Pay Rate Receive Rate Expiration Date 2019 (1) $ 175,000 December 31, 2018 2.751% 1-Month LIBOR December 31, 2022 $ 6,213 $ 137,500 December 31, 2018 2.765% 1-Month LIBOR December 31, 2022 $ 4,956 $ 137,500 December 31, 2018 2.746% 1-Month LIBOR December 31, 2022 $ 4,826 Total $ 15,995 (1)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Summary of Liabilities Measured at Fair Value on a Recurring Basis	Below is a summary of liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2019: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities $ (15,995 ) $ — $ — $ (15,995 )
Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs	Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities (1) 2019 Beginning balance - January 1 $ 5,093 Total loss included in accumulated other comprehensive loss 13,039 Settlements included in interest expense (2,137 ) Ending balance - December 31 $ 15,995 (1) Represents interest rate swap liabilities. See Note 10 for further discussion.

FOREIGN CURRENCY TRANSLATION (T

FOREIGN CURRENCY TRANSLATION (Tables)	12 Months Ended
	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Summary of Impact of Translating Financial Statements of Company's International Subsidiaries	Below is a summary of the impact of translating the financial statements of all of the Company’s international subsidiaries as of and for the years ended December 31, 2017, 2018 and 2019. Other Comprehensive Income (Loss) Exchange Rate as of December 31, For the Year Ended December 31, Country 2017 2018 2019 2017 2018 (1) 2019 (1) Brazil 3.31 3.88 4.02 $ (4,567 ) $ (34,086 ) $ (8,140 ) Argentina (1) 18.65 37.68 59.89 (8,200 ) (14,357 ) — Colombia 2,936.67 3,249.75 3,277.14 246 (1,795 ) (362 ) Chile 615.97 694.74 736.86 5,672 (8,924 ) (5,158 ) Peru 3.24 3.39 3.37 2,752 (2,136 ) 257 All other (869 ) (955 ) 650 $ (4,966 ) $ (62,253 ) $ (12,753 ) (1) For Argentina, represents the cumulative comprehensive loss recorded through June 30, 2018. The impact of translating Argentina financial results to U.S. dollars, subsequent to June 30, 2018, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statements of income. Losses of $1,463 and $3,707 were recorded for the years ended December 31, 2018 and 2019, respectively.

NONCONTROLLING INTERESTS IN S_2

NONCONTROLLING INTERESTS IN SUBSIDIARIES (Tables)	12 Months Ended
	Dec. 31, 2019
Noncontrolling Interest [Abstract]
Noncontrolling Interests in Subsidiaries	Noncontrolling interests in subsidiaries of the Company were as follows at December 31: December 31, 2018 2019 Cinemark Partners II — 24.6% interest (in one theatre) $ 8,152 $ 7,953 Laredo Theatres – 25% interest (in two theatres) 2,308 2,139 Greeley Ltd. — 49% interest (in one theatre) 1,411 1,908 Other 508 508 Total $ 12,379 $ 12,508

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	12 Months Ended
	Dec. 31, 2019
Number of Units Vested Under Restricted Stock Unit Awards	Below is a table summarizing the potential number of units that could vest under restricted stock unit awards granted during the years ended December 31, 2017, 2018 and 2019 at each of the three levels of financial performance (excluding forfeitures): Granted During the Year Ended December 31, 2017 2018 2019 Number of Value at Number of Value at Number of Value at Units Grant (1) Units Grant (1) Units Grant (1) at threshold IRR 58,545 $ 2,481 76,065 $ 2,967 136,285 $ 5,011 at target IRR 117,089 $ 4,961 152,129 $ 5,938 204,427 $ 7,517 at maximum IRR 175,634 $ 7,442 228,194 $ 8,906 306,651 $ 11,276 (1) The grant date fair value for units issued during the year ended December 31, 2017 was $42.37. The grant date fair values for the units issued during the year ended December 31, 2018 ranged from $37.55 to $39.03. The grant date fair value for units issued during the year ended December 31, 2019 was $36.77 per share.
Summary of Current Financial Performance Thresholds and Vesting Rates	The current financial performance factors and respective vesting rates for each of the 2017, 2018 and 2019 grants are as follows: Year Ended December 31, Percentage of Shares Vesting 2017 2018 2019 Threshold IRR 6.0% 6.0% 6.0% 33.3% Target IRR 8.0% 8.0% 8.0% 66.6% Maximum IRR 14.0% 14.0% 14.0% 100.0%
Restricted Stock
Summary of Restricted Stock Award Activity	Below is a summary of restricted stock award activity recorded for the periods indicated. Year Ended December 31, 2017 2018 2019 Compensation expense recognized by the Company during the period $ 7,528 $ 8,735 $ 9,266 Additional compensation expense recognized by Cinemark Holdings, Inc. during the period $ 856 $ 920 $ 919 Fair value of restricted shares held by Company employees that vested during the period $ 7,255 $ 8,699 $ 7,044 Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period $ 917 $ 802 $ 980 Income tax benefit recognized upon vesting of restricted stock awards held by Company employees $ 2,281 $ 1,543 $ 1,271 Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors $ 386 $ 201 $ 245
Cinemark Holdings, Inc.
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for Cinemark Holdings, Inc. for the years ended December 31, 2017, 2018 and 2019. Year Ended Year Ended Year Ended December 31, 2017 December 31, 2018 December 31, 2019 Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Shares of Restricted Stock Weighted Average Grant Date Fair Value Outstanding at January 1 606,618 $ 33.51 650,581 $ 35.81 704,353 $ 38.68 Granted 246,534 $ 41.70 328,734 $ 38.72 315,899 $ 37.34 Vested (192,230 ) $ 36.26 (250,442 ) $ 31.27 (209,821 ) $ 41.10 Forfeited (10,341 ) $ 33.48 (24,520 ) $ 38.62 (26,608 ) $ 37.69 Outstanding at December 31 650,581 $ 35.81 704,353 $ 38.68 783,823 $ 37.53
Cinemark Holdings, Inc. | Restricted Stock Units (RSUs)
Summary of Restricted Stock Unit Award Activity	Below is a summary of activity for restricted stock unit awards for Cinemark Holdings, Inc. for the periods indicated: Year Ended December 31, 2017 2018 2019 Number of restricted stock unit awards that vested during the period 97,115 127,084 90,895 Fair value of restricted stock unit awards that vested during the period $ 4,155 $ 4,846 $ 3,658 Accumulated dividends paid upon vesting of restricted stock unit awards $ 558 $ 526 $ 386 Compensation expense recognized during the period $ 4,297 $ 4,681 $ 4,430 Income tax benefit recognized upon vesting of restricted stock unit awards $ 1,745 $ 708 $ 397

SUPPLEMENTAL CASH FLOW INFORM_2

SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2019
Supplemental Cash Flow Elements [Abstract]
Supplemental Information to Consolidated Statements of Cash Flows	The following is provided as supplemental information to the consolidated statements of cash flows: Year Ended December 31, 2017 2018 2019 Cash paid for interest $ 99,232 $ 98,411 $ 93,907 Cash paid for income taxes, net of refunds received $ 95,043 $ 64,199 $ 88,670 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ 9,349 $ (5,728 ) $ 22,013 Theatre properties acquired under finance leases $ 46,727 $ 18,851 $ 21,535 Investment in NCM – receipt of common units (see Note 5) $ 18,363 $ 5,012 $ 1,552 Interest expense - NCM (see Notes 4 and 5) $ — $ (19,724 ) $ (28,624 ) (1) Additions to theatre properties and equipment included in accounts payable as of December 31, 2018 and 2019 were $37,004 and $14,991, respectively.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income Before Income Taxes	The Company’s provision for federal and foreign income tax expense for continuing operations consisted of the following: Year Ended December 31, 2017 2018 2019 Income before income taxes: U.S. $ 282,896 $ 292,238 $ 238,108 Foreign 64,842 21,007 38,189 Total $ 347,738 $ 313,245 $ 276,297
Current and Deferred Income Taxes	Current and deferred income taxes were as follows: Year Ended December 31, 2017 2018 2019 Current: Federal $ 55,224 $ 47,333 $ 45,758 Foreign 29,306 11,822 24,022 State 10,741 13,690 12,583 Total current expense $ 95,271 $ 72,845 $ 82,363 Deferred: Federal $ (14,046 ) $ 27,055 $ (298 ) Foreign (4,270 ) (6,166 ) 5 State 3,301 2,298 (1,550 ) Total deferred taxes $ (15,015 ) $ 23,187 $ (1,843 ) Income taxes $ 80,256 $ 96,032 $ 80,520
Reconciliation Between Income Tax Expense and Taxes Computed	A reconciliation between income tax expense and taxes computed by applying the applicable statutory federal income tax rate to income before income taxes follows: Year Ended December 31, 2017 2018 2019 Computed statutory tax expense $ 121,708 $ 65,781 $ 58,022 State and local income taxes, net of federal income tax impact 12,858 12,687 8,555 Changes in valuation allowance 44 131 2,532 Foreign tax rate differential (245 ) 2,235 4,646 Foreign dividends 13,662 — — Foreign tax credits (21,647 ) 3,927 4,143 Impacts related to 2017 Tax Act (1)(2) (44,889 ) 19,180 — Changes in uncertain tax positions 983 (6,139 ) 197 Other — net (2,218 ) (1,770 ) 2,425 Income taxes $ 80,256 $ 96,032 $ 80,520 (1) The amount for the year ended December 31, 2018 includes a one-time charge to true-up deferred taxes of $1,913 and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $17,267. (2) The amount for the year ended December 31, 2017 includes a one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433.
Tax Effects of Significant Temporary Differences and Tax Loss and Tax Credit Carryforwards	The tax effects of significant temporary differences and tax loss and tax credit carryforwards comprising the net long-term deferred income tax liabilities as of December 31, 2018 and 2019 consisted of the following: December 31, 2018 2019 Deferred liabilities: Theatre properties and equipment $ 158,797 $ 138,382 Operating lease right-of-use assets — 322,750 Intangible asset — other 33,561 39,282 Intangible asset — tradenames 73,261 72,821 Investment in partnerships 63,217 62,914 Total deferred liabilities 328,836 636,149 Deferred assets: Deferred lease expenses 13,464 — Deferred revenue - NCM 86,035 85,362 Deferred revenue - Other 4,153 9,953 Gift Cards 6,173 7,402 Operating lease obligations — 336,034 Finance lease obligations 63,895 34,956 Tax impact of items in accumulated other comprehensive income 2,237 5,131 Other tax loss carryforwards 15,608 17,053 Other tax credit carryforwards 42,989 46,577 Other expenses, not currently deductible for tax purposes 17,755 21,573 Total deferred assets 252,309 564,041 Net deferred income tax liability before valuation allowance 76,527 72,108 Valuation allowance against deferred assets – non-current 54,725 60,359 Net deferred income tax liability $ 131,252 $ 132,467 Net deferred tax (asset) liability — Foreign $ (5,449 ) $ (4,539 ) Net deferred tax liability — U.S. 136,701 137,006 Total $ 131,252 $ 132,467
Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties	The following is a reconciliation of the total amounts of unrecognized tax benefits excluding interest and penalties, for the years ended December 31, 2017, 2018 and 2019: Year Ended December 31, 2017 2018 2019 Balance at January 1, $ 17,403 $ 18,266 $ 10,561 Gross increases - tax positions in prior periods 92 — 1 Gross decreases - tax positions in prior periods (12 ) (143 ) — Gross increases - current period tax positions 265 424 202 Settlements (177 ) (7,191 ) (522 ) Foreign currency translation adjustments 695 (795 ) (7 ) Balance at December 31, $ 18,266 $ 10,561 $ 10,235

SEGMENTS (Tables)

SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2019
Segment Reporting [Abstract]
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of select financial information by reportable operating segment: Year Ended December 31, 2017 2018 2019 Revenues U.S. $ 2,236,237 $ 2,551,719 $ 2,594,246 International 769,436 682,778 702,196 Eliminations (14,126 ) (12,762 ) (13,343 ) Total revenues $ 2,991,547 $ 3,221,735 $ 3,283,099 Adjusted EBITDA U.S. $ 559,693 $ 650,189 $ 616,799 International 165,576 132,941 129,884 Total Adjusted EBITDA $ 725,269 $ 783,130 $ 746,683 Capital expenditures U.S. $ 321,040 $ 270,870 $ 230,561 International 59,822 75,203 73,066 Total capital expenditures $ 380,862 $ 346,073 $ 303,627 (1)
Reconciliation of Net Income to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA: Year Ended December 31, 2017 2018 2019 Net income $ 267,482 $ 217,213 $ 195,777 Add (deduct): Income taxes 80,256 96,032 80,520 Interest expense (1)(2) 105,918 109,994 99,941 Loss on debt amendments and refinancing 521 1,484 — Other income (3) (43,121 ) (18,450 ) (22,422 ) Distributions from DCIP (4) 5,864 5,799 23,696 Other cash distributions from equity investees (5) 20,109 24,344 29,670 Depreciation and amortization (2) 237,513 261,162 261,155 Impairment of long-lived assets 15,084 32,372 57,001 Loss on disposal of assets and other 22,812 38,702 12,008 Non-cash rent expense (6) — — (4,360 ) Deferred lease expenses (2) (1,268 ) (1,320 ) — Amortization of long-term prepaid rents (2) 2,274 2,382 — Share based awards compensation expense 11,825 13,416 13,697 Adjusted EBITDA (2) $ 725,269 $ 783,130 $ 746,683 (1) (2) (3) (4) (5) (6) The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives. Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases. See Note 3 for discussion of the impact of ASC Topic 842.
Selected Financial Information by Geographic Area	Below is a breakdown of select financial information by geographic area: Year Ended December 31, 2017 2018 2019 Revenues U.S. $ 2,236,237 $ 2,551,719 $ 2,594,246 Brazil 341,485 283,009 302,074 Other international countries 427,951 399,769 400,122 Eliminations (14,126 ) (12,762 ) (13,343 ) Total $ 2,991,547 $ 3,221,735 $ 3,283,099 December 31, 2018 December 31, 2019 Theatre Properties and Equipment-net U.S. $ 1,479,603 $ 1,436,275 Brazil 140,570 118,367 Other international countries 212,960 180,605 Total $ 1,833,133 $ 1,735,247

VALUATION AND QUALIFYING ACCO_2

VALUATION AND QUALIFYING ACCOUNTS (Tables)	12 Months Ended
	Dec. 31, 2019
Valuation And Qualifying Accounts [Abstract]
Valuation Allowance for Deferred Tax Assets	The Company’s valuation allowance for deferred tax assets for the years ended December 31, 2017, 2018 and 2019 were as follows: Valuation Allowance for Deferred Taxes Balance at January 1, 2017 $ 14,524 Additions 21,347 Deductions (625 ) Balance at December 31, 2017 $ 35,246 Additions 22,005 Deductions (2,526 ) Balance at December 31, 2018 $ 54,725 Additions 7,611 Deductions (1,977 ) Balance at December 31, 2019 $ 60,359

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information of Subsidiary Guarantors (Tables)	12 Months Ended
	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Condensed Consolidating Balance Sheet Information	CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 Other current assets 60,829 19,997 67,149 (15,178 ) 132,797 Accounts receivable from parent or subsidiaries — 284,893 — (265,363 ) 19,530 Total current assets 258,794 315,776 284,514 (280,541 ) 578,543 Theatre properties and equipment - net 664,759 789,536 378,838 - 1,833,133 Investment in subsidiaries 1,806,255 57,845 - (1,864,100 ) - Other assets 1,500,366 155,011 546,834 (112,536 ) 2,089,675 Total assets $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ 1,389 $ — $ 7,984 Current portion of capital lease obligations 11,918 9,406 5,741 — 27,065 Accounts payable and accrued expenses 297,302 58,544 96,780 (13,622 ) 439,004 Accounts payable to parent or subsidiaries 40,421 — 224,942 (265,363 ) - Total current liabilities 356,236 67,950 328,852 (278,985 ) 474,053 Long-term liabilities Long-term debt, less current portion 1,872,627 — 7,955 (107,955 ) 1,772,627 Capital lease obligations, less current portion 123,329 59,539 49,599 — 232,467 Other long-term liabilities and deferrals 460,725 60,137 77,843 (6,137 ) 592,568 Total long-term liabilities 2,456,681 119,676 135,397 (114,092 ) 2,597,662 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,367,714 673,174 723,320 (1,396,494 ) 1,367,714 Total Cinemark USA, Inc. stockholder's equity 1,417,257 1,130,542 733,558 (1,864,100 ) 1,417,257 Noncontrolling interests — — 12,379 — 12,379 Total equity 1,417,257 1,130,542 745,937 (1,864,100 ) 1,429,636 Total liabilities and equity $ 4,230,174 $ 1,318,168 $ 1,210,186 $ (2,257,177 ) $ 4,501,351 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 179,162 $ 5,704 $ 303,349 $ — $ 488,215 Other current assets 64,901 30,532 68,274 (17,030 ) 146,677 Accounts receivable from parent or subsidiaries — 408,245 — (383,926 ) 24,319 Total current assets 244,063 444,481 371,623 (400,956 ) 659,211 Theatre properties and equipment - net 659,538 752,599 323,110 — 1,735,247 Operating lease right-of-use assets 710,192 467,344 205,544 — 1,383,080 Investment in subsidiaries 1,961,159 26,719 — (1,987,878 ) — Other assets 1,489,285 157,025 538,083 (109,693 ) 2,074,700 Total assets $ 5,064,237 $ 1,848,168 $ 1,438,360 $ (2,498,527 ) $ 5,852,238 Liabilities and equity Current liabilities Current portion of long-term debt $ 6,595 $ — $ — $ — $ 6,595 Current portion of operating lease obligations 99,924 86,828 30,654 — 217,406 Current portion of finance lease obligations 11,073 4,289 70 — 15,432 Accounts payable and accrued expenses 322,849 56,249 104,575 (14,935 ) 468,738 Accounts payable to parent or subsidiaries 132,832 — 251,094 (383,926 ) — Total current liabilities 573,273 147,366 386,393 (398,861 ) 708,171 Long-term liabilities Long-term debt, less current portion 1,871,342 — 4,455 (104,455 ) 1,771,342 Operating lease obligations, less current portion 639,847 414,099 169,516 — 1,223,462 Finance lease obligations, less current portion 91,524 49,121 372 — 141,017 Other long-term liabilities and deferrals 426,552 37,346 77,474 (7,333 ) 534,039 Total long-term liabilities 3,029,265 500,566 251,817 (111,788 ) 3,669,860 Commitments and contingencies Equity Cinemark USA, Inc.'s stockholder's equity: Common stock 49,543 457,368 10,238 (467,606 ) 49,543 Other stockholder's equity 1,412,156 742,868 777,404 (1,520,272 ) 1,412,156 Total Cinemark USA, Inc. stockholder's equity 1,461,699 1,200,236 787,642 (1,987,878 ) 1,461,699 Noncontrolling interests — — 12,508 — 12,508 Total equity 1,461,699 1,200,236 800,150 (1,987,878 ) 1,474,207 Total liabilities and equity $ 5,064,237 $ 1,848,168 $ 1,438,360 $ (2,498,527 ) $ 5,852,238
Condensed Consolidating Statement of Income Information	CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2017 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,013,960 $ 1,220,993 $ 807,350 $ (50,756 ) $ 2,991,547 Cost of operations Theatre operating expenses 795,976 834,135 591,223 (50,756 ) 2,170,578 General and administrative expenses 13,176 82,955 54,780 — 150,911 Depreciation and amortization 79,676 87,463 70,374 — 237,513 Impairment of long-lived assets 3,725 1,502 9,857 — 15,084 Loss on disposal of assets and other 16,895 3,372 2,545 — 22,812 Total cost of operations 909,448 1,009,427 728,779 (50,756 ) 2,596,898 Operating income 104,512 211,566 78,571 — 394,649 Other income (expense) Interest expense (94,229 ) (7,675 ) (5,447 ) 1,433 (105,918 ) Loss on debt amendments and refinancing (521 ) — — — (521 ) Distributions from NCM — — 16,407 — 16,407 Equity in income of affiliates 255,594 16,838 33,742 (270,189 ) 35,985 Other income 2,475 1,040 5,054 (1,433 ) 7,136 Total other income 163,319 10,203 49,756 (270,189 ) (46,911 ) Income before income taxes 267,831 221,769 128,327 (270,189 ) 347,738 Income taxes 2,188 69,770 8,298 — 80,256 Net income 265,643 151,999 120,029 (270,189 ) 267,482 Less: Net income attributable to noncontrolling interests — — 1,839 — 1,839 Net income attributable to Cinemark USA, Inc. $ 265,643 $ 151,999 $ 118,190 $ (270,189 ) $ 265,643 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,192,478 $ 1,362,043 $ 723,804 $ (56,590 ) $ 3,221,735 Cost of operations Theatre operating expenses 916,726 933,858 541,981 (56,590 ) 2,335,975 General and administrative expenses 11,497 100,407 50,736 — 162,640 Depreciation and amortization 89,429 99,627 72,106 — 261,162 Impairment of long-lived assets 4,118 13,612 14,642 — 32,372 Loss on disposal of assets and other 13,321 23,337 2,044 — 38,702 Total cost of operations 1,035,091 1,170,841 681,509 (56,590 ) 2,830,851 Operating income 157,387 191,202 42,295 — 390,884 Other income (expense) Interest expense (97,585 ) (6,520 ) (7,266 ) 1,377 (109,994 ) Loss on debt amendments and refinancing (1,484 ) — — — (1,484 ) Distributions from NCM — — 15,389 — 15,389 Interest expense - NCM (19,724 ) — — — (19,724 ) Equity in income of affiliates 183,463 (12,561 ) 33,167 (164,827 ) 39,242 Other income (loss) 4,287 (14 ) (3,964 ) (1,377 ) (1,068 ) Total other income 68,957 (19,095 ) 37,326 (164,827 ) (77,639 ) Income before income taxes 226,344 172,107 79,621 (164,827 ) 313,245 Income taxes 10,609 68,624 16,799 — 96,032 Net income 215,735 103,483 62,822 (164,827 ) 217,213 Less: Net income attributable to noncontrolling interests — — 1,478 — 1,478 Net income attributable to Cinemark USA, Inc. $ 215,735 $ 103,483 $ 61,344 $ (164,827 ) $ 215,735 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION YEAR ENDED DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 1,216,308 $ 1,376,109 $ 746,858 $ (56,176 ) $ 3,283,099 Cost of operations Theatre operating expenses 947,745 981,665 567,930 (56,176 ) 2,441,164 General and administrative expenses 11,975 109,422 49,431 — 170,828 Depreciation and amortization 91,681 103,168 66,306 — 261,155 Impairment of long-lived assets 9,951 36,511 10,539 — 57,001 Loss on disposal of assets and other 5,068 4,925 2,015 — 12,008 Total cost of operations 1,066,420 1,235,691 696,221 (56,176 ) 2,942,156 Operating income 149,888 140,418 50,637 — 340,943 Other income (expense) Interest expense (97,894 ) (2,432 ) (923 ) 1,308 (99,941 ) Distributions from NCM — — 12,873 — 12,873 Interest expense - NCM (28,624 ) — — — (28,624 ) Equity in income of affiliates 171,193 (9,270 ) 33,647 (153,700 ) 41,870 Other income (loss) 4,050 (24 ) 6,458 (1,308 ) 9,176 Total other income 48,725 (11,726 ) 52,055 (153,700 ) (64,646 ) Income before income taxes 198,613 128,692 102,692 (153,700 ) 276,297 Income taxes 5,298 41,646 33,576 — 80,520 Net income 193,315 87,046 69,116 (153,700 ) 195,777 Less: Net income attributable to noncontrolling interests — — 2,462 — 2,462 Net income attributable to Cinemark USA, Inc. $ 193,315 $ 87,046 $ 66,654 $ (153,700 ) $ 193,315
Condensed Consolidating Statement of Comprehensive Income Information	CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED December Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Other comprehensive loss, net of tax Other comprehensive income of equity method investments 248 — 248 (248 ) 248 Foreign currency translation adjustments (4,966 ) — (4,966 ) 4,966 (4,966 ) Total other comprehensive loss, net of tax (4,718 ) — (4,718 ) 4,718 (4,718 ) Total comprehensive income, net of tax $ 260,925 $ 151,999 $ 115,311 $ (265,471 ) $ 262,764 Comprehensive income attributable to noncontrolling interests — — (1,839 ) — (1,839 ) Comprehensive income attributable to Cinemark USA, Inc. $ 260,925 $ 151,999 $ 113,472 $ (265,471 ) $ 260,925 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 215,735 $ 103,483 $ 62,822 $ (164,827 ) $ 217,213 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $1,243, net of settlements (3,851 ) — — — (3,851 ) Other comprehensive loss of equity method investments (139 ) — (139 ) 139 (139 ) Foreign currency translation adjustments (62,253 ) — (62,253 ) 62,253 (62,253 ) Total other comprehensive loss, net of tax (66,243 ) — (62,392 ) 62,392 (66,243 ) Total comprehensive income, net of tax $ 149,492 $ 103,483 $ 430 $ (102,435 ) $ 150,970 Comprehensive income attributable to noncontrolling interests — — (1,478 ) — (1,478 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ 149,492 $ 103,483 $ (1,048 ) $ (102,435 ) $ 149,492 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION YEAR ENDED DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 193,315 $ 87,046 $ 69,116 $ (153,700 ) $ 195,777 Other comprehensive loss, net of tax Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $2,692, net of settlements (8,210 ) — — — (8,210 ) Other comprehensive income of equity method investments (142 ) — (142 ) 142 (142 ) Foreign currency translation adjustments (12,753 ) — (12,753 ) 12,753 (12,753 ) Total other comprehensive loss, net of tax (21,105 ) — (12,895 ) 12,895 (21,105 ) Total comprehensive income, net of tax $ 172,210 $ 87,046 $ 56,221 $ (140,805 ) $ 174,672 Comprehensive income attributable to noncontrolling interests — — (2,462 ) — (2,462 ) Comprehensive income attributable to Cinemark USA, Inc. $ 172,210 $ 87,046 $ 53,759 $ (140,805 ) $ 172,210
Condensed Consolidating Statement of Cash Flows Information	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED December Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 265,643 $ 151,999 $ 120,029 $ (270,189 ) $ 267,482 Adjustments to reconcile net income to cash provided by operating activities (122,559 ) 71,023 33,515 270,189 252,168 Changes in assets and liabilities 18,223 (35,138 ) 25,649 — 8,734 Net cash provided by operating activities 161,307 187,884 179,193 — 528,384 Investing activities Additions to theatre properties and equipment (146,385 ) (172,874 ) (61,603 ) — (380,862 ) Acquisition of theatres in the U.S. and international markets, net of cash acquired (12,500 ) — (28,497 ) — (40,997 ) Proceeds from sale of theatre properties and equipment and other 2,149 12,271 678 — 15,098 Dividends received from subsidiaries 127,600 1,873 — (129,473 ) — Investment in joint ventures and other — (104 ) (3,611 ) — (3,715 ) Net cash used for investing activities (29,136 ) (158,834 ) (93,033 ) (129,473 ) (410,476 ) Financing Activities Dividends paid to parent (134,500 ) (127,000 ) (2,473 ) 129,473 (134,500 ) Repayments of long-term debt (4,282 ) — (1,389 ) — (5,671 ) Payments on capital leases (7,952 ) (9,707 ) (4,066 ) — (21,725 ) Fees paid related to debt amendments (521 ) — — — (521 ) Proceeds from financing lease — 10,200 — — 10,200 Other (1,181 ) (2,943 ) (1,088 ) — (5,212 ) Net cash used for financing activities (148,436 ) (129,450 ) (9,016 ) 129,473 (157,429 ) Effect of exchange rate changes on cash and cash equivalents — — 798 — 798 Increase (decrease) in cash and cash equivalents (16,265 ) (100,400 ) 77,942 — (38,723 ) Cash and cash equivalents: Beginning of year 146,855 281,023 133,260 — 561,138 End of year $ 130,590 $ 180,623 $ 211,202 $ — $ 522,415 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2018 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 215,735 $ 103,483 $ 62,822 $ (164,827 ) $ 217,213 Adjustments to reconcile net income to cash provided by operating activities (36,894 ) 162,811 55,915 164,827 346,659 Changes in assets and liabilities 229,326 (233,263 ) (3,636 ) — (7,573 ) Net cash provided by operating activities 408,167 33,031 115,101 — 556,299 Investing activities Additions to theatre properties and equipment (91,244 ) (173,042 ) (81,787 ) — (346,073 ) Acquisition of theatres in international markets, net of cash acquired — — (11,289 ) — (11,289 ) Proceeds from sale of theatre properties and equipment and other 1,244 2,025 651 — 3,920 Proceeds from intercompany note repayments 1,867 — — (1,867 ) — Acquisition of NCM common units (78,393 ) — — — (78,393 ) Investment in joint ventures and other — (19,896 ) 361 — (19,535 ) Net cash used for investing activities (166,526 ) (190,913 ) (92,064 ) (1,867 ) (451,370 ) Financing activities Dividends paid to parent (148,750 ) — — — (148,750 ) Repayments of long-term debt (7,984 ) — — — (7,984 ) Payment of debt issue costs (5,218 ) — — — (5,218 ) Payments on capital leases (11,610 ) (8,950 ) (4,793 ) — (25,353 ) Payments on intercompany loans — — (1,867 ) 1,867 — Other (704 ) (2,905 ) (992 ) — (4,601 ) Net cash used for financing activities (174,266 ) (11,855 ) (7,652 ) 1,867 (191,906 ) Effect of exchange rate changes on cash and cash equivalents — — (9,222 ) — (9,222 ) Increase (decrease) in cash and cash equivalents 67,375 (169,737 ) 6,163 — (96,199 ) Cash and cash equivalents: Beginning of year 130,590 180,623 211,202 — 522,415 End of year $ 197,965 $ 10,886 $ 217,365 $ — $ 426,216 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION YEAR ENDED DECEMBER 31, 2019 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 193,315 $ 87,046 $ 69,116 $ (153,700 ) $ 195,777 Adjustments to reconcile net income to cash provided by operating activities (57,371 ) 159,150 85,242 153,700 340,721 Changes in assets and liabilities 135,883 (128,525 ) 17,216 — 24,574 Net cash provided by operating activities 271,827 117,671 171,574 — 561,072 Investing activities Additions to theatre properties and equipment (107,955 ) (121,434 ) (74,238 ) — (303,627 ) Acquisition of theatres in U.S. markets, net of cash acquired (10,170 ) — — — (10,170 ) Proceeds from sale of theatre properties and equipment and other 1,687 1,154 314 — 3,155 Dividends received from subsidiary 1,345 4,523 — (5,868 ) — Net cash used for investing activities (115,093 ) (115,757 ) (73,924 ) (5,868 ) (310,642 ) Financing activities Dividends paid to parent (158,450 ) (745 ) (5,123 ) 5,868 (158,450 ) Repayments of long-term debt (6,595 ) — (1,389 ) — (7,984 ) Payments on finance leases (10,492 ) (4,043 ) (65 ) — (14,600 ) Other — (2,308 ) (2,333 ) — (4,641 ) Net cash used for financing activities (175,537 ) (7,096 ) (8,910 ) 5,868 (185,675 ) Effect of exchange rate changes on cash and cash equivalents — — (2,756 ) — (2,756 ) Increase (decrease) in cash and cash equivalents (18,803 ) (5,182 ) 85,984 — 61,999 Cash and cash equivalents: Beginning of year 197,965 10,886 217,365 — 426,216 End of year $ 179,162 $ 5,704 $ 303,349 $ — $ 488,215

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2019USD ($)Segment	Dec. 31, 2018USD ($)SegmentUnit	Dec. 31, 2017USD ($)Segment
Summary Of Significant Accounting Policies [Line Items]
Approximate remaining lease period for owned properties	20 years
Multiple of cash flows used to estimate fair value of long-lived asset	6.5	6.5	6.5
Number of domestic reporting units for which quantitative goodwill assessment performed | Unit		3
Goodwill impairment charges	$ 0	$ 0	$ 0
General liability claim per occurrence, cap	500,000	250,000	250,000
Aggregate annual cap per policy year	6,000,000	4,750,000	3,900,000
Annual cap for self-insured workers compensation plan	5,000,000	5,000,000	5,000,000
Medical claim per occurrence, cap	250,000	250,000	$ 250,000
Insurance Reserves	$ 11,577,000	$ 10,827,000
Minimum Percentage for Tax position measure as largest amount of benefit	50.00%
Reportable operating segments | Segment	2	2	2
Trade Names
Summary Of Significant Accounting Policies [Line Items]
Impairment of intangible assets	$ 0	$ 0	$ 0
U.S. Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting units | Segment		20
Multiplication Value to Cash flows for the determination of fair value of Reporting units	8	8	8
International Operating Segment
Summary Of Significant Accounting Policies [Line Items]
Number of reporting units | Segment		7
Minimum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	20.00%
Maximum
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	50.00%
Cost method investment, ownership Percentage	20.00%
Pre-funding claims and covers claims per occurrence			$ 250,000

Estimated Useful Lives of Asset

Estimated Useful Lives of Assets (Detail)	12 Months Ended
	Dec. 31, 2019
Buildings On Owned Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	40 years
Buildings On Leased Land
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
Land and Buildings Under Capital and Finance Leases
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life	[1]
Theatre furniture and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	3 years
Theatre furniture and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	15 years
Leasehold Improvements
Property, Plant and Equipment [Line Items]
Estimated useful life of assets	Lesser of lease term or useful life
[1]	Amortization of capital and finance lease assets is included in depreciation and amortization expense on the consolidated statements of income. Accumulated amortization of capital and finance lease assets as of December 31, 2018 and 2019 was $177,733 and $36,384, respectively.

Estimated Useful Lives of Ass_2

Estimated Useful Lives of Assets (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 1,612,990	$ 1,571,017
Property Under Capital and Finance Lease
Property, Plant and Equipment [Line Items]
Accumulated depreciation and amortization	$ 36,384	$ 177,733

Intangible Assets and Amortizat

Intangible Assets and Amortization Method (Detail)	12 Months Ended
	Dec. 31, 2019
Finite Lived Intangible Assets [Line Items]
Goodwill	Indefinite-lived
Tradename	Indefinite-lived and definite-lived.  Definite-lived tradename assets have a remaining useful life of approximately one to six years.
Vendor Contracts
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying contracts. The remaining term of the underlying contract is one year.
Finite-Lived Intangible Asset, Useful Life	1 year
Favorable/unfavorable leases
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Based on the pattern in which the economic benefits are realized over the terms of the lease agreements. See Note 3 for discussion of the impact of ASC Topic 842 on the recording of favorable and unfavorable leases.
Other Intangible Assets
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Amortization Method	Straight-line method over the terms of the underlying agreement or the expected useful life of the intangible asset. The remaining useful lives of these intangible assets range from one to five years.
Other Intangible Assets | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Other Intangible Assets | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Trade Names | Minimum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year
Trade Names | Maximum
Finite Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	6 years

Adoption of ASC Topic 842 - L_3

Adoption of ASC Topic 842 - Lease Accounting - Additional Information (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Jan. 01, 2019
Lease [Line Items]
Operating lease right-of-use assets	[1]	$ 1,383,080
Operating lease liabilities		1,440,868
Finance lease assets	[1],[2]	116,135
Finance lease liabilities		156,449
Theatres
Lease [Line Items]
Noncancelable lease payments payable under operating lease, lease not yet commenced		$ 242,898
Minimum | Real Estate
Lease [Line Items]
Noncancelable operating and finance leases, term		10 years
Minimum | Equipment
Lease [Line Items]
Noncancelable operating leases, term		5 years
Maximum | Real Estate
Lease [Line Items]
Noncancelable operating and finance leases, term		25 years
Maximum | Equipment
Lease [Line Items]
Noncancelable operating leases, term		11 years
ASC Topic 842
Lease [Line Items]
Deferred rent liabilities			$ (39,235)
Lease intangibles			(5,780)
Deferred lease incentive liabilities			(12,960)
Long-term prepaid rents			7,707
Operating lease right-of-use assets			1,491,245
Operating lease liabilities			1,545,210
Finance lease assets			57,440
Finance lease liabilities			57,440
ASC Topic 842 | Adjustment
Lease [Line Items]
Operating lease right-of-use assets			110,442
Operating lease liabilities			$ 126,376
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.
[2]	Finance lease assets are net of accumulated amortization of $36,384 as of December 31, 2019.

Schedule of Operating and Finan

Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Assets
Operating lease assets	$ 1,383,080	[1]
Finance lease assets	$ 116,135	[1],[2]
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:PropertyPlantAndEquipmentNet
Total lease assets	$ 1,499,215	[1]
Liabilities, Current
Operating	217,406	[1]
Finance	15,432	[1]
Liabilities, Noncurrent
Operating	1,223,462	[1]
Finance	141,017	[1]
Total lease liabilities	$ 1,597,317	[1]
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.
[2]	Finance lease assets are net of accumulated amortization of $36,384 as of December 31, 2019.

Schedule of Operating and Fin_2

Schedule of Operating and Finance Right-of-Use Assets and Lease Liabilities (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Leases [Abstract]
Finance lease assets, accumulated amortization	$ 36,384

Schedule of Aggregate Lease Cos

Schedule of Aggregate Lease Costs by Lease Classification (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Operating lease costs
Total operating lease costs	$ 355,394
Finance lease costs
Total finance lease costs	22,520
Depreciation and Amortization
Finance lease costs
Depreciation of leased assets	14,734
Interest Expense
Finance lease costs
Interest on lease liabilities	7,786
Equipment | Utilities and Other
Operating lease costs
Total operating lease costs	9,172	[1]
Real Estate | Facility Lease Expense
Operating lease costs
Total operating lease costs	$ 346,222	[2],[3]
[1]	Includes approximately $4,700 of short-term lease payments for the year ended December 31, 2019.
[2]	Approximately $1,614 of lease payments are included in general and administrative expenses primarily related to office leases for the year ended December 31, 2019.
[3]	Includes approximately $68,799 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenues or attendance and variable common area maintenance costs for the year ended December 31, 2019

Schedule of Aggregate Lease C_2

Schedule of Aggregate Lease Costs by Lease Classification (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Lease Cost [Line Items]
Lease payments	$ 281,895
Equipment | Utilities and Other
Lease Cost [Line Items]
Short term lease payments	4,700
Real Estate | Facility Lease Expense
Lease Cost [Line Items]
Variable lease payments	68,799
Lease payments	$ 1,614

Schedule of Maturity of Lease L

Schedule of Maturity of Lease Liabilities by Lease Classification (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Leases [Abstract]
Operating Leases, 2020	$ 280,268
Operating Leases, 2021	263,978
Operating Leases, 2022	235,266
Operating Leases, 2023	205,210
Operating Leases, 2024	166,233
Operating Leases, After 2024	580,852
Operating Leases, Total lease payments	1,731,807
Operating Leases, Less: Interest	290,939
Operating Leases, Present value of lease liabilities	1,440,868
Finance Leases, 2020	22,416
Finance Leases, 2021	22,671
Finance Leases, 2022	21,935
Finance Leases, 2023	21,246
Finance Leases, 2024	20,165
Finance Leases, After 2024	88,913
Finance Leases, Total lease payments	197,346
Finance Leases, Less: Interest	40,897
Finance Leases, Present value of lease liabilities	156,449
Total Leases, 2020	302,684
Total Leases, 2021	286,649
Total Leases, 2022	257,201
Total Leases, 2023	226,456
Total Leases, 2024	186,398
Total Leases, After 2024	669,765
Total Leases, Total lease payments	1,929,153
Total Leases, Less: Interest	331,836
Total Leases, Present value of lease liabilities	$ 1,597,317

Future Minimum Lease Payments U

Future Minimum Lease Payments Under Noncancelable Operating and Capital Leases (Detail) $ in Thousands	Dec. 31, 2018USD ($)
Leases [Abstract]
Future minimum operating lease payments, current	$ 253,323
Future minimum operating lease payments, in two years	242,336
Future minimum operating lease payments, in three years	230,396
Future minimum operating lease payments, in four years	204,628
Future minimum operating lease payments, in five years	176,802
Future minimum operating lease payments, thereafter	677,091
Future minimum operating lease payments, total	1,784,576
Future minimum capital leases payments, current	42,434
Future minimum capital leases payments, in two years	41,502
Future minimum capital leases payments, in three years	34,589
Future minimum capital leases payments, in four years	32,462
Future minimum capital leases payments, in five years	28,534
Future minimum capital leases payments, thereafter	166,375
Future minimum capital leases payments, total	345,896
Amounts representing interest payments	(86,364)
Present value of future minimum payments	259,532
Current portion of capital lease obligations	(27,065)
Capital lease obligations, less current portion	$ 232,467

Schedule of Weighted-Average Re

Schedule of Weighted-Average Remaining Lease Term and Discount Rate (Detail)	Dec. 31, 2019
Equipment
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	3 years 10 months 24 days	[1]
Weighted-average remaining lease term - Finance leases	5 years 3 months 18 days	[1]
Weighted-average discount rate - Operating leases	4.30%	[2]
Weighted-average discount rate - Finance leases	4.60%	[2]
Real Estate
Lease [Line Items]
Weighted-average remaining lease term - Operating leases	7 years 10 months 24 days	[1]
Weighted-average remaining lease term - Finance leases	10 years	[1]
Weighted-average discount rate - Operating leases	4.80%	[2]
Weighted-average discount rate - Finance leases	4.80%	[2]
[1]	The lease assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been executed.  The Company does not consider a lease renewal exercise as reasonably certain until immediately before the necessary notification is provided to the landlord.
[2]	The discount rate for each lease represents the incremental borrowing rate at which the Company would borrow, on a collateralized basis, over a similar term and at an amount equal to the lease payments in a similar economic environment.

Schedule of Minimum Cash Lease

Schedule of Minimum Cash Lease Payments (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Cash paid for amounts included in the measurement of lease liabilities
Cash outflows for operating leases	$ 281,895
Cash outflows for finance leases - operating activities	7,575
Cash outflows for finance leases - financing activities	14,600
Non-cash amount of leased assets obtained in exchange for:
Finance lease liabilities	21,535
Real Estate
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities - real estate	113,318
Equipment
Non-cash amount of leased assets obtained in exchange for:
Operating lease liabilities - real estate	$ 795

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2019USD ($)
Revenue Recognition [Line Items]
Receivables related to contracts with customers	$ 31,620,000
Assets related to costs to obtain or fulfill contract with customers	0
NCM
Revenue Recognition [Line Items]
Remaining performance obligations	$ 174,000,000
Deferred revenue amortization year and month	2041-02
NCM | Minimum
Revenue Recognition [Line Items]
Percentage of incremental borrowing rates	4.40%
NCM | Maximum
Revenue Recognition [Line Items]
Percentage of incremental borrowing rates	8.00%

Summary of Revenues Disaggregat

Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Disaggregation of Revenue [Line Items]
Total revenues		$ 3,283,099	$ 3,221,735	$ 2,991,547
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	2,580,903	2,538,957
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		702,196	682,778
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenues		1,805,321	1,834,173	1,794,982
Admissions Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	1,431,790	1,461,151
Admissions Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		373,531	373,022
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenues		1,161,083	1,108,793	$ 1,038,788
Concession Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	936,241	892,391
Concession Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		224,842	216,402
Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenues		164,727	139,860
Screen Advertising, Screen Rental and Promotional Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	128,839	78,591
Screen Advertising, Screen Rental and Promotional Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		35,888	61,269
Other Revenues
Disaggregation of Revenue [Line Items]
Total revenues		151,968	138,909
Other Revenues | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	84,033	106,824
Other Revenues | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 67,935	$ 32,085
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 18 for additional information on intercompany eliminations.

Summary of Revenues Disaggreg_2

Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Disaggregation of Revenue [Line Items]
Total revenues		$ 3,283,099	$ 3,221,735	$ 2,991,547
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	2,580,903	2,538,957
International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		702,196	682,778
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenues		3,110,501	3,061,660
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	2,488,716	2,453,313
Goods and Services Transferred at a Point in Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		621,785	608,347
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenues		172,598	160,075
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues	[1]	92,187	85,644
Goods and Services Transferred Over Time | International Operating Segment
Disaggregation of Revenue [Line Items]
Total revenues		$ 80,411	$ 74,431
[1]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 18 for additional information on intercompany eliminations.

Changes in Deferred Revenues (D

Changes in Deferred Revenues (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2019		$ 456,317
Amounts recognized as accounts receivable		12,767
Cash received from customers in advance		227,125
Common units received from NCM (see Note 7)		1,552
Interest accrued related to significant financing component		28,624
Revenue recognized during period		(238,431)
Foreign currency translation adjustments		(1,174)
Balance at December 31, 2019		486,780	$ 456,317
NCM Screen Advertising Advances
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2019	[1]	350,242
Common units received from NCM (see Note 7)		(1,552)	(5,012)	$ (18,363)
Interest accrued related to significant financing component	[1],[2]	28,624
Revenue recognized during period	[1]	(32,064)
Balance at December 31, 2019	[1]	348,354	350,242
NCM Screen Advertising Advances | NCM
Change in Contract with Customer Liability [Line Items]
Common units received from NCM (see Note 7)	[1]	1,552
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2019	[3]	106,075
Amounts recognized as accounts receivable	[3]	12,767
Cash received from customers in advance	[3]	227,125
Revenue recognized during period	[3]	(206,367)
Foreign currency translation adjustments	[3]	(1,174)
Balance at December 31, 2019	[3]	$ 138,426	$ 106,075
[1]	See Significant Financing Component
[2]	As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption.  In addition, the Company determined that a significant financing component existed for the ESA.  See Note 4 for further discussion of the impact of the adoption of ASC Topic 606.
[3]	Includes liabilities associated with outstanding gift cards and SuperSavers, points or rebates outstanding under the Company’s loyalty and membership programs and revenues not yet recognized for screen advertising and other promotional activities. Classified as accounts payable and accrued expenses or other long-term liabilities on the consolidated balance sheet.

Aggregate Amount of Transaction

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Other Deferred Revenues
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 138,426
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	125,334
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	12,897
Other Deferred Revenues | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 195

Aggregate Amount of Transacti_2

Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Detail 1) $ in Thousands	Dec. 31, 2019USD ($)
Other Deferred Revenues
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Remaining performance obligations	$ 138,426

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		Jul. 05, 2018	Dec. 31, 2019		Dec. 31, 2018		Dec. 31, 2017
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment			$ 1,552
Interest accrued related to significant financing component			(28,624)
Equity in earnings			41,870		$ 39,242		$ 35,985
NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			275,592
Beginning Balance			(350,242)
Purchase of additional common units		$ 78,393			78,393
Ending Balance			265,792		275,592
Ending Balance			(348,354)		(350,242)
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			275,592		200,550		189,995
Receipt of common units due to annual common unit adjustment			1,552		5,012		18,363
Purchase of additional common units					78,393
Receipt of excess cash distributions			(23,452)		(19,786)		(15,093)
Receipt under tax receivable agreement			(2,492)		(2,419)		(2,265)
Equity in earnings			14,592		13,842		9,550
Ending Balance			265,792		275,592		200,550
NCM Screen Advertising Advances
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			(350,242)		(351,706)		(343,928)
Impact of adoption of ASC Topic 606	[1]				(9,288)
Receipt of common units due to annual common unit adjustment			(1,552)		(5,012)		(18,363)
Interest accrued related to significant financing component	[1],[2]		(28,624)
Amortization of screen advertising advances			32,064	[1]	15,764		10,585
Ending Balance			(348,354)		(350,242)		(351,706)
NCM Screen Advertising Advances | NCM
Schedule Of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment	[2]		1,552
Distributions from NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			(15,389)		(16,407)
Receipt of excess cash distributions			(11,631)		(13,231)		(14,158)
Receipt under tax receivable agreement			(1,242)		(2,158)		(2,249)
Ending Balance			(12,873)		(15,389)		(16,407)
Equity in Earnings
Schedule Of Equity Method Investments [Line Items]
Beginning Balance			(13,842)		(9,550)
Ending Balance			(14,592)		(13,842)		(9,550)
Equity in Earnings | NCM
Schedule Of Equity Method Investments [Line Items]
Equity in earnings			(14,592)		(13,842)		(9,550)
Other Revenues
Schedule Of Equity Method Investments [Line Items]
Total Revenues			(47,631)		(21,859)
Revenues earned under ESA	[3]		(13,782)	[4]	(31,867)	[1]	(11,274)
Ending Balance			(45,846)		(47,631)		(21,859)
Other Revenues | NCM
Schedule Of Equity Method Investments [Line Items]
Amortization of screen advertising advances			(32,064)	[1]	(15,764)		(10,585)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance	[4]		19,724
Revenues earned under ESA	[1],[3],[4]				19,724
Interest accrued related to significant financing component	[1],[4]		28,624
Ending Balance	[4]		28,624		19,724
Cash Received
Schedule Of Equity Method Investments [Line Items]
Total Cash Received			49,737		45,039
Revenues earned under ESA	[3]		13,782	[4]	12,143	[1]	11,274
Receipt of excess cash distributions			35,083		33,017		29,251
Receipt under tax receivable agreement			3,734		4,577		4,514
Total Cash Received			$ 52,599		$ 49,737		$ 45,039
[1]	As a result of adoption of ASC Topic 606, the Company determined that the deferred revenue associated with the ESA and CUA agreement should be amortized on a straight-line basis versus the units of revenue method followed prior to adoption.  In addition, the Company determined that a significant financing component existed for the ESA.  See Note 4 for further discussion of the impact of the adoption of ASC Topic 606.
[2]	See Significant Financing Component
[3]	Amounts include the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire. The amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire were approximately $11,110, $11,965 and $11,478 for the years ended December 31, 2017, 2018 and 2019, respectively.
[4]	Approximately $4,828 represents screen rental revenues earned under the amendment to the ESA.  See Note 4.

Summary of Activity with NCM _2

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Equity Method Investments [Line Items]
Company's beverage concessionaire advertising costs	$ 11,478	$ 11,965	$ 11,110
Screen Advertising Rental Revenue
Schedule Of Equity Method Investments [Line Items]
Revenues earned under ESA	$ 4,828

Investment in National CineMe_3

Investment in National CineMedia LLC - Additional Information (Detail) $ / shares in Units, $ in Thousands	Mar. 29, 2019USD ($)shares	Jul. 05, 2018USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Jul. 04, 2018	Dec. 31, 2016USD ($)
Schedule Of Equity Method Investments [Line Items]
Number of additional common units of NCM received under common unit adjustment agreement | shares	219,056
Value of common units received from NCM	$ 1,552			$ 1,552	$ 5,012	$ 18,363
Interest in common units of NCM owned by Company			25.00%	25.00%
Number of common units of NCM owned by Company | shares			39,737,700	39,737,700
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Common unit convertible into share of NCMI common stock, conversion ratio	1
Value of common units in cash					78,393
Estimated fair value of investment using NCM's stock price			$ 289,688	$ 289,688
NCMI common stock price | $ / shares			$ 7.29	$ 7.29
Investment in NCM			$ 265,792	$ 265,792	275,592	200,550		$ 189,995
NCM
Schedule Of Equity Method Investments [Line Items]
Remaining performance obligations			174,000	$ 174,000
Deferred revenue amortization year and month				2041-02
Number of common units of NCM acquired by Company | shares		10,738,740
Value of common units in cash		$ 78,393			78,393
Common unit price per share | $ / shares		$ 7.30
Interest in common units of NCM owned by Company		25.00%					18.00%
Investment in NCM			265,792	$ 265,792	275,592
Deferred revenue or NCM screen advertising advances extended term				2041-02
NCM | Adoption of ASC Topic 606
Schedule Of Equity Method Investments [Line Items]
Increase in screen advertising advances			62,893
Screen advertising advances, tax			15,346
Reduction in retained earnings			(47,547)
Reduction in other revenues			(1,403)
Increase in interest expense			4,721
Reduction of net income			$ (4,630)
NCM | Theatre Properties and Equipment
Schedule Of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising				$ 61	$ 74	$ 102

Summary of Common Units Receive

Summary of Common Units Received Under Adjustment Agreement (Detail) - USD ($) $ in Thousands	Mar. 29, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Equity Method Investments [Line Items]
Number of Common Units Received	219,056
Fair Value of Common Units Received	$ 1,552	$ 1,552	$ 5,012	$ 18,363
Annual Common Unit Adjustment
Schedule Of Equity Method Investments [Line Items]
Date Common Units Received		Mar. 31, 2019	Mar. 29, 2018	Mar. 31, 2017
Number of Common Units Received		219,056	908,042	1,487,218
Fair Value of Common Units Received		$ 1,552	$ 5,012	$ 18,363

Summary of Recognition of Reven

Summary of Recognition of Revenue Related to Deferred Revenue (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
NCM Screen Advertising Advances
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 348,354	[1]
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year	[1]
Revenue remaining performance obligation, amount	$ 7,669	[1]
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-01-31
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year	[1]
Revenue remaining performance obligation, amount	$ 8,197	[1]
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year	[1]
Revenue remaining performance obligation, amount	$ 8,762	[1]
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year	[1]
Revenue remaining performance obligation, amount	$ 9,368	[1]
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year	[1]
Revenue remaining performance obligation, amount	$ 10,016	[1]
NCM Screen Advertising Advances | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period		[1]
Revenue remaining performance obligation, amount	$ 304,342	[1]
[1]	Amounts are net of the estimated interest to be accrued for the periods presented

Summary of Recognition of Rev_2

Summary of Recognition of Revenue Related to Deferred Revenue (Detail1) $ in Thousands	Dec. 31, 2019USD ($)
NCM Screen Advertising Advances
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]
Revenue remaining performance obligation, amount	$ 348,354	[1]
[1]	Amounts are net of the estimated interest to be accrued for the periods presented

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	12 Months Ended
	Dec. 26, 2019	Dec. 27, 2018	Dec. 28, 2017
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 444,800	$ 441,400	$ 426,100
Operating income	155,700	154,300	153,900
Net income	98,800	98,400	$ 101,900
Current assets	185,400	172,700
Noncurrent assets	706,600	726,800
Current liabilities	125,500	115,200
Noncurrent liabilities	947,800	924,900
Members' deficit	$ (181,300)	$ (140,600)

Summary of Activity for Each of

Summary of Activity for Each of Company's Other Investments (Detail) - USD ($)		12 Months Ended
		Dec. 31, 2019		Dec. 31, 2018		Dec. 31, 2017
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		$ 156,766,000
Equity in income (loss)		41,870,000		$ 39,242,000		$ 35,985,000
Cash distributions received		(53,366,000)		(30,143,000)		(25,973,000)
Investments, ending balance		155,285,000		156,766,000
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Cash distributions received	[1]	(23,696,000)		(5,799,000)		(5,864,000)
Other Affiliates
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		156,766,000		120,045,000		98,317,000
Cash contributions				22,076,000		3,715,000
Equity in income (loss)		27,278,000		25,400,000		26,435,000
Equity in comprehensive income (loss)		(141,000)		(139,000)		248,000
Cash distributions received		(27,422,000)		(7,938,000)		(8,615,000)
Other		(1,196,000)	[2]	(2,678,000)	[3]	(55,000)
Investments, ending balance		155,285,000		156,766,000		120,045,000
Other Affiliates | Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		125,252,000		106,215,000		87,819,000
Cash contributions				2,076,000		1,112,000
Equity in income (loss)		23,281,000		22,899,000		22,900,000
Equity in comprehensive income (loss)		(141,000)		(139,000)		248,000
Cash distributions received		(23,696,000)		(5,799,000)		(5,864,000)
Investments, ending balance		124,696,000		125,252,000		106,215,000
Other Affiliates | AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		5,266,000		5,916,000		5,980,000
Equity in income (loss)		3,276,000		1,270,000		2,336,000
Cash distributions received		(3,520,000)		(1,920,000)		(2,400,000)
Investments, ending balance		5,022,000		5,266,000		5,916,000
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		2,255,000		3,598,000		2,750,000
Equity in income (loss)		1,120,000		1,313,000		1,199,000
Cash distributions received		(206,000)		(219,000)		(351,000)
Other	[3]			(2,437,000)
Investments, ending balance		3,169,000		2,255,000		3,598,000
Other Affiliates | FE Concepts
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		19,918,000		104,000
Cash contributions				20,000,000		104,000
Equity in income (loss)		(399,000)		(82,000)
Other	[3]			(104,000)
Investments, ending balance		19,519,000		19,918,000		104,000
Other Affiliates | Other Investments
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance		4,075,000		4,212,000		1,768,000
Cash contributions						2,499,000
Other		(1,196,000)	[2]	(137,000)	[3]	(55,000)
Investments, ending balance		$ 2,879,000		$ 4,075,000		$ 4,212,000
[1]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 6.  These distributions are reported entirely within the U.S. operating segment.
[2]	Consists primarily of mark-to-market adjustment on an investment in marketable securities.
[3]	Other activity for DCDC for the year ended December 31, 2018 consisted of returns of capital originally contributed by the Company.

Other Investments - Additional

Other Investments - Additional Information (Detail) $ in Thousands	Apr. 30, 2018USD ($)	Dec. 31, 2019USD ($)StudioProjectionSystem	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		50.00%
Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		20.00%
Digital Cinema Implementation Partners
Schedule Of Equity Method Investments [Line Items]
Number of major motion picture studio, long-term digital cinema deployment agreements | Studio		6
Description of digital cinema deployment agreements		The DCDAs end on the earlier to occur of (i) the tenth anniversary of the "mean deployment date" for all digital projection systems scheduled to be deployed over a period of up to five years, or (ii) the date DCIP achieves "cost recoupment", each as defined in the DCDAs.
Percentage of voting interest		33.00%
Economic interest in Digital Cinema Implementation Partners		24.30%
Number of equipment being leased under master equipment lease agreement | ProjectionSystem		3,866
Digital Cinema Implementation Partners | Maximum
Schedule Of Equity Method Investments [Line Items]
Deployment period of digital cinema deployment agreements		5 years
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees		$ 15,376	$ 12,481	$ 13,950
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest		14.60%
Payments for content delivery services		$ 896	$ 927	$ 848
CNMK Texas Properties, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000
CNMK Texas Properties, LLC | AWSR Investments, LLC
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	50.00%
Cash contributions	$ 20,000
Management fee revenues		$ 64

Summary Financial Information_2

Summary Financial Information for DCIP (Detail) - Other Affiliates - Digital Cinema Implementation Partners - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Equity Method Investments [Line Items]
Revenues	$ 171,531	$ 172,534	$ 177,382
Operating income	99,812	102,236	106,687
Net income	95,820	94,757	$ 93,103
Current assets	51,382	57,907
Noncurrent assets	581,547	684,545
Current liabilities	70,515	67,408
Noncurrent liabilities	190	125,596
Members' equity	$ 562,224	$ 549,448

Transactions with DCIP (Detail)

Transactions with DCIP (Detail) - Digital Cinema Implementation Partners - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Equity Method Investments [Line Items]
Equipment lease payments	$ 4,399	$ 4,862	$ 5,743
Warranty reimbursements from DCIP	(11,800)	(10,800)	(8,511)
Management services fees	$ 596	$ 730	$ 823

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019		Dec. 31, 2018
Goodwill [Line Items]
Beginning Balance	[1]	$ 1,276,324		$ 1,284,079
Acquisitions of theatres		9,680	[2]	7,204	[3]
Foreign currency translation adjustments		(2,633)		(14,959)
Ending Balance	[1]	1,283,371		1,276,324
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	1,174,041		1,174,041
Acquisitions of theatres	[2]	8,812
Ending Balance	[1]	1,182,853		1,174,041
International Operating Segment
Goodwill [Line Items]
Beginning Balance	[1]	102,283		110,038
Acquisitions of theatres		868	[2]	7,204	[3]
Foreign currency translation adjustments		(2,633)		(14,959)
Ending Balance	[1]	$ 100,518		$ 102,283
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
[2]	Amounts represent acquisition of two theatres in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018
[3]	Amount represents preliminary purchase price allocation for theatres acquired in Brazil.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2019USD ($)Theatre	Dec. 31, 2018Theatre
Goodwill [Line Items]
Number of theatres acquired | Theatre	2
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses | $	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses | $	$ 27,622
Number of theatres acquired | Theatre		2

Intangible Assets - Net (Detail

Intangible Assets - Net (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019		Dec. 31, 2018
Intangible Assets [Line Items]
Intangible assets with finite lives, Beginning balance		$ 105,256		$ 105,895
Other, Gross carrying amount	[1]	(6)		(1,842)
Intangible assets with finite lives, Ending balance		100,680		105,256
Intangible assets with finite lives, Accumulated amortization, Beginning balance		(74,603)		(68,869)
Accumulated amortization additions		0	[2]	0	[3]
Accumulated amortization		(4,994)		(5,734)
Other Accumulated Amortization of Intangible Assets	[1]	0		0
Intangible assets with finite lives, Accumulated amortization, Ending balance		(79,597)		(74,603)
Net intangible assets with finite lives, Beginning balance		30,653		37,026
Intangible assets with finite lives, additions		(143)	[2]	1,203	[3]
Other, Finite lived intangible assets	[1]	(6)		(1,842)
Net intangible assets with finite lives, Ending balance		21,083		30,653
Indefinite-lived Intangible Assets, Tradename and Other, Beginning Balance		300,257		299,735
Indefinite lived intangible assets, additions		492	[2]	853	[3]
Other, Tradename and other	[1]	(63)		(331)
Indefinite-lived Intangible Assets, Tradename, Ending Balance		300,686		300,257
Total intangible assets - net, Beginning balance		330,910		336,761
Other, Total intangible assets - net	[1]	(69)		(2,173)
Total intangible assets - net, Ending balance		321,769		$ 330,910
ASC Topic 842
Intangible Assets [Line Items]
Impact of Adoption, Gross carrying amount	[4]	(4,427)
Impact of Adoption, Accumulated amortization	[4]	0
Impact of Adoption, Finite lived intangible assets	[4]	0
Impact of Adoption, Trade and other	[4]	0
Impact of Adoption, Total intangible assets - net	[4]	$ 0
[1]	Amount represents the write-off of fully amortized intangible assets related to non-compete agreements, the acquisition of tradeable liquor licenses, and foreign currency translation adjustments.
[2]	Amount represents intangible assets recorded as a result of two theatres acquired in the U.S. and final purchase price adjustment for theatres acquired in Brazil during the year ended December 31, 2018.
[3]	Activity represents preliminary fair values recorded as a result of the acquisition of theatres in Brazil.
[4]	See Note 3 for further discussion of the impact of the adoption of ASC Topic 842.

Intangible Assets-Net (Parenthe

Intangible Assets-Net (Parenthetical) (Detail)	Dec. 31, 2019Theatre
Intangible Assets Net Excluding Goodwill [Abstract]
Number of theatres acquired	2

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Finite Lived Intangible Assets Net [Abstract]
For the year ended December 31, 2020	$ 5,036
For the year ended December 31, 2021	3,127
For the year ended December 31, 2022	2,974
For the year ended December 31, 2023	2,876
For the year ended December 31, 2024	2,876
Thereafter	4,194
Total	$ 21,083	$ 30,653	$ 37,026

Long-Lived Asset Impairment Los

Long-Lived Asset Impairment Losses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Impaired Long-Lived Assets Held and Used [Line Items]
Impairment of long-lived assets	$ 57,001	$ 32,372	$ 15,084
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	36,005	18,597	5,227
Theatre operating lease right-of-use assets	10,457
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties	8,821	$ 13,775	$ 9,857
Theatre operating lease right-of-use assets	$ 1,718

Impairment of Long-Lived Asse_3

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract]
Estimated aggregate fair value of long-lived assets impaired during current period	$ 62,649

Deferred Changes and Other Asse

Deferred Changes and Other Assets (Detail) - USD ($) $ in Thousands		Dec. 31, 2019	Dec. 31, 2018
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Abstract]
Long-term prepaid rents	[1]		$ 15,943
Construction and other deposits		$ 6,981	8,183
Equipment to be placed in service		12,929	10,466
Other		19,204	6,463
Total		$ 39,114	$ 41,055
[1]	See Note 3 for discussion of impact of the adoption of ASC Topic 842.

Long Term Debt (Detail)

Long Term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Mar. 29, 2018	[1]	Nov. 28, 2017	[1]	Jun. 16, 2017	[1]
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan	$ 646,327	$ 652,922
Other		1,389
Total	1,801,327	1,809,311
Less current portion	6,595	7,984
Less debt issuance costs, net of accumulated amortization of $30,289 and $35,599, respectively	23,390	28,700	$ 4,962		$ 330		$ 521
Long-term debt, less current portion	1,771,342	1,772,627
5.125% senior notes due 2022
Debt Instrument [Line Items]
Senior notes	400,000	400,000
4.875% senior notes due 2023
Debt Instrument [Line Items]
Senior notes	$ 755,000	$ 755,000
[1]	Reflected as a reduction of long term debt on the consolidated balance sheet.

Long Term Debt (Parenthetical)

Long Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Debt issue costs, accumulated amortization	$ 35,599	$ 30,289

Long Term Debt - Additional Inf

Long Term Debt - Additional Information (Detail)		Mar. 21, 2016USD ($)	May 24, 2013USD ($)	Dec. 18, 2012USD ($)	Dec. 31, 2019USD ($)Agreement	Dec. 31, 2016USD ($)	Dec. 31, 2012	Dec. 31, 2018USD ($)
Debt Instrument [Line Items]
Amount outstanding under the term loan					$ 646,327,000			$ 652,922,000
Percentage voting stock of foreign subsidiaries					65.00%
Multiple consolidated interest expense under sub condition two of condition two under dividend restriction					1.75
Carrying value of long-term debt					$ 1,801,327,000			1,809,311,000
Fair value of long-term debt					$ 1,826,503,000			1,774,066,000
Number of interest rate swap agreements | Agreement					3
Net of deferred taxes					$ 2,692,000
Designated as Hedging Instrument | Cash Flow Hedging
Debt Instrument [Line Items]
Estimated fair value	[1]				15,995,000
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Swap Agreements
Debt Instrument [Line Items]
Estimated fair value					15,995,000
Net of deferred taxes					3,935,000
Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Quarterly principal payments due					$ 1,649,000
Last quarterly payment date					Dec. 31, 2024
Final principal payment					$ 613,351,000
Actual coverage ratio					298.00%
Amended senior secured credit facility, dividend that could have distributed					$ 3,196,752,000
Amended Senior Secured Credit Facility | Maximum
Debt Instrument [Line Items]
Senior secured leverage ratio required					500.00%
4.875% senior notes due 2023
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes			$ 530,000,000
Actual coverage ratio					660.00%
Interest rate			4.875%
Debt instrument, maturity date			Jun. 1, 2023
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control					101.00%
Senior notes indenture, amount that could have distributed					$ 3,353,829,000
Debt covenants, required minimum coverage ratio					200.00%
4.875 % Senior Notes Due June 1, 2023
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes		$ 225,000,000				$ 755,000,000
Interest rate		4.875%				4.875%
Debt instrument, maturity date						Jun. 1, 2023
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control		99.00%
5.125% senior notes due 2022
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes				$ 400,000,000
Actual coverage ratio					660.00%
Interest rate				5.125%
Debt instrument, maturity date							Dec. 15, 2022
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control					101.00%
Debt covenants, required minimum coverage ratio					200.00%
Debt instrument, maturity period				2022
Description of debt Instrument frequency of periodic payment					Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year.
Senior notes indenture, amount that could have distributed					$ 3,347,932,000
Term Loan Credit facility | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes					$ 700,000,000
Term Loan Credit facility | Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Final principal payment due date					Mar. 29, 2025
Percentage of Variable rate added to federal funds effective rate					0.50%
Percentage of variable margin rate added to one-month Eurodollar rate					1.00%
Percentage of variable margin rate added to Eurodollar rate					1.75%
Debt instrument description of interest					a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum.
Amount outstanding under the term loan					$ 646,327,000
Average interest rate on outstanding borrowings					4.20%
Term Loan Credit facility | Amended Senior Secured Credit Facility | One Month Eurodollar Rate
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate					0.75%
Revolving Credit Line | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes					$ 100,000,000
Revolving Credit Line | Amended Senior Secured Credit Facility
Debt Instrument [Line Items]
Percentage of Variable rate added to federal funds effective rate					0.50%
Percentage of variable margin rate added to one-month Eurodollar rate					1.00%
Debt instrument description of interest					a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum.
Amount outstanding under the revolving credit line					$ 0			$ 0
Available borrowing capacity					$ 98,870,000
Revolving Credit Line | Amended Senior Secured Credit Facility | Minimum
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate					1.50%
Revolving Credit Line | Amended Senior Secured Credit Facility | Maximum
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate					2.25%
Revolving Credit Line | Amended Senior Secured Credit Facility | One Month Eurodollar Rate | Minimum
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate					0.50%
Revolving Credit Line | Amended Senior Secured Credit Facility | One Month Eurodollar Rate | Maximum
Debt Instrument [Line Items]
Percentage of variable margin rate added to Eurodollar rate					1.25%
[1]	Approximately $5,253 is included in accrued other current liabilities and $10,742 is included in other long-term liabilities on the consolidated balance sheet as of December 31, 2019.

Long Term Debt - Amendment of C

Long Term Debt - Amendment of Credit Agreement (Detail) - USD ($) $ in Thousands	Mar. 29, 2018		Nov. 28, 2017		Jun. 16, 2017		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Debt Issue Cost Paid	$ 4,962	[1]	$ 330	[1]	$ 521	[1]	$ 23,390	$ 28,700
Loss on Debt Amendment	$ 1,484	[2]	$ 331	[2]	$ 190	[2]		$ 1,484	$ 521
Amended Credit Agreement June 16, 2017
Debt Instrument [Line Items]
Nature of Amendment							Reduced term loan interest rate by 0.25%; modified certain definitions and other provisions in the Credit Agreement
Amended Credit Agreement November 28, 2017
Debt Instrument [Line Items]
Nature of Amendment							Extended maturity of revolving credit line to December 2022; reduced the interest rate applicable to borrowings under the credit line
Amended Credit Agreement March 29, 2018
Debt Instrument [Line Items]
Nature of Amendment							Extended maturity of term loan to March 2025; reduced term loan interest rate by 0.25%; reduced real property mortgage requirements
[1]	Reflected as a reduction of long term debt on the consolidated balance sheet.
[2]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

Long Term Debt - Amendment of_2

Long Term Debt - Amendment of Credit Agreement (Parenthetical) (Detail)	Mar. 29, 2018	Nov. 28, 2017	Jun. 16, 2017
Debt Disclosure [Abstract]
Debt instrument, reduction in interest rate	0.25%		0.25%
Debt instrument, extended maturity date	2025-03	2022-12

Maturities of Long-Term Debt, E

Maturities of Long-Term Debt, Excluding Unamortized Debt Issuance Costs (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
2020	$ 6,595
2021	6,595
2022	406,595
2023	761,595
2024	6,595
Thereafter	613,352
Total	$ 1,801,327	$ 1,809,311

Long Term Debt - Summary of Com

Long Term Debt - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) - Cash Flow Hedging - Designated as Hedging Instrument $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
Estimated Fair Value	$ 15,995	[1]
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Notional Amount	$ 175,000
Effective Date	Dec. 31, 2018
Pay Rate	2.751%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 6,213	[1]
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.765%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 4,956	[1]
Interest Rate Swap Agreement 3
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.746%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2022
Estimated Fair Value	$ 4,826	[1]
[1]	Approximately $5,253 is included in accrued other current liabilities and $10,742 is included in other long-term liabilities on the consolidated balance sheet as of December 31, 2019.

Long Term Debt - Summary of C_2

Long Term Debt - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Parenthetical) (Detail) $ in Thousands	Dec. 31, 2019USD ($)
Accrued Other Current Liabilities
Debt Instrument [Line Items]
Estimated Fair Value	$ 5,253
Other Long-term Liabilities
Debt Instrument [Line Items]
Estimated Fair Value	$ 10,742

Summary of Liabilities Measured

Summary of Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value Measurements, Recurring $ in Thousands	Dec. 31, 2019USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	$ (15,995)
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	$ (15,995)

Reconciliation of Beginning and

Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)	[1]
Fair Value Disclosures [Abstract]
Beginning balance - January 1	$ 5,093
Total loss included in accumulated other comprehensive loss	13,039
Settlements included in interest expense	(2,137)
Ending balance - December 31	$ 15,995
[1]	Represents interest rate swap liabilities.  See Note 10 for further discussion.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Fair value of assets transfers in or out, level 1 to level 2	$ 0	$ 0	$ 0
Fair value of assets transfers in or out, level 2 to level 1	0	0	0
Fair value, asset transfers into Level 3	0	0	0
Fair value, asset transfers out of Level 3	$ 0	$ 0	$ 0

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Foreign Currency Translation [Line Items]
Accumulated other comprehensive income (loss)	$ 340,112	$ 319,007
Cumulative foreign currency adjustments	$ 328,053	315,300
Cumulative inflation rate	100.00%
Cumulative inflation period	3 years
Reclassification of cumulative foreign currency translation adjustments		$ 518	$ (1,551)
Canada
Foreign Currency Translation [Line Items]
Reclassification of cumulative foreign currency translation adjustments			$ 1,551

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Thousands		12 Months Ended
		Dec. 31, 2019USD ($)		Dec. 31, 2018USD ($)		Dec. 31, 2017USD ($)
Foreign Currency Translation [Line Items]
Other Comprehensive Income (Loss)		$ (12,753)		$ (62,253)		$ (4,966)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate		4.02		3.88		3.31
Other Comprehensive Income (Loss)		$ (8,140)	[1]	$ (34,086)	[1]	$ (4,567)
Argentina
Foreign Currency Translation [Line Items]
Exchange Rate	[1]	59.89		37.68		18.65
Other Comprehensive Income (Loss)	[1]			$ (14,357)		$ (8,200)
Colombia
Foreign Currency Translation [Line Items]
Exchange Rate		3,277.14		3,249.75		2,936.67
Other Comprehensive Income (Loss)		$ (362)	[1]	$ (1,795)	[1]	$ 246
Chile
Foreign Currency Translation [Line Items]
Exchange Rate		736.86		694.74		615.97
Other Comprehensive Income (Loss)		$ (5,158)	[1]	$ (8,924)	[1]	$ 5,672
Peru
Foreign Currency Translation [Line Items]
Exchange Rate		3.37		3.39		3.24
Other Comprehensive Income (Loss)		$ 257	[1]	$ (2,136)	[1]	$ 2,752
Other foreign countries
Foreign Currency Translation [Line Items]
Other Comprehensive Income (Loss)		650	[1]	(955)	[1]	(869)
International Subsidiaries | Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other Comprehensive Income (Loss)		$ (12,753)	[1]	$ (62,253)	[1]	$ (4,966)
[1]	For Argentina, represents the cumulative comprehensive loss recorded through June 30, 2018.  The impact of translating Argentina financial results to U.S. dollars, subsequent to June 30, 2018, has been recorded in foreign currency exchange gain (loss) on the Company’s consolidated statements of income.  Losses of $1,463 and $3,707 were recorded for the years ended December 31, 2018 and 2019, respectively.

Summary of Impact of Translat_2

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Foreign Currency Translation [Line Items]
Foreign currency exchange loss	$ 3,394	$ 11,660	$ (893)
Argentina
Foreign Currency Translation [Line Items]
Foreign currency exchange loss	$ 3,707	$ 1,463

Non-controlling Interest in Sub

Non-controlling Interest in Subsidiaries (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 12,508	$ 12,379
Cinemark Partners II
Noncontrolling Interest [Line Items]
Noncontrolling interests	7,953	8,152
Laredo Theatre
Noncontrolling Interest [Line Items]
Noncontrolling interests	2,139	2,308
Greeley Ltd
Noncontrolling Interest [Line Items]
Noncontrolling interests	1,908	1,411
Other
Noncontrolling Interest [Line Items]
Noncontrolling interests	$ 508	$ 508

Non-controlling Interest in S_2

Non-controlling Interest in Subsidiaries (Parenthetical) (Detail)	Dec. 31, 2019	Dec. 31, 2018
Cinemark Partners II
Noncontrolling Interest [Line Items]
Ownership share	24.60%	24.60%
Laredo Theatre
Noncontrolling Interest [Line Items]
Ownership share	25.00%	25.00%
Greeley Ltd
Noncontrolling Interest [Line Items]
Ownership share	49.00%	49.00%

Noncontrolling Interests in S_3

Noncontrolling Interests in Subsidiaries - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Noncontrolling Interest [Abstract]
Changes in ownership interest in subsidiaries	$ 0	$ 0	$ 0

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Stockholders Equity Note [Line Items]
Preferred stock, shares	1,000,000
Preferred stock, par value	$ 1
Preferred stock, issued	0
Preferred stock, outstanding	0
Restricted Stock
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 15,524
Remaining Compensation Expense recognition period (in years)	2 years
Restricted Stock | Cinemark USA, Inc.
Stockholders Equity Note [Line Items]
Unrecognized compensation expense	$ 15,107
Restricted Stock | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Shares of restricted stock, granted	315,899	328,734	246,534
Market value of common stock on the dates of grant	$ 37.34	$ 38.72	$ 41.70
Unrecognized compensation expense	$ 417
Restricted Stock | Directors
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	0.00%
Restricted Stock | Minimum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 34.01
Restricted Stock | Minimum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Forfeiture rate for restricted stock awards	10.00%
Restricted Stock | Maximum | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 41.61
Restricted Stock | Maximum | Employees
Stockholders Equity Note [Line Items]
Award vesting period for restricted stock granted	4 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant	$ 36.77		$ 42.37
Unrecognized compensation expense	$ 9,872
Remaining Compensation Expense recognition period (in years)	2 years
Share-based compensation arrangement by share-based payment award, description	The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) for a two year measurement period, as defined in the award agreement, based on a formula utilizing a multiple of Adjusted EBITDA subject to certain specified adjustments (as defined in the restricted stock unit award agreement).
Share-based compensation arrangement by share-based payment award, vesting condition	All payouts of restricted stock units that vest will be subject to an additional service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date.
Internal rate of return, performance period	2 years
Percentage of IRR expected	9.00%
Percentage of IRR, which is the threshold	6.00%	6.00%	6.00%
Percentage of IRR, which is the target	8.00%	8.00%	8.00%
Percentage of IRR, which is the maximum	14.00%	14.00%	14.00%
Percentage of IRR, which is the threshold, before modification	7.00%
Percentage of IRR, which is the target before modification	9.50%
Percentage of IRR, which is the maximum before modification	13.00%
Number of hypothetical shares of common stock at maximum IRR level	749,895
Actual cumulative forfeitures (in units)	6,195
Restricted Stock Units (RSUs) | Stock Grants 2017 and 2018
Stockholders Equity Note [Line Items]
Impact of modification of awards	$ 132
Restricted Stock Units (RSUs) | Stock Grants 2017
Stockholders Equity Note [Line Items]
Impact of final performance measure	$ 563
Achieved Percentage of IRR	9.30%
Restricted Stock Units (RSUs) | Stock Grants 2016
Stockholders Equity Note [Line Items]
Achieved Percentage of IRR	7.20%
Restricted Stock Units (RSUs) | Stock Grants 2018 and 2019
Stockholders Equity Note [Line Items]
Estimated Percentage of IRR	8.00%
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Stockholders Equity Note [Line Items]
Number of hypothetical shares of common stock	306,651	228,194	175,634
Restricted Stock Units (RSUs) | Minimum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 37.55
Expected forfeiture rate	0.00%	0.00%	0.00%
Restricted Stock Units (RSUs) | Maximum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 39.03
Expected forfeiture rate	5.00%	5.00%	5.00%
Class A common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	1,500	1,500
Class B common stock
Stockholders Equity Note [Line Items]
Common stock, shares outstanding	182,648	182,648

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock - Cinemark Holdings, Inc. - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance	704,353	650,581	606,618
Shares of Restricted Stock, Granted	315,899	328,734	246,534
Shares of Restricted Stock, Vested	(209,821)	(250,442)	(192,230)
Shares of Restricted Stock, Forfeited	(26,608)	(24,520)	(10,341)
Shares of Restricted Stock, Ending balance	783,823	704,353	650,581
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning	$ 38.68	$ 35.81	$ 33.51
Weighted Average Grant Date Fair Value, Granted	37.34	38.72	41.70
Weighted Average Grant Date Fair Value, Vested	41.10	31.27	36.26
Weighted Average Grant Date Fair Value, Forfeited	37.69	38.62	33.48
Weighted Average Grant Date Fair Value Outstanding, Ending	$ 37.53	$ 38.68	$ 35.81

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	$ 9,266	$ 8,735	$ 7,528
Restricted Stock | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period	7,044	8,699	7,255
Income tax benefit recognized upon vesting of share based awards	$ 1,271	$ 1,543	$ 2,281
Restricted Stock | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	209,821	250,442	192,230
Compensation expense recognized during the period	$ 919	$ 920	$ 856
Restricted Stock | Cinemark Holdings, Inc. | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted shares that vested during the period	980	802	917
Income tax benefit recognized upon vesting of share based awards	$ 245	$ 201	$ 386
Restricted Stock Units (RSUs) | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period	90,895	127,084	97,115
Fair value of restricted shares that vested during the period	$ 3,658	$ 4,846	$ 4,155
Accumulated dividends paid upon vesting of restricted stock unit awards	386	526	558
Income tax benefit recognized upon vesting of share based awards	397	708	1,745
Compensation expense recognized during the period	$ 4,430	$ 4,681	$ 4,297

Summary of Potential Number of

Summary of Potential Number of Units that Could Vest Under Restricted Stock Unit Awards (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Disclosure Of Restricted Stock Unit [Abstract]
Number of units at threshold IRR		136,285	76,065	58,545
Number of units at target IRR		204,427	152,129	117,089
Number of units at maximum IRR		306,651	228,194	175,634
Fair value of units at threshold IRR	[1]	$ 5,011	$ 2,967	$ 2,481
Fair value of units at target IRR	[1]	7,517	5,938	4,961
Fair value of units at maximum IRR	[1]	$ 11,276	$ 8,906	$ 7,442
[1]	The grant date fair value for units issued during the year ended December 31, 2017 was $42.37.  The grant date fair values for the units issued during the year ended December 31, 2018 ranged from $37.55 to $39.03.  The grant date fair value for units issued during the year ended December 31, 2019 was $36.77 per share.

Summary of Potential Number o_2

Summary of Potential Number of Units that Could Vest Under Restricted Stock Unit Awards (Parenthetical) (Detail) - Restricted Stock Units (RSUs) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted	$ 36.77		$ 42.37
Minimum
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted		$ 37.55
Maximum
Schedule Of Restricted Stock Unit [Line Items]
Weighted Average Grant Date Fair Value, Granted		$ 39.03

Summary of Financial Performanc

Summary of Financial Performance Thresholds and Vesting Rates (Detail) - Restricted Stock Units (RSUs)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of IRR, which is the threshold	6.00%	6.00%	6.00%
Percentage of IRR, which is the target	8.00%	8.00%	8.00%
Percentage of IRR, which is the maximum	14.00%	14.00%	14.00%
Threshold IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	33.30%
Targeted IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	66.60%
Maximum IRR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of Shares Vesting	100.00%

Supplemental Information to Con

Supplemental Information to Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		Mar. 29, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest			$ 93,907	$ 98,411	$ 99,232
Cash paid for income taxes, net of refunds received			88,670	64,199	95,043
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]		22,013	(5,728)	9,349
Theatre properties acquired under finance leases			21,535	18,851	46,727
Investment in NCM – receipt of common units (see Note 5)		$ 1,552	1,552	5,012	$ 18,363
NCM
Noncash investing and financing activities:
Interest expense - NCM (see Notes 4 and 5)			$ (28,624)	$ (19,724)
[1]	Additions to theatre properties and equipment included in accounts payable as of December 31, 2018 and 2019 were $37,004 and $14,991, respectively.

Supplemental Information to C_2

Supplemental Information to Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 14,991	$ 37,004

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Taxes [Line Items]
Corporate income tax rate percent	21.00%		35.00%
Accumulated undistributed earnings and profits	$ 432,994
One-time transition tax accumulated undistributed earnings and profits	370,389
Valuation allowance against deferred assets – non-current	60,359	$ 54,725
Gross unrecognized tax benefits, including interest and penalties	14,294	13,953
Unrecognized tax benefit that if recognized would impact effective tax rate	14,294	13,953
Accrued for interest and penalties	4,058	$ 3,390
Decrease in unrecognized tax benefits reasonably possible	9,494
Decrease in accrued interest reasonably possible	$ (3,952)
Foreign | Minimum
Income Taxes [Line Items]
Tax credit carryforwards expiring year	2024
State | Minimum
Income Taxes [Line Items]
Net operating losses carried forward expiring period	5 years
State | Maximum
Income Taxes [Line Items]
Net operating losses carried forward expiring period	20 years
Net operating losses carried forward expiring year	2037

Income Before Income Taxes (Det

Income Before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income before income taxes, U.S.	$ 238,108	$ 292,238	$ 282,896
Income before income taxes, Foreign	38,189	21,007	64,842
Income before income taxes	$ 276,297	$ 313,245	$ 347,738

Current and Deferred Income Tax

Current and Deferred Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Current:
Federal	$ 45,758	$ 47,333	$ 55,224
Foreign	24,022	11,822	29,306
State	12,583	13,690	10,741
Total current expense	82,363	72,845	95,271
Deferred:
Federal	(298)	27,055	(14,046)
Foreign	5	(6,166)	(4,270)
State	(1,550)	2,298	3,301
Total deferred taxes	(1,843)	23,187	(15,015)
Income taxes	$ 80,520	$ 96,032	$ 80,256

Reconciliation Between Income T

Reconciliation Between Income Tax Expenses (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Computed statutory tax expense		$ 58,022	$ 65,781	$ 121,708
State and local income taxes, net of federal income tax impact		8,555	12,687	12,858
Changes in valuation allowance		2,532	131	44
Foreign tax rate differential		4,646	2,235	(245)
Foreign dividends				13,662
Foreign tax credits		4,143	3,927	(21,647)
Impacts related to 2017 Tax Act	[1],[2]		19,180	(44,889)
Changes in uncertain tax positions		197	(6,139)	983
Other — net		2,425	(1,770)	(2,218)
Income taxes		$ 80,520	$ 96,032	$ 80,256
[1]	The amount for the year ended December 31, 2017 includes a one-time benefit due to re-measurement of net deferred tax liabilities using a lower U.S. corporate tax rate and a reassessment of permanently reinvested earnings of ($79,834), a deemed repatriation tax of $14,512, and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $20,433.
[2]	The amount for the year ended December 31, 2018 includes a one-time charge to true-up deferred taxes of $1,913 and a reduction in deferred tax assets with regard to foreign tax credit carryforwards of $17,267.

Reconciliation Between Income_2

Reconciliation Between Income Tax Expenses (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
One-time benefit due to re-measurement of net deferred tax liabilities		$ (79,834)
One-time charge to true-up deferred taxes	$ 1,913
Deemed repatriation tax amount		14,512
Reduction in deferred tax assets with regard to foreign tax credit carryforwards	$ 17,267	$ 20,433

Net Long-Term Deferred Income T

Net Long-Term Deferred Income Tax Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Theatre properties and equipment	$ 138,382	$ 158,797
Operating lease right-of-use assets	322,750
Intangible asset — other	39,282	33,561
Intangible asset — tradenames	72,821	73,261
Investment in partnerships	62,914	63,217
Total deferred liabilities	636,149	328,836
Deferred lease expenses		13,464
Deferred revenue - NCM	85,362	86,035
Deferred revenue - Other	9,953	4,153
Gift Cards	7,402	6,173
Operating lease obligations	336,034
Finance lease obligations	34,956	63,895
Tax impact of items in accumulated other comprehensive income	5,131	2,237
Other tax loss carryforwards	17,053	15,608
Other tax credit carryforwards	46,577	42,989
Other expenses, not currently deductible for tax purposes	21,573	17,755
Total deferred assets	564,041	252,309
Net deferred income tax liability before valuation allowance	72,108	76,527
Valuation allowance against deferred assets – non-current	60,359	54,725
Net deferred income tax liability	132,467	131,252
Foreign
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax (asset)	(4,539)	(5,449)
U.S.
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]
Net deferred income tax liability	$ 137,006	$ 136,701

Reconciliation of Total Amounts

Reconciliation of Total Amounts of Unrecognized Tax Benefits Excluding Interest and Penalties (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Beginning Balance	$ 10,561	$ 18,266	$ 17,403
Gross increases - tax positions in prior periods	1		92
Gross decreases - tax positions in prior periods		(143)	(12)
Gross increases - current period tax positions	202	424	265
Settlements	(522)	(7,191)	(177)
Foreign currency translation adjustments	(7)	(795)	695
Ending Balance	$ 10,235	$ 10,561	$ 18,266

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Commitments And Contingencies Disclosure [Line Items]
Employer matching contribution payments	$ 6,052	$ 5,076
Liability recorded for employer contribution payments	$ 1,539
Messrs. Mitchell, Gamble, Fernandes and Cavalier
Commitments And Contingencies Disclosure [Line Items]
Employment agreements term extension	1 year
Mr Zoradi
Commitments And Contingencies Disclosure [Line Items]
Employment agreement expiration date	Dec. 31, 2020

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Revenues		$ 3,283,099	$ 3,221,735	$ 2,991,547
Adjusted EBITDA	[1]	746,683	783,130	725,269
Capital expenditures		303,627	346,073	380,862
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues	[2]	2,580,903	2,538,957
International Operating Segment
Segment Reporting Information [Line Items]
Revenues		702,196	682,778
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		2,594,246	2,551,719	2,236,237
Adjusted EBITDA		616,799	650,189	559,693
Capital expenditures		230,561	270,870	321,040
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		702,196	682,778	769,436
Adjusted EBITDA		129,884	132,941	165,576
Capital expenditures		73,066	75,203	59,822
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (13,343)	$ (12,762)	$ (14,126)
[1]	Amounts for the year ended December 31, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases.  See Note 3 for further discussion.
[2]	U.S. segment revenues include eliminations of intercompany transactions with the international operating segment.  See Note 18 for additional information on intercompany eliminations.

Reconciliation of Net Income to

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		Mar. 29, 2018	[3]	Nov. 28, 2017	[3]	Jun. 16, 2017	[3]	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Net income								$ 195,777	$ 217,213	$ 267,482
Add (deduct):
Income taxes								80,520	96,032	80,256
Interest expense	[1],[2]							99,941	109,994	105,918
Loss on debt amendments and refinancing		$ 1,484		$ 331		$ 190			1,484	521
Other income	[4]							(22,422)	(18,450)	(43,121)
Other cash distributions from equity investees								53,366	30,143	25,973
Depreciation and amortization	[1]							261,155	261,162	237,513
Impairment of long-lived assets								57,001	32,372	15,084
Loss on disposal of assets and other								12,008	38,702	22,812
Non-cash rent expense	[5]							(4,360)
Deferred lease expenses	[1]								(1,320)	(1,268)
Amortization of long-term prepaid rents	[1]								2,382	2,274
Share based awards compensation expense								13,697	13,416	11,825
Adjusted EBITDA	[1]							746,683	783,130	725,269
Digital Cinema Implementation Partners
Add (deduct):
Other cash distributions from equity investees	[6]							23,696	5,799	5,864
Other Investees
Add (deduct):
Other cash distributions from equity investees	[7]							$ 29,670	$ 24,344	$ 20,109
[1]	Amounts for the year ended December 31, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases.  See Note 3 for further discussion.
[2]	Includes amortization of debt issue costs.
[3]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.
[4]	Includes interest income, foreign currency exchange gain (loss), interest expense – NCM and equity in income of affiliates and excludes distributions from NCM.
[5]	The adoption of ASC Topic 842 impacted how the Company amortizes lease related assets and liabilities such as deferred lease expenses, favorable and unfavorable lease intangible assets, long-term prepaid rents and deferred lease incentives.  Beginning January 1, 2019, these items are amortized to facility lease expense for theatre operating leases and utilities and other for equipment operating leases.  See Note 3 for discussion of the impact of ASC Topic 842.
[6]	See discussion of cash distributions from DCIP, which were recorded as a reduction of the Company’s investment in DCIP, at Note 6.  These distributions are reported entirely within the U.S. operating segment.
[7]	Includes cash distributions received from equity investees, other than those from DCIP noted above, that were recorded as a reduction of the respective investment balances (see Notes 5 and 6).  These distributions are reported entirely within the U.S. operating segment.

Selected Financial Informatio_2

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 3,283,099	$ 3,221,735	$ 2,991,547
Theatre Properties and Equipment - net	1,735,247	1,833,133
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	2,594,246	2,551,719	2,236,237
Theatre Properties and Equipment - net	1,436,275	1,479,603
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	302,074	283,009	341,485
Theatre Properties and Equipment - net	118,367	140,570
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	400,122	399,769	427,951
Theatre Properties and Equipment - net	180,605	212,960
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (13,343)	$ (12,762)	$ (14,126)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2019USD ($)TheatreFacilityLease	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
FE Concepts LLC
Related Party Transaction [Line Items]
Management fees	$ 64,000
Equity method investment, ownership percentage	50.00%
Event fees	$ 78,000
Laredo Theatres, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of Directors	8.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	694,000	$ 654,000	$ 586,000
Copper Beech Capital LLC
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 114,000	68,000	131,000
Pinstack
Related Party Transaction [Line Items]
Amount paid for the event for employees and their families		5,000	36,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	14
Number of parking facilities leased | Facility	1
Total number of leases | Lease	15
Number of leases with minimum annual rent | Lease	14
Number of leases without minimum annual rent | Lease	1
Total rent paid to Syufy	$ 25,678,000	$ 23,447,000	$ 22,483,000
Management fees	$ 30,000

Valuation Allowance of Deferred

Valuation Allowance of Deferred Tax Assets (Detail) - Valuation Allowance of Deferred Tax Assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning Balance	$ 54,725	$ 35,246	$ 14,524
Additions	7,611	22,005	21,347
Deductions	(1,977)	(2,526)	(625)
Ending Balance	$ 60,359	$ 54,725	$ 35,246

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Dec. 31, 2019USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 755,000
Interest rate	4.875%

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents		$ 488,215	$ 426,216
Other current assets		146,677	132,797
Accounts receivable from parent or subsidiaries		24,319	19,530
Total current assets		659,211	578,543
Theatre properties and equipment - net		1,735,247	1,833,133
Operating lease right-of-use assets	[1]	1,383,080
Investment in subsidiaries		0	0
Other assets		2,074,700	2,089,675
Total assets		5,852,238	4,501,351
Current liabilities
Current portion of long-term debt		6,595	7,984
Current portion of capital lease obligations			27,065
Current portion of operating lease obligations	[1]	217,406
Current portion of finance lease obligations	[1]	15,432
Accounts payable and accrued expenses		468,738	439,004
Accounts payable to parent or subsidiaries		0	0
Total current liabilities		708,171	474,053
Long-term liabilities
Long-term debt, less current portion		1,771,342	1,772,627
Capital lease obligations, less current portion			232,467
Operating lease obligations, less current portion	[1]	1,223,462
Finance lease obligations, less current portion	[1]	141,017
Other long-term liabilities and deferrals		534,039	592,568
Total long-term liabilities		3,669,860	2,597,662
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Other stockholder's equity		1,412,156	1,367,714
Total Cinemark USA, Inc.'s stockholder's equity		1,461,699	1,417,257
Noncontrolling interests		12,508	12,379
Total equity		1,474,207	1,429,636	$ 1,421,495	$ 1,284,080
Total liabilities and equity		5,852,238	4,501,351
Eliminations
Current assets
Cash and cash equivalents		0	0
Other current assets		(17,030)	(15,178)
Accounts receivable from parent or subsidiaries		(383,926)	(265,363)
Total current assets		(400,956)	(280,541)
Theatre properties and equipment - net		0	0
Operating lease right-of-use assets		0
Investment in subsidiaries		(1,987,878)	(1,864,100)
Other assets		(109,693)	(112,536)
Total assets		(2,498,527)	(2,257,177)
Current liabilities
Current portion of long-term debt		0	0
Current portion of capital lease obligations			0
Current portion of operating lease obligations		0
Current portion of finance lease obligations		0
Accounts payable and accrued expenses		(14,935)	(13,622)
Accounts payable to parent or subsidiaries		(383,926)	(265,363)
Total current liabilities		(398,861)	(278,985)
Long-term liabilities
Long-term debt, less current portion		(104,455)	(107,955)
Capital lease obligations, less current portion			0
Operating lease obligations, less current portion		0
Finance lease obligations, less current portion		0
Other long-term liabilities and deferrals		(7,333)	(6,137)
Total long-term liabilities		(111,788)	(114,092)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		(467,606)	(467,606)
Other stockholder's equity		(1,520,272)	(1,396,494)
Total Cinemark USA, Inc.'s stockholder's equity		(1,987,878)	(1,864,100)
Noncontrolling interests		0	0
Total equity		(1,987,878)	(1,864,100)
Total liabilities and equity		(2,498,527)	(2,257,177)
Cinemark USA, Inc.
Current assets
Cash and cash equivalents		179,162	197,965
Other current assets		64,901	60,829
Accounts receivable from parent or subsidiaries		0	0
Total current assets		244,063	258,794
Theatre properties and equipment - net		659,538	664,759
Operating lease right-of-use assets		710,192
Investment in subsidiaries		1,961,159	1,806,255
Other assets		1,489,285	1,500,366
Total assets		5,064,237	4,230,174
Current liabilities
Current portion of long-term debt		6,595	6,595
Current portion of capital lease obligations			11,918
Current portion of operating lease obligations		99,924
Current portion of finance lease obligations		11,073
Accounts payable and accrued expenses		322,849	297,302
Accounts payable to parent or subsidiaries		132,832	40,421
Total current liabilities		573,273	356,236
Long-term liabilities
Long-term debt, less current portion		1,871,342	1,872,627
Capital lease obligations, less current portion			123,329
Operating lease obligations, less current portion		639,847
Finance lease obligations, less current portion		91,524
Other long-term liabilities and deferrals		426,552	460,725
Total long-term liabilities		3,029,265	2,456,681
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543	49,543
Other stockholder's equity		1,412,156	1,367,714
Total Cinemark USA, Inc.'s stockholder's equity		1,461,699	1,417,257
Noncontrolling interests		0	0
Total equity		1,461,699	1,417,257
Total liabilities and equity		5,064,237	4,230,174
Subsidiary Guarantors
Current assets
Cash and cash equivalents		5,704	10,886
Other current assets		30,532	19,997
Accounts receivable from parent or subsidiaries		408,245	284,893
Total current assets		444,481	315,776
Theatre properties and equipment - net		752,599	789,536
Operating lease right-of-use assets		467,344
Investment in subsidiaries		26,719	57,845
Other assets		157,025	155,011
Total assets		1,848,168	1,318,168
Current liabilities
Current portion of long-term debt		0	0
Current portion of capital lease obligations			9,406
Current portion of operating lease obligations		86,828
Current portion of finance lease obligations		4,289
Accounts payable and accrued expenses		56,249	58,544
Accounts payable to parent or subsidiaries		0	0
Total current liabilities		147,366	67,950
Long-term liabilities
Long-term debt, less current portion		0	0
Capital lease obligations, less current portion			59,539
Operating lease obligations, less current portion		414,099
Finance lease obligations, less current portion		49,121
Other long-term liabilities and deferrals		37,346	60,137
Total long-term liabilities		500,566	119,676
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		457,368	457,368
Other stockholder's equity		742,868	673,174
Total Cinemark USA, Inc.'s stockholder's equity		1,200,236	1,130,542
Noncontrolling interests		0	0
Total equity		1,200,236	1,130,542
Total liabilities and equity		1,848,168	1,318,168
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents		303,349	217,365
Other current assets		68,274	67,149
Accounts receivable from parent or subsidiaries		0	0
Total current assets		371,623	284,514
Theatre properties and equipment - net		323,110	378,838
Operating lease right-of-use assets		205,544
Investment in subsidiaries		0	0
Other assets		538,083	546,834
Total assets		1,438,360	1,210,186
Current liabilities
Current portion of long-term debt		0	1,389
Current portion of capital lease obligations			5,741
Current portion of operating lease obligations		30,654
Current portion of finance lease obligations		70
Accounts payable and accrued expenses		104,575	96,780
Accounts payable to parent or subsidiaries		251,094	224,942
Total current liabilities		386,393	328,852
Long-term liabilities
Long-term debt, less current portion		4,455	7,955
Capital lease obligations, less current portion			49,599
Operating lease obligations, less current portion		169,516
Finance lease obligations, less current portion		372
Other long-term liabilities and deferrals		77,474	77,843
Total long-term liabilities		251,817	135,397
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock		10,238	10,238
Other stockholder's equity		777,404	723,320
Total Cinemark USA, Inc.'s stockholder's equity		787,642	733,558
Noncontrolling interests		12,508	12,379
Total equity		800,150	745,937
Total liabilities and equity		$ 1,438,360	$ 1,210,186
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.

Condensed Consolidating Stateme

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		Mar. 29, 2018	[3]	Nov. 28, 2017	[3]	Jun. 16, 2017	[3]	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Condensed Financial Statements, Captions [Line Items]
Revenues								$ 3,283,099	$ 3,221,735	$ 2,991,547
Cost of operations
Theatre operating expenses								2,441,164	2,335,975	2,170,578
General and administrative expenses								170,828	162,640	150,911
Depreciation and amortization	[1]							261,155	261,162	237,513
Impairment of long-lived assets								57,001	32,372	15,084
Loss on disposal of assets and other								12,008	38,702	22,812
Total cost of operations								2,942,156	2,830,851	2,596,898
Operating income								340,943	390,884	394,649
Other income (expense)
Interest expense	[1],[2]							(99,941)	(109,994)	(105,918)
Loss on debt amendments and refinancing		$ (1,484)		$ (331)		$ (190)			(1,484)	(521)
Equity in income of affiliates								41,870	39,242	35,985
Other income (loss)								9,176	(1,068)	7,136
Total other expense								(64,646)	(77,639)	(46,911)
Income before income taxes								276,297	313,245	347,738
Income taxes								80,520	96,032	80,256
Net income								195,777	217,213	267,482
Less: Net income attributable to noncontrolling interests								2,462	1,478	1,839
Net income attributable to Cinemark USA, Inc.								193,315	215,735	265,643
Eliminations
Condensed Financial Statements, Captions [Line Items]
Revenues								(56,176)	(56,590)	(50,756)
Cost of operations
Theatre operating expenses								(56,176)	(56,590)	(50,756)
General and administrative expenses								0	0	0
Depreciation and amortization								0	0	0
Impairment of long-lived assets								0	0	0
Loss on disposal of assets and other								0	0	0
Total cost of operations								(56,176)	(56,590)	(50,756)
Operating income								0	0	0
Other income (expense)
Interest expense								1,308	1,377	1,433
Loss on debt amendments and refinancing									0	0
Equity in income of affiliates								(153,700)	(164,827)	(270,189)
Other income (loss)								(1,308)	(1,377)	(1,433)
Total other expense								(153,700)	(164,827)	(270,189)
Income before income taxes								(153,700)	(164,827)	(270,189)
Income taxes								0	0	0
Net income								(153,700)	(164,827)	(270,189)
Less: Net income attributable to noncontrolling interests								0	0	0
Net income attributable to Cinemark USA, Inc.								(153,700)	(164,827)	(270,189)
NCM
Other income (expense)
Distributions from NCM								12,873	15,389	16,407
Interest expense - NCM								(28,624)	(19,724)
NCM | Eliminations
Other income (expense)
Distributions from NCM								0	0	0
Interest expense - NCM								0	0
Cinemark USA, Inc.
Condensed Financial Statements, Captions [Line Items]
Revenues								1,216,308	1,192,478	1,013,960
Cost of operations
Theatre operating expenses								947,745	916,726	795,976
General and administrative expenses								11,975	11,497	13,176
Depreciation and amortization								91,681	89,429	79,676
Impairment of long-lived assets								9,951	4,118	3,725
Loss on disposal of assets and other								5,068	13,321	16,895
Total cost of operations								1,066,420	1,035,091	909,448
Operating income								149,888	157,387	104,512
Other income (expense)
Interest expense								(97,894)	(97,585)	(94,229)
Loss on debt amendments and refinancing									(1,484)	(521)
Equity in income of affiliates								171,193	183,463	255,594
Other income (loss)								4,050	4,287	2,475
Total other expense								48,725	68,957	163,319
Income before income taxes								198,613	226,344	267,831
Income taxes								5,298	10,609	2,188
Net income								193,315	215,735	265,643
Less: Net income attributable to noncontrolling interests								0	0	0
Net income attributable to Cinemark USA, Inc.								193,315	215,735	265,643
Cinemark USA, Inc. | NCM
Other income (expense)
Distributions from NCM								0	0	0
Interest expense - NCM								(28,624)	(19,724)
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues								1,376,109	1,362,043	1,220,993
Cost of operations
Theatre operating expenses								981,665	933,858	834,135
General and administrative expenses								109,422	100,407	82,955
Depreciation and amortization								103,168	99,627	87,463
Impairment of long-lived assets								36,511	13,612	1,502
Loss on disposal of assets and other								4,925	23,337	3,372
Total cost of operations								1,235,691	1,170,841	1,009,427
Operating income								140,418	191,202	211,566
Other income (expense)
Interest expense								(2,432)	(6,520)	(7,675)
Loss on debt amendments and refinancing									0	0
Equity in income of affiliates								(9,270)	(12,561)	16,838
Other income (loss)								(24)	(14)	1,040
Total other expense								(11,726)	(19,095)	10,203
Income before income taxes								128,692	172,107	221,769
Income taxes								41,646	68,624	69,770
Net income								87,046	103,483	151,999
Less: Net income attributable to noncontrolling interests								0	0	0
Net income attributable to Cinemark USA, Inc.								87,046	103,483	151,999
Subsidiary Guarantors | NCM
Other income (expense)
Distributions from NCM								0	0	0
Interest expense - NCM								0	0
Subsidiary Non-Guarantors
Condensed Financial Statements, Captions [Line Items]
Revenues								746,858	723,804	807,350
Cost of operations
Theatre operating expenses								567,930	541,981	591,223
General and administrative expenses								49,431	50,736	54,780
Depreciation and amortization								66,306	72,106	70,374
Impairment of long-lived assets								10,539	14,642	9,857
Loss on disposal of assets and other								2,015	2,044	2,545
Total cost of operations								696,221	681,509	728,779
Operating income								50,637	42,295	78,571
Other income (expense)
Interest expense								(923)	(7,266)	(5,447)
Loss on debt amendments and refinancing									0	0
Equity in income of affiliates								33,647	33,167	33,742
Other income (loss)								6,458	(3,964)	5,054
Total other expense								52,055	37,326	49,756
Income before income taxes								102,692	79,621	128,327
Income taxes								33,576	16,799	8,298
Net income								69,116	62,822	120,029
Less: Net income attributable to noncontrolling interests								2,462	1,478	1,839
Net income attributable to Cinemark USA, Inc.								66,654	61,344	118,190
Subsidiary Non-Guarantors | NCM
Other income (expense)
Distributions from NCM								12,873	15,389	$ 16,407
Interest expense - NCM								$ 0	$ 0
[1]	Amounts for the year ended December 31, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases.  See Note 3 for further discussion.
[2]	Includes amortization of debt issue costs.
[3]	Reflected as a loss on debt amendments and refinancing on the consolidated statement of income for the year in which the amendments were effective.

Condensed Consolidating State_2

Condensed Consolidating Statement of Comprehensive Income Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Condensed Statement Of Income Captions [Line Items]
Net income	$ 195,777	$ 217,213	$ 267,482
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	(8,210)	(3,851)	0
Other comprehensive income (loss) in equity method investments	(142)	(139)	248
Foreign currency translation adjustments	(12,753)	(62,253)	(4,966)
Total other comprehensive loss, net of tax	(21,105)	(66,243)	(4,718)
Total comprehensive income, net of tax	174,672	150,970	262,764
Comprehensive income attributable to noncontrolling interests	(2,462)	(1,478)	(1,839)
Comprehensive income attributable to Cinemark USA, Inc.	172,210	149,492	260,925
Eliminations
Condensed Statement Of Income Captions [Line Items]
Net income	(153,700)	(164,827)	(270,189)
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	0	0
Other comprehensive income (loss) in equity method investments	142	139	(248)
Foreign currency translation adjustments	12,753	62,253	4,966
Total other comprehensive loss, net of tax	12,895	62,392	4,718
Total comprehensive income, net of tax	(140,805)	(102,435)	(265,471)
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	(140,805)	(102,435)	(265,471)
Cinemark USA, Inc.
Condensed Statement Of Income Captions [Line Items]
Net income	193,315	215,735	265,643
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	(8,210)	(3,851)
Other comprehensive income (loss) in equity method investments	(142)	(139)	248
Foreign currency translation adjustments	(12,753)	(62,253)	(4,966)
Total other comprehensive loss, net of tax	(21,105)	(66,243)	(4,718)
Total comprehensive income, net of tax	172,210	149,492	260,925
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	172,210	149,492	260,925
Subsidiary Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	87,046	103,483	151,999
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	0	0
Other comprehensive income (loss) in equity method investments	0	0	0
Foreign currency translation adjustments	0	0	0
Total other comprehensive loss, net of tax	0	0	0
Total comprehensive income, net of tax	87,046	103,483	151,999
Comprehensive income attributable to noncontrolling interests	0	0	0
Comprehensive income attributable to Cinemark USA, Inc.	87,046	103,483	151,999
Subsidiary Non-Guarantors
Condensed Statement Of Income Captions [Line Items]
Net income	69,116	62,822	120,029
Other comprehensive loss, net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	0	0
Other comprehensive income (loss) in equity method investments	(142)	(139)	248
Foreign currency translation adjustments	(12,753)	(62,253)	(4,966)
Total other comprehensive loss, net of tax	(12,895)	(62,392)	(4,718)
Total comprehensive income, net of tax	56,221	430	115,311
Comprehensive income attributable to noncontrolling interests	(2,462)	(1,478)	(1,839)
Comprehensive income attributable to Cinemark USA, Inc.	$ 53,759	$ (1,048)	$ 113,472

Condensed Consolidating State_3

Condensed Consolidating Statement of Comprehensive Income Information (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Condensed Financial Information Of Subsidiaries Disclosure [Abstract]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 2,692	$ 1,243	$ 0

Condensed Consolidating State_4

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	Jul. 05, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Operating activities
Net income		$ 195,777	$ 217,213	$ 267,482
Adjustments to reconcile net income to cash provided by operating activities		340,721	346,659	252,168
Changes in assets and liabilities		24,574	(7,573)	8,734
Net cash provided by operating activities		561,072	556,299	528,384
Investing activities
Additions to theatre properties and equipment		(303,627)	(346,073)	(380,862)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		(10,170)	(11,289)	(40,997)
Proceeds from sale of theatre properties and equipment and other		3,155	3,920	15,098
Proceeds from intercompany note repayments			0
Dividends received from subsidiaries		0		0
Investment in joint ventures and other			(19,535)	(3,715)
Net cash used for investing activities		(310,642)	(451,370)	(410,476)
Financing activities
Dividends paid to parent		(158,450)	(148,750)	(134,500)
Repayments of long-term debt		(7,984)	(7,984)	(5,671)
Payment of debt issue costs			(5,218)	(1,146)
Payments on finance and capital leases		(14,600)	(25,353)	(21,725)
Payments on intercompany loans			0
Fees paid related to debt amendments			(704)	(521)
Proceeds from financing lease				10,200
Other		(4,641)	(4,601)	(5,212)
Net cash used for financing activities		(185,675)	(191,906)	(157,429)
Effect of exchange rate changes on cash and cash equivalents		(2,756)	(9,222)	798
Increase (decrease) in cash and cash equivalents		61,999	(96,199)	(38,723)
Cash and cash equivalents:
Beginning of period		426,216	522,415	561,138
End of period		488,215	426,216	522,415
Eliminations
Operating activities
Net income		(153,700)	(164,827)	(270,189)
Adjustments to reconcile net income to cash provided by operating activities		153,700	164,827	270,189
Changes in assets and liabilities		0	0	0
Net cash provided by operating activities		0	0	0
Investing activities
Additions to theatre properties and equipment		0	0	0
Acquisition of theatres in the U.S. and international markets, net of cash acquired		0	0	0
Proceeds from sale of theatre properties and equipment and other		0	0	0
Proceeds from intercompany note repayments			(1,867)
Dividends received from subsidiaries		(5,868)		(129,473)
Investment in joint ventures and other			0	0
Net cash used for investing activities		(5,868)	(1,867)	(129,473)
Financing activities
Dividends paid to parent		5,868	0	129,473
Repayments of long-term debt		0	0	0
Payment of debt issue costs			0
Payments on finance and capital leases		0	0	0
Payments on intercompany loans			1,867
Fees paid related to debt amendments				0
Proceeds from financing lease				0
Other		0	0	0
Net cash used for financing activities		5,868	1,867	129,473
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Increase (decrease) in cash and cash equivalents		0	0	0
Cash and cash equivalents:
Beginning of period		0	0	0
End of period		0	0	0
NCM
Investing activities
Acquisition of NCM common units	$ (78,393)		(78,393)
NCM | Eliminations
Investing activities
Acquisition of NCM common units			0
Cinemark USA, Inc.
Operating activities
Net income		193,315	215,735	265,643
Adjustments to reconcile net income to cash provided by operating activities		(57,371)	(36,894)	(122,559)
Changes in assets and liabilities		135,883	229,326	18,223
Net cash provided by operating activities		271,827	408,167	161,307
Investing activities
Additions to theatre properties and equipment		(107,955)	(91,244)	(146,385)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		(10,170)	0	(12,500)
Proceeds from sale of theatre properties and equipment and other		1,687	1,244	2,149
Proceeds from intercompany note repayments			1,867
Dividends received from subsidiaries		1,345		127,600
Investment in joint ventures and other			0	0
Net cash used for investing activities		(115,093)	(166,526)	(29,136)
Financing activities
Dividends paid to parent		(158,450)	(148,750)	(134,500)
Repayments of long-term debt		(6,595)	(7,984)	(4,282)
Payment of debt issue costs			(5,218)
Payments on finance and capital leases		(10,492)	(11,610)	(7,952)
Payments on intercompany loans			0
Fees paid related to debt amendments				(521)
Proceeds from financing lease				0
Other		0	(704)	(1,181)
Net cash used for financing activities		(175,537)	(174,266)	(148,436)
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Increase (decrease) in cash and cash equivalents		(18,803)	67,375	(16,265)
Cash and cash equivalents:
Beginning of period		197,965	130,590	146,855
End of period		179,162	197,965	130,590
Cinemark USA, Inc. | NCM
Investing activities
Acquisition of NCM common units			(78,393)
Subsidiary Guarantors
Operating activities
Net income		87,046	103,483	151,999
Adjustments to reconcile net income to cash provided by operating activities		159,150	162,811	71,023
Changes in assets and liabilities		(128,525)	(233,263)	(35,138)
Net cash provided by operating activities		117,671	33,031	187,884
Investing activities
Additions to theatre properties and equipment		(121,434)	(173,042)	(172,874)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		0	0	0
Proceeds from sale of theatre properties and equipment and other		1,154	2,025	12,271
Proceeds from intercompany note repayments			0
Dividends received from subsidiaries		4,523		1,873
Investment in joint ventures and other			(19,896)	(104)
Net cash used for investing activities		(115,757)	(190,913)	(158,834)
Financing activities
Dividends paid to parent		(745)	0	(127,000)
Repayments of long-term debt		0	0	0
Payment of debt issue costs			0
Payments on finance and capital leases		(4,043)	(8,950)	(9,707)
Payments on intercompany loans			0
Fees paid related to debt amendments				0
Proceeds from financing lease				10,200
Other		(2,308)	(2,905)	(2,943)
Net cash used for financing activities		(7,096)	(11,855)	(129,450)
Effect of exchange rate changes on cash and cash equivalents		0	0	0
Increase (decrease) in cash and cash equivalents		(5,182)	(169,737)	(100,400)
Cash and cash equivalents:
Beginning of period		10,886	180,623	281,023
End of period		5,704	10,886	180,623
Subsidiary Guarantors | NCM
Investing activities
Acquisition of NCM common units			0
Subsidiary Non-Guarantors
Operating activities
Net income		69,116	62,822	120,029
Adjustments to reconcile net income to cash provided by operating activities		85,242	55,915	33,515
Changes in assets and liabilities		17,216	(3,636)	25,649
Net cash provided by operating activities		171,574	115,101	179,193
Investing activities
Additions to theatre properties and equipment		(74,238)	(81,787)	(61,603)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		0	(11,289)	(28,497)
Proceeds from sale of theatre properties and equipment and other		314	651	678
Proceeds from intercompany note repayments			0
Dividends received from subsidiaries		0		0
Investment in joint ventures and other			361	(3,611)
Net cash used for investing activities		(73,924)	(92,064)	(93,033)
Financing activities
Dividends paid to parent		(5,123)	0	(2,473)
Repayments of long-term debt		(1,389)	0	(1,389)
Payment of debt issue costs			0
Payments on finance and capital leases		(65)	(4,793)	(4,066)
Payments on intercompany loans			(1,867)
Fees paid related to debt amendments				0
Proceeds from financing lease				0
Other		(2,333)	(992)	(1,088)
Net cash used for financing activities		(8,910)	(7,652)	(9,016)
Effect of exchange rate changes on cash and cash equivalents		(2,756)	(9,222)	798
Increase (decrease) in cash and cash equivalents		85,984	6,163	77,942
Cash and cash equivalents:
Beginning of period		217,365	211,202	133,260
End of period		$ 303,349	217,365	$ 211,202
Subsidiary Non-Guarantors | NCM
Investing activities
Acquisition of NCM common units			$ 0

Supplemental Schedules - Conden

Supplemental Schedules - Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Thousands		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents		$ 488,215	$ 426,216
Other current assets		170,996
Total current assets		659,211	578,543
Theatre properties and equipment, net		1,735,247	1,833,133
Operating lease right-of-use assets	[1]	1,383,080
Other assets		2,074,700	2,089,675
Total assets		5,852,238	4,501,351
Current liabilities
Current portion of long-term debt		6,595	7,984
Current portion of operating lease obligations	[1]	217,406
Current portion of finance lease obligations	[1]	15,432
Accounts payable and accrued expenses		468,738	439,004
Total current liabilities		708,171	474,053
Long-term liabilities
Long-term debt, less current portion		1,771,342	1,772,627
Operating lease obligations, less current portion	[1]	1,223,462
Finance lease obligations, less current portion	[1]	141,017
Other long-term liabilities and deferrals		534,039	592,568
Total long-term liabilities		3,669,860	2,597,662
Commitments and contingencies
Equity		1,474,207	1,429,636	$ 1,421,495	$ 1,284,080
Total liabilities and equity		5,852,238	$ 4,501,351
Restricted Subsidiaries
Current assets
Cash and cash equivalents		364,218
Other current assets		296,608
Total current assets		660,826
Theatre properties and equipment, net		1,735,247
Operating lease right-of-use assets		1,383,080
Other assets		1,905,837
Total assets		5,684,990
Current liabilities
Current portion of long-term debt		6,595
Current portion of operating lease obligations		217,406
Current portion of finance lease obligations		15,432
Accounts payable and accrued expenses		473,140
Total current liabilities		712,573
Long-term liabilities
Long-term debt, less current portion		2,018,542
Operating lease obligations, less current portion		1,223,462
Finance lease obligations, less current portion		141,017
Other long-term liabilities and deferrals		475,112
Total long-term liabilities		3,858,133
Commitments and contingencies
Equity		1,114,284
Total liabilities and equity		5,684,990
Unrestricted Subsidiaries
Current assets
Cash and cash equivalents		123,997
Other current assets		(121,210)
Total current assets		2,787
Other assets		523,082
Total assets		525,869
Long-term liabilities
Other long-term liabilities and deferrals		58,927
Total long-term liabilities		58,927
Commitments and contingencies
Equity		466,942
Total liabilities and equity		525,869
Eliminations
Current assets
Other current assets		(4,402)
Total current assets		(4,402)
Other assets		(354,219)
Total assets		(358,621)
Current liabilities
Accounts payable and accrued expenses		(4,402)
Total current liabilities		(4,402)
Long-term liabilities
Long-term debt, less current portion		(247,200)
Total long-term liabilities		(247,200)
Commitments and contingencies
Equity		(107,019)
Total liabilities and equity		$ (358,621)
[1]	The operating lease right-of-use assets and liabilities recorded on the Company’s consolidated balance sheet generally do not include renewal options that have not yet been exercised.  The Company does not consider a lease renewal as reasonably certain until immediately before the necessary notification is provided to the landlord.

Supplemental Schedules - Cond_2

Supplemental Schedules - Condensed Consolidating Statement of Income (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Condensed Financial Statements, Captions [Line Items]
Revenues		$ 3,283,099	$ 3,221,735	$ 2,991,547
Cost of operations
Theatre operating costs		2,441,164	2,335,975	2,170,578
General and administrative expenses		170,828	162,640	150,911
Depreciation and amortization	[1]	261,155	261,162	237,513
Impairment of long-lived assets		57,001	32,372	15,084
Loss on disposal of assets and other		12,008	38,702	22,812
Total cost of operations		2,942,156	2,830,851	2,596,898
Operating income		340,943	390,884	394,649
Other income (expense)		(64,646)	(77,639)	(46,911)
Income before income taxes		276,297	313,245	347,738
Income taxes		80,520	96,032	80,256
Net income		195,777	217,213	267,482
Less: Net income attributable to noncontrolling interests		2,462	1,478	1,839
Net income attributable to Cinemark USA, Inc.		193,315	$ 215,735	$ 265,643
Restricted Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Revenues		3,283,099
Cost of operations
Theatre operating costs		2,441,164
General and administrative expenses		170,819
Depreciation and amortization		261,155
Impairment of long-lived assets		57,001
Loss on disposal of assets and other		12,008
Total cost of operations		2,942,147
Operating income		340,952
Other income (expense)		(140,932)
Income before income taxes		200,020
Income taxes		61,372
Net income		138,648
Less: Net income attributable to noncontrolling interests		2,462
Net income attributable to Cinemark USA, Inc.		136,186
Unrestricted
Cost of operations
General and administrative expenses		9
Total cost of operations		9
Operating income		(9)
Other income (expense)		76,286
Income before income taxes		76,277
Income taxes		19,148
Net income		57,129
Net income attributable to Cinemark USA, Inc.		$ 57,129
[1]	Amounts for the year ended December 31, 2019 were impacted by the adoption of ASC Topic 842 and the resulting change in the classification of certain of the Company’s leases.  See Note 3 for further discussion.

Supplemental Schedules - Cond_3

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Net income	$ 195,777	$ 217,213	$ 267,482
Other comprehensive income (loss), net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	(8,210)	(3,851)	0
Other comprehensive loss in equity method investments	(142)	(139)	248
Foreign currency translation adjustments	(12,753)	(62,253)	(4,966)
Total other comprehensive loss, net of tax	(21,105)	(66,243)	(4,718)
Total comprehensive income, net of tax	174,672	150,970	262,764
Comprehensive income attributable to noncontrolling interests	(2,462)	(1,478)	(1,839)
Comprehensive income attributable to Cinemark USA, Inc.	172,210	$ 149,492	$ 260,925
Restricted Subsidiaries
Net income	138,648
Other comprehensive income (loss), net of tax
Unrealized loss due to fair value adjustments on interest rate swap agreements, net of taxes of $0, $1,243 and $2,692, net of settlements	(8,210)
Foreign currency translation adjustments	(12,753)
Total other comprehensive loss, net of tax	(20,963)
Total comprehensive income, net of tax	117,685
Comprehensive income attributable to noncontrolling interests	(2,462)
Comprehensive income attributable to Cinemark USA, Inc.	115,223
Unrestricted Subsidiaries
Net income	57,129
Other comprehensive income (loss), net of tax
Other comprehensive loss in equity method investments	(142)
Total other comprehensive loss, net of tax	(142)
Total comprehensive income, net of tax	56,987
Comprehensive income attributable to Cinemark USA, Inc.	$ 56,987

Supplemental Schedules - Cond_4

Supplemental Schedules - Condensed Consolidating of Comprehensive Income (Parenthetical) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2019USD ($)
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
Unrealized gain due to fair value adjustments on interest rate swap agreements, taxes	$ 2,692

Supplemental Schedules - Cond_5

Supplemental Schedules - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Operating activities
Net income	$ 195,777	$ 217,213	$ 267,482
Adjustments to reconcile net income to cash provided by operating activities	340,721	346,659	252,168
Changes in assets and liabilities	24,574	(7,573)	8,734
Net cash provided by operating activities	561,072	556,299	528,384
Investing activities
Additions to theatre properties and equipment and other	(303,627)	(346,073)	(380,862)
Acquisition of theatres in the U.S. and international markets, net of cash acquired	(10,170)	(11,289)	(40,997)
Proceeds from sale of theatre properties and equipment and other	3,155	3,920	15,098
Net cash used for investing activities	(310,642)	(451,370)	(410,476)
Financing activities
Dividends paid to parent	(158,450)	(148,750)	(134,500)
Repayments on long-term debt	(7,984)	(7,984)	(5,671)
Payments on finance leases	(14,600)
Other	(4,641)	(4,601)	(5,212)
Net cash used for financing activities	(185,675)	(191,906)	(157,429)
Effect of exchange rate changes on cash and cash equivalents	(2,756)	(9,222)	798
Increase (decrease) in cash and cash equivalents	61,999	(96,199)	(38,723)
Cash and cash equivalents:
Beginning of period	426,216	522,415	561,138
End of period	488,215	426,216	$ 522,415
Restricted Subsidiaries
Operating activities
Net income	138,648
Adjustments to reconcile net income to cash provided by operating activities	336,220
Changes in assets and liabilities	11,074
Net cash provided by operating activities	485,942
Investing activities
Additions to theatre properties and equipment and other	(303,627)
Acquisition of theatres in the U.S. and international markets, net of cash acquired	(10,170)
Proceeds from sale of theatre properties and equipment and other	3,155
Net cash used for investing activities	(310,642)
Financing activities
Dividends paid to parent	(158,450)
Borrowings from parent/subsidiary	5,500
Repayments on long-term debt	(6,595)
Payments on finance leases	(14,600)
Other	(4,641)
Net cash used for financing activities	(178,786)
Effect of exchange rate changes on cash and cash equivalents	(2,756)
Increase (decrease) in cash and cash equivalents	(6,242)
Cash and cash equivalents:
Beginning of period	370,460
End of period	364,218	370,460
Unrestricted Subsidiaries
Operating activities
Net income	57,129
Adjustments to reconcile net income to cash provided by operating activities	4,501
Changes in assets and liabilities	13,500
Net cash provided by operating activities	75,130
Investing activities
Loans to parent/subsidiaries	(5,500)
Net cash used for investing activities	(5,500)
Financing activities
Repayments on long-term debt	(1,389)
Net cash used for financing activities	(1,389)
Increase (decrease) in cash and cash equivalents	68,241
Cash and cash equivalents:
Beginning of period	55,756
End of period	123,997	$ 55,756
Eliminations
Investing activities
Loans to parent/subsidiaries	5,500
Net cash used for investing activities	5,500
Financing activities
Borrowings from parent/subsidiary	(5,500)
Net cash used for financing activities	$ (5,500)